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INTRODUCTION
Total hip arthroplasty (THA) is one of the most successful and cost effective operations 
in medicine. It has even been called the operation of the 20th century.1 Throughout the 
world large numbers of THA are performed annually. In the UK and the USA together 
over 500.000 THA procedures are performed every year.2 In the Netherlands, according 
to the Dutch Arthroplasty Registry (LROI), around 28.000 THA were implanted in 2015.3 
Approximately 93% of operations are performed for severe osteoarthritis with intractable 
pain and functional limitations.4 For those patients not responding to conservative 
measurements, THA is an effective treatment. The survival outcomes in patients over 65 
years can be considered excellent.5-7 Patients regain their mobility and their health status 
improves as result of a decrease in pain and increase in quality of life4, 8, 9. The improvements 
made in THA over the years have led to high expectations by patients and strict survival 
criteria as described for example in the criteria of the National institute for Health and 
Care Excellence (NICE) and the Orthopaedic Data Evaluation Panel (ODEP) ratings.10, 11 
Nowadays the long term survival rate of the prosthesis in older patients is expected to be 
95% or more after ten years of follow-up. Due to the success of THA in older patients over 
the past few years, THA are currently offered to younger patients in increasing numbers. 
These younger patients can suffer from primary end-stage osteoarthritis, however, end-
stage secondary osteoarthritis is a more common diagnosis. In the Netherlands, common 
causes of end-stage secondary osteoarthritis in patients receiving a THA at an age of 
under 50 are for example developmental dysplasia of the hip (DDH), osteonecrosis of 
the femoral head, rheumatoid arthritis and post-Perthes’ disease.3 Literature shows 
comparable early results of THA in patients younger than 50 compared to older 
patients. This is in contrast to the long-term results which still are inferior in young 
patients.3, 5-7, 12-20 This less successful survival and the fact that many young patients will 
outlive their primary total hip implant due to their longer life expectancy both contribute 
to inevitably higher numbers of revision procedures in these younger patients21.Therefore 
these young patients must be treated with specific attention. We must focus on techniques 
and materials that can guarantee durable solutions in order to facilitate inevitable future 
revisions. It is imperative that patients need to be informed on their long-term expected 
survival, their chances on facing future revisions and the expected outcome of these 
revisions.22-26
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This thesis focuses on THA in this specific category of patients who are younger than 
50 years at the moment of their primary THA implantation. It is aimed at investigating 
the long-term results of the cemented THA, the importance and technique of subsequent 
revisions in young patients and improving the survival and possibilities to revise by using 
a biological approach during the primary THA.
THE HISTORY OF CEMENTED THA
Sir John Charnley introduced the concept of a cemented THA as early as 1959 and used 
polymethylmethacrylate bone cement to fill the gaps between the implant and bone in 
order to create stability of the prosthesis.27 This was a few decades after the introduction 
of the total hip arthroplasty in 1923, when Smith-Petersen performed his first trial of 
a hip replacement using a glass cup between the femoral head and the acetabulum.28 
The concept of cemented fixation in orthopedic implants came from Haoush who used 
dental cement for prosthetic fixation.29, 30 Unfortunately, the results were not successful. 
In retrospect, his unsuccessful results were known to be caused by the designs of his used 
implants. Charnley introduced a new design and replaced the polytetrafluorethylene 
initially used for the acetabular cup by polyethylene in 1963, because of a high wear 
rate of the polytetrafluorethylene. This concept is still the base for many new cemented 
designs that have been developed throughout the last decades.
Cementing technique
The developments in the technique of cementing have been well described by Breusch 
and Malchau.31 The first generation cementing techniques already emphasized the 
importance of pressurizing the cement into the bone in an attempt to create an adequate 
cement pressure. This was done by means of ‘thumbing’ down the cement from proximal 
to distal in the femur, the so called ‘finger-packing’ technique. The cement mixing 
technique consisted of hand mixing the two components in an open bowl. The cement 
was stuffed into the femoral canal and in the prepared acetabulum by hand. The second 
generation cementing technique included the use of a distal intramedullary cement 
restrictor, which allowed for cement containment and better pressurization. The cement 
gun added the possibility to fill the femoral canal in a retrograde manner, to create higher 
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cement pressure distally than proximally. By introducing pressurization a method was 
found to overcome blood pressure and consequently blood entrapment into the cement-
bone interface was prevented which improved the results of cemented THA.32 Bone 
lavage prior to cementation was introduced after the observation that it aided the cement 
penetration into the bone. New concepts were pulsatile lavage, stem centralizing devices 
and vacuum mixing of the cement, which have shown to reduce the long-term revision 
risk. The procedure that includes all these steps is called the third generation cementing 
technique (Table I). Figure 1 illustrates some differences between the first and third 
cementing technique that can be seen on a anteroposterior radiograph of the hip. Long-
term result studies reporting on the outcome in younger patients often include the first 
and second generation cementing techniques.33, 34 This demands for careful evaluation of 
long-term results when comparing different types of fixation techniques, as the results of 
the cemented prosthesis have greatly improved with the abovementioned developments.
TABLE I. 
Description of the different generation cementing techniques
Evolution of cementing techniques
First Generation Second Generation Third Generation
Limited bone-bed preparation Bone-bed preparation (bulb syringe irrigation/drying)
Pulsatile lavage for thorough bone-
bed preparation
Unplugged femur Distal femur cement restrictor Improved distal cement restrictor
Stiff cement and ‘finger packing 
technique’
Retrograde cement application with 
cement gun
Retrograde cement application via 
cement gun
Digital pressurization Femoral and acetabular cement pressurization
Femoral pressurizer and acetabular 
pressurizer
Hand mixing of cement Open atmosphere cement mixing by hand
Vacuum mixing, stem centralizer, 
cement spacers
Prosthesis 
Unfortunately, when surgeons started using cemented THA in patients under the age of 
50, the results were less favourable compared to older patients. Furthermore, a critical 
paper of Hungerford et al. caused suspicion regarding the use of cemented THA in 
1988.35, 36 Problems such as loosening of the prosthesis and osteolysis were thought to 
be caused by the use of cement. In retrospect, these problems were not caused by the 
cement but by the polyethylene particles generated by wear of the cup which indirectly 
caused loss of bone around the prosthesis and finally to failure of the prosthesis. Professor 
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William Harris introduced the term ‘particle disease’ to stress the importance of particles 
generated by a prosthesis for induction of host response. 
FIGURE 1.
Cementing techniques in total hip arthroplasty
1a: example of a well cemented THA, third generation cementing technique. 1b: example of an 
insufficient cementing technique.
This process starts with very small (micrometers and less in size) polyethylene particles 
accumulating in the joint cavity due to friction of the metal head against the polyethylene 
during movement.37,38 These particles stimulate periprosthetic cells to express pro-
inflammatory and pro-osteoclastic cytokines leading to increased activity and survival of 
osteoclasts and inhibiting the osteogenic activity of osteoblasts. As a result, osteoresorption 
predominates over osteogenesis, eventually leading to macroscopic bone defects around 
the implant.
This periprosthetic osteolysis often precedes aseptic loosening and unfortunately is 
asymptomatic for a long time. Later, the same problems were also seen in noncemented 
THA, as the problems caused by wear for both fixations were comparable. However, 
correctly or not, the thesis that cement was responsible for these problems was the start 
A B
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of a shift towards the increased use of noncemented designs and the use of alternate 
bearings, initially in younger patients.37
As mentioned before, noncemented fixation techniques show osteolysis as well, 
indicating that it was not the cement that caused the described problems but especially 
the polyethylene wear.39 Now the polyethylene was seen as the cause of osteolysis, and 
new types of polyethylene such as highly cross-linked and Vitamin E polyethylene 
were introduced.40-42 In addition, other bearing types were introduced, for example the 
ceramics-on-ceramics and the metal-on-metal bearings. However, the outcomes in young 
patients remained less favorable compared to older patients. In 1996, as an auspicious 
solution the resurfacing prosthesis was introduced for these younger patients.43, 44 This 
type of prosthesis was not a completely new concept since several different types of 
resurfacing hip prostheses had already been developed and introduced on the market 
in the 1970’s. But the materials used back in those days were very sensitive to wear, 
especially because a large metal head and a large early type of polyethylene cup were 
used. This resulted in polyethylene debris, which caused extensive osteolysis. At that 
time the osteolysis was not recognized as the cause of failure and problems were for 
example attributed to avascular necrosis of the underlying bone of the femoral head. The 
newly designed resurfacing implants were based on a large metal head and a large metal 
cup; this resulted in a metal-on-metal articulation. Initially these new implants were 
successful, and they were immediately produced by many different manufacturers and 
implanted by many orthopedic surgeons all over the world. However, large differences 
in the 5-year survival rates between all these different implants were shown in literature 
and questions were subsequently raised on the safety of these type of implants.45 At 
the same time more knowledge was gained on the metal-on-metal articulations in 
THA.46,47 Especially the articulations using a large metal head, used widely in young 
patients, showed the same problems and complications as the older types of resurfacing 
prosthesis e.g. neck fractures and osteolysis. In addition another new problem was seen, 
even in well functioning prostheses: high metal serum concentrations, which could even 
reach toxic levels and were a sign of high wear of the prosthesis, leading to revisions in 
some cases. Intra-operative pseudo tumors could be found, which were formed by soft 
tissue reacting to the metal ions. In addition, the trend to use large metal heads on a 
standardized femoral component, an articulation comparable to the resurfacing THA 
and very attractive to prevent dislocations, led to a new problem again: coupling of the 
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large metal head on the small taper of the stem resulted in a second source of metal debris 
(truniosis).48 In the mean time the survival of cemented THA in young patients, using 
modern cementation techniques, improved.49, 50 These good results and the unexpected 
problems seen in metal-on-metal articulations led to the question how young patients 
with end-stage osteoarthritis should be treated. This yielded to an interesting discussion 
once again. Regarding the femoral stems, currently almost no difference in survival is seen 
between cemented and noncemented components. However the acetabular component is 
still the weakest link in the THA in younger patients.17, 19, 51-56 So far no consensus exists on 
the use of either a cemented or a noncemented prosthesis in younger patients. Therefore 
the aim of the research described in this thesis is to investigate if a cemented THA is a 
reliable long-term solution in younger patients with end-stage osteoarthritis
BONE STOCK DEFICIENCY
Another very important issue in THA is loss of bone stock and how to address it. In both 
primary and revision hip surgery this can be a technical challenge. Especially in younger 
patients who often suffer from secondary osteoarthritis as a result of underlying diseases, 
e.g. developmental dysplasia of the hip, osteonecrosis, trauma or juvenile rheumatoid 
arthritis, an associated loss of the acetabular bone stock is often seen. Bone loss on the 
acetabular side will harm the outcome of the acetabular component, both in cemented 
and noncemented cups. In young patients it is important to not simply use more metal to 
augment or compensate for the bone loss, but to use a biological solution. Young patients 
will often outlive their THA due to a longer life expectancy and they will need good bone 
stock in case of (re)-revision. Loosening of an implant, primary or revision, will definitely 
lead to bone stock loss and any technique to prevent bone stock loss at the primary or 
revision surgery seems to be the most attractive solution. 
When performing THA surgery, initial stable socket fixation, restoring the center of 
rotation and optimizing contact between host bone and cement and also the implant 
are the important factors to create a long-term stable fixation. This can be achieved by 
reconstructing any bone stock loss in a biological way at the time of primary THA.57 
It is important to study the anteroposterior pelvic and cross table lateral radiographs 
of the hip to determine any amount and the location of existing osteolysis. CT scans can 
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be performed in order to determine the exact amount and location of bone loss even 
more accurately, especially on the acetabular side. Defects can be classified according to 
the system of the American Academy of Orthopaedic Surgeons Committee of the Hip 
(AAOS) as can be seen in table II and figure 2.58
TABLE II.
The classifications system of acetabular bone defects according 
to the American Academy of Orthopaedic Surgeons.
Type I Segmental defect
Type II Cavitary defect
Type III Combined defect
Type IV Pelvic discontinuity
Type V Arthrodesis
FIGURE 2.
This image shows different types of acetabular bone defects, illustrating the difference between 
a segmental and a cavitary defect. 
There are many options to address bone stock loss in revision surgery, but they do not 
always include reconstruction of the bone stock itself. Jumbocups or large hemispherical 
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cups are commonly used in order to fill these defects, without actually restoring bone 
stock.59 This results in an even more technically difficult situation when facing further 
revisions of these prostheses as bone stock is initially not restored and defects often become 
even more extensive. Acceptable survival results have been published but knowledge 
lacks on the revisability of these cups when they fail.60-62 Bilobed implants, eccentric or 
oblong acetabular implants have been designed to achieve an increased prosthesis-bone 
contact in case of acetabular defects and restore the anatomical hip centre of rotation 
but results are not all that favorable and again bone stock is not restored.63-65 The use 
of antiprotrusio cages has been diminished over the last years as more contemporary 
technologies have become available, however often the outcome was very acceptable.66, 67 
More recently custom made implants were introduced to treat extremely large defects.68 
No long-term results of these implants are known yet.
Techniques that have emphasized reconstructing bone loss are impaction bone grafting 
(IBG) using autograft, allograft or mixes and of course structural allografts. Structural 
allografts have shown acceptable long-term results in AAOS type III defects.69 Trabecular 
metal acetabular implants have a potential to provide a better environment for biologic 
fixation when limited host bone is available. Multiple sizes and shapes of these acetabular 
augments can be used for various sizes of acetabular defects. The use of such a modular 
system allows biological fixation rather than mechanical fixation and can avoid the use of 
structural allografts. In case of a massive uncontained or contained defect, a trabecular 
metal cup-cage construct can be used. Short-term clinical and radiographic results are 
promising, but long-term durability is not yet known.70 Other potential complications 
include the potential for debris generation, fatigue failure and no restoration of bone 
stock for future revisions. 
IBG for the acetabulum was developed by Slooff in our institution in 1979 and was 
based on the concept of Hastings and Parker who reconstructed contained acetabular 
defects in hips with protrusio acetabuli with the use of noncompacted small particle bone 
grafts.71 McCollum et al adapted this technique using wafers of bone.72 Slooff became 
inspired by these techniques that used non-compressed chips or wafers of bone. The 
disadvantage of these techniques however was the limited contact between the cement and 
the bone grafts due to gelfoam strips which were placed around the periphery of the graft 
to prevent interposition of cement between it and the articular surface. Slooff recognized 
that due to this gelsheet between the graft and the cement no penetration of the cement 
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into the graft could occur. To improve stability Slooff decided to apply impaction of the 
bone grafts with a trial socket prosthesis. At time of the initial surgeries a metal mesh was 
placed on top of the impacted bone graft to prevent extensive cement-graft penetration, 
as it was thought that the cement could be harmful for the incorporation of the bone 
graft. In case of a segmental bone defect of the medial wall, a medial wall mesh was used 
to close this bone defect. The bone graft was impacted on top of this mesh and a second 
mesh was placed on top of the graft. The bone graft was impacted with an acetabular 
trial prostheses and the final cup was chosen one size smaller than the last trial cup used 
for impaction to allow for a 2 mm cement layer all around the new cup. Histological 
studies in a goat model showed that the bone grafts did incorporate well, despite the fact 
that they were in contact with the cement.73 To prove the concept, biopsies were taken 
at any revision surgery in patients in whom a primary or revision cemented THA with 
impaction grafting had been performed earlier. The results in the first published series 
showed completely incorporated grafts at 28 months.74 In a follow-up study of 24 biopsies, 
in 21 hips good results and incorporation was shown up to 15 years postoperatively.75 The 
process of incorporation of these bone grafts was also studied by Heekin et al.76 Post-
mortem analysis showed revascularised and gradually incorporated grafts.
Some principles of the IBG technique have proven to be essential in order to achieve 
success. Smaller chips (2-4mm) are not recommended for the acetabular revisions, large 
bone chips (8-12 mm) produce better cup stability.77 In addition, impaction should not 
be performed by compressing the bone grafts with the reversed reamer technique as this 
leads to inferior cup stability.78 The use of a metal mallet is highly recommended. The 
success of this technique has also been described in younger patients.79
IBG has proven to be a successful technique in primary and revision surgery in the 
presence of an acetabular bone stock defect.79-82 This led to the introduction in primary 
THA in young patients of a cemented THA in combination with IBG in absence of a bone 
stock defect as it can improve bone cement interdigitation and thereby improve the cup 
survival. This new development will be addressed in this thesis.
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FIGURE 3.
Acetabular impaction bone grafting in hips without acetabular bone defects
a) no acetabular bone defects are seen and no mesh is used. b) The femoral head was morselized 
with a rongeur to provide cancellous bone chips with a diameter of 0.7-1.0 centimeters. In case 
the femoral head was affected and sclerotic, a femoral head allograft from the bone bank was 
obtained. c) With a metal impacter, the bone chips are compressed tightly. d) Bone cement is 
introduced in a relatively viscous state and is pressurized to force bone cement into the graft 
before placement of the cup.
OUTLINE OF THIS THESIS
At Radboudumc patients have always received a cemented THA. In case of a bone stock 
deficiency IBG was added. Therefore the primary objective of this thesis is to evaluate the 
longterm results of cemented THA. For this purpose the clinical and radiographic results 
of cemented THA with or without IBG will be investigated. Furthermore, the objective 
is to investigate if IBG may improve the results of cemented THA in young patients in 
absence of an acetabular bonestock defect. Finally it will be investigated what amount 
of reliable information is available regarding long-term arthroplasty survival of primary 
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THA that includes the outcome of subsequent revision arthroplasty as well. 
At the start of this thesis the resurfacing hip prosthesis is being used in increasing 
numbers in young patients. Although these types of prosthesis have never been used at 
Radboudumc, this thesis will start with presenting a state-of-the-art of this frequently 
used type of prosthesis in young patients. 
Questions addressed in this thesis:
1. Resurfacing hip arthroplasty in younger patients: what is the state-of-the-art and 
what should we advise patients under 55 years of age?
2. What is the long-term outcome of a cemented total hip arthroplasty in patients 
under 30 years, and what is the outcome of subsequent revisions in this group of 
patients?
3. Can the cemented highly polished Exeter stem be used as a long-term solution in 
patients under 40 years old?
4. What are the 30-year radiographic and clinical outcomes of primary and revision 
acetabular reconstructions with impaction bone grafting in patients less than 50 
years old?
5. What is the clinical and radiographical outcome of the Contemporary acetabular 
component in patients under 50 years old, with and without IBG?
6. What is known of both the survival data of primary THA and the survival of the 
subsequent revisions within the same cohorts of patients under 50 years of age?
7. Can we safely use impaction bone grafting in patients without an acetabular 
defect in order to improve future long-term outcome?
Chapter 2 presents the state of the art of THA in young patients at the time of publication 
in 2011 to inform patients and colleagues of other specialties such as general practitioners 
on the developments, survival and complications of resurfacing arthroplasty. It includes 
a literature review on the long-term survival results of the resurfacing prosthesis and, 
in addition, it summarizes the knowledge on complications and drawback alerts which 
received a lot of media attention at that time. 
In the very young patients under 30 years of age, literature on long-term results 
of THA is scarce. The long-term results of a cemented THA in patients under 30 are 
presented in Chapter 3. Additionally the survival outcome of the subsequent revisions in 
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the same cohort of patients is investigated and described. 
In Chapter 4 the focus is specifically on the stem survival. From 1998 onwards only 
the Exeter stem (Stryker-Howmedica, Newbury, UK) has been used in our institute. 
No long-term evidence for the use of the Exeter stem in young patients under 40 years 
is known and we aimed to investigate whether the long-term results can support our 
consistent use of this cemented femoral component in younger patients. The clinical and 
radiographic outcome at minimum ten year follow-up are described. Special attention 
has been given to radiographic analysis to check for alarming signs as the early indication 
of aseptic loosening and subsequently as proof for safe use of this femoral component in 
this age group.
In Chapter 5 we evaluate the 30-year radiographic and survival results of primary 
and revision acetabular reconstructions with the use of IBG as developed by Slooff in the 
Radboudumc in patients under 50.
Chapter 6 describes the clinical and radiographical outcome of the Contemporary 
acetabular component in patients under 50, both with and without IBG. 
A next step in research regarding THA and revision arthroplasty would be to combine 
the results of primary and revision arthroplasties in a cohort of young patients, because 
the revisability is very important for young patients. In Chapter 7 a systemic literature 
is performed in order to describe what is known on the combined outcome of both the 
survival data of primary THA as well as the survival of subsequent revisions in the same 
cohorts of young patients under 50. 
In Chapter 8 the next step, ‘Can IBG safely be used in patients without any bone stock 
defects’ in younger patients using a cemented THA and IBG is described. Can this new 
technique safely be used in patients without any bone stock defects in order to be one step 
ahead and improve the bone-cement interdigitation without any early complications? 
This is the first step to evaluate if this concept might improve bone stock at time of 
revisions as well, as the aim is to improve the long-term results of revision arthroplasty in 
younger patients as well. 
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ABSTRACT
Hip resurfacing arthroplasty was introduced as an alternative to the conventional 
total hip arthroplasty which had shown suboptimal results in younger patients. 
Application of the resurfacing technique in younger patients has increased over the 
last few years. To date, no randomized controlled trials with a minimum follow-
up span of 10 years comparing hip resurfacing to conventional hip replacement 
have been conducted in patients under 55 years of age. Australian and English hip 
registries demonstrate high revision rates after 5 years for some brands of resurfacing 
implants. In addition to these disappointing revision rates, the complication of aseptic 
lymphocytic vasculitis caused by metal particles evoking a local tissue reaction 
has been increasingly reported. The resurfacing procedure recently received some 
negative media attention in the Netherlands, leading to confusion among patients. 
In order to ease patient doubts, it is important to correctly inform them as to the 
type of implant used, for example, by means of the website or an information card.
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In 2007 gaven wij in dit tijdschrift een overzicht van de beschikbare opties voor een 
heupprothese bij een jonge patiënt.1 Bij patiënten onder de 50 jaar werden destijds naast 
de gecementeerde en ongecementeerde conventionele totaleheupprothesen (THP), 
in toenemende mate ‘resurfacing’ prothesen gebruikt. Dit zijn heupprothesen die de 
kraakbeenoppervlakken vervangen, maar het oorspronkelijke bot zoveel mogelijk intact 
laten (figuur 1). Ter vergelijking zijn in figuur 2 de onderdelen van een conventionele 
totaleheupprothese weergegeven.
FIGUUR 1.
(a) Afbeelding van een ‘resurfacing’ prothese met een grote kopdiameter; (b) röntgenopname na 
plaatsing van deze resurfacing prothese (eerder gepubliceerde figuur).1
De resultaten op de korte termijn waren gunstig. Bij grote belasting ontstaan echter 
metaalpartikels ten gevolge van slijtage van deze metaal-op-metaalprothesen. Het 
was onduidelijk wat de langetermijngevolgen hiervan zouden zijn.2 Recent deed het 
Amerikaanse bedrijf DePuy Orthopaedics een officiële recall waarbij de resurfacing 
prothesen van deze firma van de markt werden gehaald wegens slechte resultaten. Ook 
heeft deze firma standaardheupprothesen die gebruik maakten van een metalen kop met 
grote diameter op een metalen kom (‘large head metal-on-metal’) van de markt genomen.
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FIGUUR 2.
Schematische weergave van de onderdelen waaruit een totaleheupprothese (‘total hip’) bestaat
Deze berichtgeving leidt tot veel onduidelijkheid binnen zowel de medische wereld als 
onze jonge patiëntengroep, aangezien deze prothese ook in Nederland is toegepast. In dit 
artikel bespreken we daarom de huidige stand van zaken rond de resurfacing prothese bij 
jonge patiënten.
HET POTENTIËLE VOORDEEL VAN DE RESURFACING 
PROTHESE
Jonge patiënten gebruiken hun prothese intensiever dan ouderen, waardoor een grotere 
belasting van de prothese ontstaat, met als gevolg een snellere slijtage. Fixatie van de 
prothese is bij de jonge patiënt veelal lastiger, doordat zij vaak een onderliggende 
heupafwijking hebben waardoor de anatomie veranderd is. Gezien de levensverwachting 
van de jonge patiënten zal een groot deel van deze groep minstens eenmaal gedurende 
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hun leven een revisie-operatie moeten ondergaan. Het is voor deze groep dus van extra 
belang een prothese te kiezen die gemakkelijk te reviseren is.
De resurfacing prothese werd geïntroduceerd als de prothese die makkelijker te reviseren 
zou zijn vanwege het botsparende effect. Bij de resurfacing prothese wordt over de 
femurkop een metalen kap geplaatst, waardoor er minder femoraal bot hoeft te worden 
verwijderd. Bij een conventionele heupprothese wordt het collum met de heupkop 
gereseceerd. De huidige resurfacing prothese maakt gebruik van metaal-op-metaal-
articulatie en heeft een ongecementeerde fixatie van het acetabulum en meestal een 
gecementeerde fixatie in het femur. De kop van deze systemen heeft een grote diameter, 
wat ertoe bijdraagt dat de kans op het uit de kom schieten van de resurfacing prothesen 
lager is dan bij een conventionele gecementeerde of ongecementeerde heupprothese. 
Bovendien werden na de operatie alle sporten toegestaan en zou de bewegingsuitslag 
groter zijn. Deze prothese werd populair onder de naam ‘sportheup’. In vergelijkende 
studies echter werd een grotere bewegingsuitslag niet bevestigd.3,4
RESULTATEN RESURFACING PROTHESE
Patiënten jonger dan 55 jaar
Om de stand van zaken in beeld te brengen, hebben we gezocht naar studies gepubliceerd 
in de periode tot en met 31 december 2010, die de overleving van de resurfacing prothesen 
na minimaal 10 jaar of na gemiddeld 10 jaar beschreven. Daarbij was ons criterium dat 
de leeftijd van alle patiënten ten tijde van de operatie lager dan 55 jaar moest zijn. Net als 
in 2007 gebruikten wij als definitie voor een ‘goed resultaat’ dat 10 jaar na plaatsing meer 
dan 90% van de implantaten nog in situ was, conform de definitie van de NICE-2003-
studiegroep.5
Voor het doorzoeken van Pubmed gebruikten wij de volgende zoekvraag: 
((((((((resurfacing arthroplasty)) OR (metal-on-metal))) AND (hip OR hips))) AND 
(young OR adult* OR child* OR middle-age OR middle-aged OR adolescent*))) AND 
((((cohort study)) OR (cohort analysis)) OR (follow-up study OR follow-up studies 
OR followup study OR followup studies)). Daarnaast hebben we de elektronische 
cochranedatabase en Web of Science doorzocht; hierbij maakten we gebruik van dezelfde 
zoektermen. De resultaten zijn weergegeven in figuur 3.
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FIGUUR 3.
Schematische weergave van de resultaten van de zoekstrategie
Er waren geen studies met 10 jaar follow-up waarin alleen patiënten jonger dan 55 jaar 
waren geïncludeerd. Als aanvulling gebruikten we daarom de Australische en Engelse 
heupregisters. Deze bevatten weliswaar evenmin data met 10 jaar follow-up, maar hierin 
worden wel systematisch de resultaten voor de resurfacing prothese gedurende meerdere 
jaren vastgelegd. Uit die data blijkt dat met name vrouwen onder de 55 jaar een verhoogd 
602 artikelen gevonden 
 Pubmed 367 
 Cochrane 23 
 Web of Science 212
geëxcludeerd: 
 11 studies in andere taal dan Engels, Frans, Duits of Nederlands 
 119 dubbele resultaten
472 artikelen gescreend op titel
geëxcludeerd: 
 225 studies waarin niet de overleving van resurfacing  
 heupprothesen was bestudeerd
247 artikelen gescreend op abstract
geëxcludeerd: 207 studies 
 4 casusbeschrijvingen 
 1 commentaar op onderzoek 
 5 voldeden niet aan inclusiecriterium ‘leeftijd patiënt’ 
 103 voldeden niet aan inclusiecriterium ’10 jaar follow-up’ 
 94 betroffen niet het juiste onderwerp (bijvoorbeeld ander  
 soort prothese, onjuist eindpunt)
40 artikelen volledig doorgenomen
geëxcludeerd: 
 40 studies die onjuiste eindpunten van de follow-up hadden  
 of niet voldeden aan het leeftijdscriterium
0 artikelen geïncludeerd
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risico op revisie hebben als zij een resurfacing prothese hebben gekregen (tabellen I en 
II).6,7 In het Australische heupregister waren nog geen gegevens bekend van 9 jaar follow-
up na het plaatsen van de gecementeerde prothese bij patiënten jonger dan 55 jaar. Ook 
de uitkomsten van een RCT die de langetermijnresultaten bij jonge patiënten in beeld zal 
brengen, zijn nog niet beschikbaar.8
Tot slot hebben we gezocht naar Nederlandse cohortstudies over de resurfacing 
prothese bij patiënten jonger dan 55 jaar. Daarvan was er slechts 1 beschikbaar, met een 
follow-upduur van gemiddeld 9 jaar (uitersten: 1-16), waarin 114 resurfacing prothesen 
waren geïncludeerd. De resultaten lieten een 10-jaarsoverleving van de prothese tot 
aan revisie zien van 47% (95%-BI: 37-57).9 Dit betrof echter geen metaal-op-metaal-
articulatie.
TABEL I. 
Cumulatieve percentages revisie-operaties na plaatsing van een heupprothese bij patiënten 
jonger dan 55 jaar (gegevens afkomstig uit het Australisch Heupregister)
Type prothese Percentage revisie-operaties* (95% BI)
1 jaar na 
plaatsing
3 jaar na 
plaatsing
5 jaar na 
plaatsing
7 jaar na 
plaatsing
9 jaar na 
plaatsing
Gecementeerde THP 1.1 (0.5-2.3) 2.3 (1.3- 4.0) 3.8 (2.4-6.0) 4.8 (3.1-7.4) Nog niet bekend
Ongecementeerde THP 1.4 (1.2-1.7) 3.1 (2.8-3.5) 3.9 (3.5-4.3) 4.7 (4.2-5.3) 5.7 (4.7-6.9)
Hybride THP 1.1 (0.7-1.6) 1.9 (1.4-2.6) 2.9 (2.1-3.8) 4.9 (3.7-6.4) 5.6 (4.2-7.3)
Resurfacing 1.5 (1.2-1.9) 2.7 (2.3-3.2) 4.1 (3.5-4.7) 5.6 (4.8-6.5) 7.1 (5.6-9.1)
THP = totale heupprothese 
*Revisiepercentage voor patiënten die ten tijde van de operatie < 55 jaar oud waren zoals weergegeven in het Australische 
heupregister. Het begrip ‘revisie’ omvat in dit register revisies van de femurcomponent (die bestaat uit een kop en een steel), 
de acetabulumcomponent, wissel van de kop en ‘insert’, revisie van beide componenten en revisie van alleen de kop.
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TABEL II. 
Cumulatieve percentages revisie-operaties na 3 en 5 jaar na plaatsing van een heupprothese 
bij mannelijke en vrouwelijke patiënten jonger dan 55 jaar (gegevens afkomstig uit het Engelse 
heupregister)
Type prothese Aantal patiënten Percentage revisie-operaties* (95%-BI)
3 jaar na plaatsing 5 jaar na plaatsing
Mannen
Gecementeerde THP 1.669 2.7 (1.9-3.8) 4.4 (3.2-6.0)
Ongecementeerde THP 3.858 2.9 (2.3-3.6) 4.0 (3.1-6.0)
Hybride THP 1.498 1.8 (1.2-2.7) 2.6 (1.7-3.8)
Resurfacing 4.215 3.6 (3.0-4.3) 5.6 (4.5-6.9)
LHMoM THP 1.564 4.5 (3.3-6.1) 6.4 (4.5-8.9)
Vrouwen
Gecementeerde THP 2174 2.5 (1.8-3.4) 3.6 (2.7-4.8)
Ongecementeerde THP 5082 2.7 (2.2-3.3) 4.3 (3.4-5.5)
Hybride THP 1840 2.2 (1.5-3.1) 4.0 (2.8-5.8)
Resurfacing 2647 5.4 (4.5-6.5) 8.3 (6.8-10.0)
LHMoM THP 1037 6.3 (4.6-8.6) 9.2 (5.9-14.1)
*Revisiepercentage voor patiënten die ten tijde van de operatie < 55 jaar oud waren zoals weergegeven in het Engelse 
heupregister. Het begrip ‘revisie’ omvat in dit register een re-operatie waarbij één of meer componenten van de prothese 
werd vervangen. Percentages zijn berekend met behulp van de overlevingsanalyse volgens Kaplan en Meier.
Patiënten van alle leeftijden
Wanneer we nogmaals de heupregisters bekijken, maar dan voor alle leeftijden, blijkt uit 
het Australische heupregister dat de resurfacing prothese in het algemeen een hogere 
revisiegraad na 9 jaar heeft dan de THP, namelijk 7,2% versus 5,2%, bij de indicatie 
‘artrose’.6 Vrouwen boven de 65 jaar die een metaal-op-metaal resurfacing prothese 
ontvingen, hebben na 3 jaar al een 3-7 maal hogere kans op revisie dan vrouwen van 
dezelfde leeftijd die een conventionele THP ontvingen.6,10 Voor mannen onder de 55 jaar 
daarentegen is het revisiepercentage voor de resurfacing prothese vrijwel gelijk aan dat 
van een conventionele THP.6,10 Dit verschil is mogelijk ook gerelateerd aan de grootte van 
de kop, aangezien een kleinere kop, die vaak bij vrouwen geplaatst wordt, leidt tot een 
hoger risico op revisie.
Voor patiënten van alle leeftijden laat het Engelse heupregister het laagste 
revisiepercentage na 5 jaar zien bij patiënten die een gecementeerde THP hadden 
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gekregen, namelijk 2,0 % (95%-BI: 1,8-2,1).7 Voor een ongecementeerde THP was dit 
2,7% (95%-BI: 2,4-3,0), voor een hybride prothese 3,4% (95%-BI: 3,2-3,7) en voor een 
resurfacing prothese 6,3% (95%-BI: 5,7-7,0).7 Het hoogste faalpercentage werd gezien na 
plaatsing van een metaal-op-metaal THP met een grote kop (‘large head metal-on-metal’ 
(LHMoM)), namelijk 7,8% (95%-BI: 6,6-9,3).7 Er zijn overigens grote verschillen in de 
revisiepercentages tussen de verschillende merken resurfacing prothesen (tabel III).
TABEL III. 
Cumulatieve revisiepercentages 5 jaar na plaatsing van een resurfacing prothese, weergegeven 
per merk heupprothese
Merk resurfacing prothese* Cumulatief revisiepercentage (95% BI)
ASR (DePuy Orthopaedics, Warsaw, VS) 10.9 (8.7-13.6)
BHR (Smith&Nephew, Warwick, VK) 3.5 (3.1-4.0)
Cormet (Corin, Cirencester, VK) 6.0 (3.5-10.2)
Durom (Zimmer, Warsaw, VS) 7.6 (5.7-10.0)
*Alleen implantaten waarvan er jaarlijks meer dan 100 worden geplaatst en waarvan het cumulatieve percentage revisies 
na 5 jaar bekend was, zijn weergegeven. Gegevens zijn afkomstig uit het Australisch heupregister.6
REDENEN VOOR TEGENVALLENDE RESULTATEN
Allereerst blijkt de operatietechniek van de resurfacing prothese lastiger, omdat bij 
plaatsing van deze heupprothese collum en heupkop intact moeten blijven. De rol van de 
chirurg is hierbij belangrijk en de leercurve is vaak lang.11,12
Over het daadwerkelijke activiteitenniveau van de patiënt als factor die het resultaat 
bepaalt komen verschillende cijfers naar voren. Patiënten met een THP krijgen vaak het 
advies om niet overdreven actief te zijn, wat het beeld van de resultaten kan vertekenen.13 
Uit een recente RCT bleek overigens dat het activiteitenniveau na plaatsing van een 
resurfacing prothese niet overduidelijk hoger was dan bij patiënten die een THP hadden 
gekregen.14
Complicaties
Ook bij een resurfacing prothese kunnen luxaties optreden, al is de incidentie laag 
(0-1,8%).10 Naast de reeds bekende vroege complicaties van een resurfacing prothese, 
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zoals de collumfractuur (incidentie: 0,4-6,0%),10 verschijnt een toenemend aantal 
artikelen die wijzen op het ontstaan van een andere complicatie. Het gaat hierbij om 
een wekedelenreactie op metaalionen die in de literatuur onder verschillende namen 
wordt beschreven, zoals ‘adverse reactions to metal debris’ (ARMD) en ‘pseudotumor’. 
De histologische term is aseptische lymfocytaire vasculitis (ALVAL).
De oorzaak van deze complicatie is waarschijnlijk in de meerderheid van de 
gevallen een stijging van de concentratie metaalionen tot een toxisch niveau. Deze hoge 
concentraties ontstaan door toegenomen slijtage, veelal bij malpositie.10,15 Een andere 
mogelijke hypothese stelt dat er langzaam metaalionen afgegeven worden door de 
prothesedragende oppervlakken als een soort bijproduct naast de normale slijtage.
De slijtageproducten van metalen prothesen zijn aantoonbaar in de naastgelegen 
periprosthetische weke delen en op verder weg gelegen plekken zoals lymfeklieren, 
lever en milt. Deze slijtagepartikels vormen samen met lokale eiwitten haptenen, die 
een contactallergische reactie van het vertraagde type (type IV) opwekken in het lokale 
weefsel. De lokaal destructieve reactie kan lijden tot pijn, wekedelennecrose, osteolyse en 
loslating van de prothesecomponenten, waardoor revisie noodzakelijk is.15,16 De geschatte 
incidentie varieert van 1 tot 6,5%, maar verwacht wordt dat deze in de loop van de tijd 
toeneemt met een hoger aantal revisies als gevolg.15,17,18 Verder hebben veel patiënten een 
stijgende metaalspiegel in het serum waarvan de klinische relevantie nog niet duidelijk 
is.19
De revisie van een resurfacing prothese naar een conventionele THP wegens loslating 
van de femurcomponent of een collumfractuur is technisch goed uitvoerbaar en het 
resultaat komt overeen met dat van een primaire plaatsing van een conventionele THP. 
Wel worden bij deze patiënten veel luxaties gezien. Revisies wegens pseudotumoren zijn 
echter lastiger dan in eerste instantie werd gedacht en gaan gepaard met een hoog aantal 
re-revisies.20
TECHNISCHE ONTWIKKELINGEN EN HUIDIGE SITUATIE
In de jaren 60 en 70 van de vorige eeuw werden de eerste ontwerpen van metaal-op-
polyethyleen en metaal-op-metaal resurfacing prothesen ontwikkeld. Deze vroege 
prothesen leden onder een inconsistente productie met wisselende resultaten. Het 
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principe van metaal-op-metaal werd verdrongen door de steeds beter ontwikkelde 
gecementeerde THP.
De metaal-op-polyethyleen resurfacing prothesen werden in de jaren 70 nog wel 
verder ontwikkeld, maar de gebruikte materialen waren te gevoelig voor slijtage. Het 
polyethyleen debris dat bij deze prothesen vrijkwam leidde tot osteolyse achter de kom. 
Destijds werd osteolyse nog niet als dusdanig herkend en werden de waargenomen 
complicaties toegeschreven aan andere factoren, waaronder avasculaire necrose. Daarbij 
kwamen bij dit type prothese regelmatig collumfracturen voor.21
De tweede, huidige generatie resurfacing prothesen werd geïntroduceerd in 1996.22,23 
Vanaf dat jaar ontstonden de resurfacing prothesen zoals ze tegenwoordig door verschillende 
fabrikanten worden geproduceerd. Deze resurfacing prothesen vertonen, zoals gezegd, 
onderling grote verschillen in overleving (zie tabel 3).6 De BHR (Smith & Nephew, 
Warwick, VK), ontwikkeld in 1996, heeft vanaf zijn introductie goede overlevingscijfers 
laten zien en vindt nog steeds toepassing in een geselecteerde patiëntengroep.24 Bij het 
recentelijk van de markt gehaalde ASR-systeem (DePuy Orthopaedics, Warsaw, VS) was 
het revisiepercentage na slechts 5 jaar follow-up 10,9% (95%-BI: 8,7-13,6). Om een beter 
inzicht te krijgen in de resultaten is de Nederlandse Orthopaedische Vereniging (NOV) 
per 1 april 2008 gestart met het landelijk implantaatregister ‘Landelijke Registratie 
Orthopedische Implantaten’ (LROI).
Recent werd duidelijk dat vergelijkbare problemen als bij de metaal-op-metaal 
resurfacing prothesen ook spelen bij conventionele heupprothesen die gebruik maken 
van een metaal-op-metaal-articulatie met een grote kop (doorsnede ≥36 mm). Dit 
probleem lijkt zich echter niet voor te doen bij een kop met een doorsnede van 28 of 
32 mm.25 Juist de metaal-op-metaal-articulatie met een grote kop werd echter de laatste 
jaren steeds populairder bij jonge patiënten. Er is nog veel onduidelijk, maar de taper van 
de steel van de conventionele heupprothese met metaal-op-metaal-articulatie met grote 
kop lijkt veel metaaldeeltjes te genereren.
De productiewijze, vorm en positie van het implantaat bepalen in belangrijke mate de 
overleving van de heupprothese.26 Ook bij goed functionerende implantaten zijn echter 
problemen met metaalconcentraties gesignaleerd. Bij sommige patiënten waren te hoge 
metaalconcentraties op zich al de reden voor een revisie.
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Onzekerheid onder patiënten
Het terugroepen van de ASR-prothese door de fabrikant heeft ook in ons land voor onrust 
gezorgd. De problemen met de resurfacing prothese zijn in de lekenpers breed uitgemeten 
en daarnaast weten patiënten vaak niet exact welk type prothese ze hebben. De NOV 
ziet geen reden voor het terugroepen van de resurfacing prothese in het algemeen en de 
meer conventionele THP met grote metalen kop, maar adviseert patiënten wel zich op de 
hoogte te stellen van de huidige stand van zaken. Hierbij kan aan de patiënten worden 
uitgelegd dat met de huidige kennis een afwachtende houding gerechtvaardigd is als de 
patiënt geen pijn of andere klachten heeft. Een mogelijkheid tot gerichte controle dient 
echter wel te worden aangeboden. 
Door alleen patiënten aan te schrijven die een metaal-op-metaal THP hebben gehad, 
zijn er naar onze mening veel patiënten in Nederland in onzekerheid blijven rondlopen. 
Via websites van ziekenhuizen zou men bekend kunnen maken waar en in welke 
periode de metaal-op-metaal prothesen geplaatst zijn, om deze onrust weg te nemen. 
Ook de LROI kan daar aan bijdragen. Een preventieve maatregel om patiënten beter te 
informeren is het meegeven van kaartjes na een operatie met daarop het type prothese 
dat de patiënt gekregen heeft.
CONCLUSIE
Uit de voorgaande uiteenzetting blijkt dat de resurfacing prothese op een aantal punten 
niet aan de verwachtingen van een aantal jaar geleden voldoet. Het activiteitenniveau 
van de jonge patiënt die een resurfacing prothese heeft gekregen blijkt niet overduidelijk 
hoger te liggen dan na plaatsing van een THP. Wanneer we daarbij het aantal revisies en 
de complicaties door metaaldeeltjes in acht nemen wordt duidelijk dat de resurfacing 
prothese niet de oplossing is voor alle patiënten. Wel zijn er grote verschillen in uitkomst 
per merk.
Bij de huidige stand van zaken blijkt de resurfacing prothese mogelijk wel geschikt 
voor met name jonge, actieve mannen. Daarnaast blijft de conventionele THP bestaan 
als optie voor de jonge patiënt; dit type prothese zorgt in het algemeen voor een grote 
toename in kwaliteit van leven. Onzekerheid bij patiënten over welk type prothese bij 
hen geplaatst is dient zo snel mogelijk te worden weggenomen. Dit geldt voor zowel de 
resurfacing prothese als de metaal-op-metaal THP met grote kop.
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LEERPUNTEN
• De ‘resurfacing’ prothese is een veelgebruikte heupprothese bij patiënten jonger dan 
55 jaar.
• De voordelen van de resurfacing prothese zouden zijn dat deze botsparend is, een 
hoog activiteitenniveau toe staat en makkelijk is te reviseren. 
• Op de korte termijn zijn de resultaten goed, maar er zijn grote verschillen 
tussen de diverse merken resurfacing prothesen in revisiepercentages op de 
middellangetermijn.
• Een frequente complicatie is de ontstekingsreactie van weke delen door vrijgekomen 
metaaldeeltjes, resulterend in pijn, weefselverlies en osteolyse.
• Recentelijk heeft de Amerikaanse firma DePuy Orthopaedics zijn resurfacing 
heupprothese teruggeroepen; de aandacht hiervoor in de lekenpers heeft tot veel 
onrust bij patiënten geleid.
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ABSTRACT
Background: The number of total hip arthroplasties in patients under 30 years is 
increasing over the years. Almost all of them will face at least one or more future 
revisions in their life. Therefore, the implant used should have a high survival rate, 
and needs to be easily revisable resulting in a low re-revision rate. Several studies 
have evaluated the outcome of total hip arthroplasties in patients under 30 years. 
However, only a few reported on the follow-up outcome of 10 years or more. In 
addition, none of these reports published data of the subsequent revisions of these 
implants within their original report.
Methods: We studied historically prospective collected data of 48 consecutive 
patients (69 hips) younger than 30 years, treated with a cemented primary total 
hip prosthesis between 1988 and 2004. Since the last evaluation of this cohort, two 
patients were lost to follow-up. For all hip revisions in this cohort, again cemented 
implants were used, mostly in combination with bone impaction grafting. Kaplan-
Meier survival curves at 10- and 15 years for the primary total hip arthroplasties and 
revisions were determined.
Results: The mean age at time of primary surgery was 25 years (range, 16 to 29 
years). Mean follow-up of the primary hips was 11.5 years (range, 7 to 23 years). 
During follow-up 13 revisions were performed; in 3 cases a two-stage total revision 
was performed for septic loosening and 9 cups were revised for aseptic loosening. 
There were no aseptic stem revisions. The 10 and 15-year survival rates with 
endpoint revision for aseptic loosening of the primary total hip were 90% (95% 
confidence interval (CI): 79-96) and 82% (95% CI: 65-92) respectively. None of our 
13 subsequent revisions needed a re-revision within 10 years after re-implantation.
Conclusions: Cemented total hip implants in patients under 30 years have an 
encouraging outcome at 10 and 15 years after surgery in these young patients. The 13 
revised hips, treated with bone grafting and the third generation cement technique, 
were performing well with no re-revisions within ten years after surgery. 
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BACKGROUND
The number of total hip arthroplasties in very young patients is rising. Different solutions 
to treat these young patients with secondary osteoarthritis have been used over the last 
decade. Non-cemented, cemented, hybrids, metal-on-metal total hip arthroplasties 
and resurfacing prostheses all have been used in young patients, with different success 
rates.1-22 Obviously, in these very young patients it is important to use total hip implants 
with a proven long-term outcome.23 Additionally, we have to keep in mind that these 
young people will inevitably face one or more revisions in their life, due to their longer 
life expectancy. As a result, the implant used should have an acceptable and reliable long-
term clinical outcome as it needs to be easy revisable without creating a bone stock defect. 
Both survival of the primary THA and subsequent revision THA are important outcome 
measurements in these young patients. So far, only a few reports present long-term results 
of total hip arthroplasties in patients under 30 years and none present the outcomes of the 
first revision THA’s in the same cohort (table I).
TABLE I. 
Characteristics and survivorship of THA in patients 30 years or younger at time of operation with 
a mean follow-up of more than ten years in literature up to March 2011
Study No hips No patients Mean age 
in years 
(range)
Mean  
follow-up 
in years (range)
Survivorship/revised 
hips for all reasons
Cemented
Cage et al. 4 29 17* 18.4 (15-21) 10.6 (8-15) 1 revision at 11 yrs
Chmel et al. 7 66 39 19.9 (11-29) 15.1 (11-22) 70% at 15 yrs (acetabular 
revision)
Sochart and  
Porter 8
83 55 24.9 (17-29) 20 (5-30) 89% at 10 yrs ; 65% at 
25 yrs
Torchia et al. 6 63 50 17 (11-19) 12.6 (1.6-18.6) 27 revisions#
Witt et al. 3 96 54 16.7 (11-27) 11.5 (5-18) 24 (25%) at average 9.5 
years follow-up
Wroblewski et 
al. 18 
39 28 17.9 (12-19) 12.6 (2.3 – 29.0) for 
non-revision
16 revisions at mean 19.1 
yrs (8-34)
(current study) 69 48 24.6 (16-29) 11.3 (2-23.4) 86% at 10 yrs ; 75% at 
15 yrs
Uncemented
Wangen et al. 16 49 44 25 (15-30) 13 (10-16) 24 revisions of acetabular 
component#
*mixed group of patients with total hip and total knee prosthesis 
#at mean follow-up
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Although cemented total hip implants are not commonly used in young patients, we 
have always used cemented total hip implants in all ages, including patients younger than 
thirty years. Furthermore, we have one essential addition in young patients: in case of 
substantial acetabular bone stock deficiencies, we have reconstructed this bone stock loss 
using impaction bone grafting (IBG). In these young patients, secondary osteoarthritis 
resulting from underlying diseases is often seen in combination with associated loss 
of the acetabular bone stock (e.g. in developmental dysplasia of the hips and juvenile 
rheumatoid arthritis). This hampers an optimal insertion and fixation of the cup. We 
believe that IBG for the reconstruction of acetabular bone stock deficiencies in young 
patients is a biologically attractive approach, which restores bone stock already before the 
inevitable future revision.17 
In all revisions we applied the same philosophy of using IBG on the acetabular side 
with a cemented cup. In case of femoral bone stock loss, femoral grafting was performed 
as well in order to achieve a durable reconstruction.24 
The purpose of the current study is to present the clinical and radiographical results 
of 69 consecutive cemented total hip arthroplasties in 48 patients less than 30 years old 
after a mean follow up of more than 10 years, reporting the survival data with endpoint 
revision for any reason, aseptic loosing and radiological failure. In addition to the results 
of the primary total hip arthroplasties, the current state of our revisions and re-revisions 
within this group after the primary total hip arthroplasty will be assessed. Results will be 
compared to results of similar or other techniques found in the literature.
METHODS
In 2011, at a minimum follow-up of 7 years (7 to 23 years), we performed a historical 
prospective study on 48 consecutive patients (69 hips) younger than 30 years, who 
received a primary cemented total hip arthroplasty between April 1988 and May 2004. 
All indications except reconstructions for tumors were included. There was no selection 
bias as we used cemented total hips in all cases. The group consisted of 32 female (46 hips) 
and 16 male patients (23 hips). The mean age at surgery was 25 years (range, 16 to 29). 
Four patients (6 hips) died during follow-up of causes not related to their hip surgery. The 
mean age during surgery of these 4 patients was 24 years (range, 20 to 26). Their mean 
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follow-up until death was 9 years (range, 1 to 18). None of them was revised before death 
and all of them were followed up to their death on a regular base. Therefore, we included 
all their data. Two patients (3 hips) were lost to follow-up since our first evaluation of this 
cohort, including one patient with 2 THA’s after 3.5 years of follow-up of both hips and 
one patient with one THA after 11 years.17 Their data were included in the study up to 
their latest clinical and radiographic control. Table II lists the indications for the THA in 
all patients.
TABLE II. 
Indication for total hip arthroplasty (n=69)
Indication Number of hips
Juvenile rheumatoid arthritis 18
Osteonecrosis of femoral head 21
Systemic lupus erythematosus 7
Acute lymphatic leukemia 3
Crohn’s disease 3
Nephropathy, kidney transplantation 2
Hypothalamic disorder 1
Aplastic anemia 1
Wegener’s disease 1
Unknown origin 3
Developmental dysplasia of the hip 7
Multiple epiphyseal dysplasia 2
Legg-Calvé-Perthes disease 6
Ankylosing spondylitis 5
Morquio’s disease 2
Ankylosis of unknown origin 2
Polycystic disease of the femoral head of unknown origin 2
Arthritis and osteomyelitits 2
Posttraumatic osteoarthritis 1
Psoriatic arthritis 1
In all cases, a posterolateral approach without a trochanteric osteotomy was used. Although 
we used different implants over the years, all of them were fully cemented (Table III). All 
cups were made of conventional polyethylene and only cobalt-chrome femoral heads of 
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22 mm (9 hips), 28 mm (49 hips) and 32 mm (11 hips) were used. Up to 1990, all femoral 
components were inserted using a second-generation cementing technique, while from 
1990 onwards the third cementing technique was used. Palacos cement was used until 
1989 (Merck, Darmstadt, Germany); from 1989 on we used Surgical Simplex (Stryker-
Howmedica, Newburry, UK). Antibiotics (cefazolin) were given during a maximum of 24 
hours postoperatively to prevent infections. 
TABLE III. 
Types of implant
Type of acetabular implant Number of hips Type of femoral implant Number of hips
Müller®/Allopro® cup 14 M.E. Müller® straight stem 11
EliteTM Plus LPW 26 Charnley Elite (Plus) stemTM 13
Exeter/ContemporaryTM 29 Exeter StemTM 45
In case of bone stock deficiency during the primary procedure, we used the IBG technique 
to reconstruct acetabular defects (29 hips) (Figure 1 and 2). This technique has been 
described in the literature in detail before.17,25 Acetabular defects were classified according 
to the classification system of the American Academy of Orthopaedic Surgeons (AAOS) 
Committee on the Hip.26 In 5 hips a Type I defect was present. A Type II defect was 
seen in 16 hips and a Type III defect in 8 hips. In 23 hips, femoral head autografts were 
used, whereas fresh-frozen nonirradiated femoral head allografts were used as a source 
for bone chips in 3 hips with a Type III defect. In another 3 hips, both autografts and a 
fresh frozen allograft femoral head were used. 
Postoperatively, patients were treated with subcutaneous low-molecular-weight 
heparin for 6 weeks. Before 1999, oral anticoagulants were prescribed for 3 months 
according to our previous postoperative protocol. Indomethacin was administered for 
7 days to prevent heterotopic ossification. Alternatively, one dose (7Gy) of radiotherapy 
was given, when indomethacin was contraindicated. Patients without a defect or a simple 
minor cavitary defect were mobilized under the supervision of a physiotherapist two days 
after surgery. In case of extended reconstructions, 10% touch weight bearing with crutches 
was allowed for 6 weeks, followed by 50% touch weight bearing for another 6 weeks, before 
full weight bearing was allowed. In case of very extensive acetabular reconstructions, e.g. 
severe pelvic dislocation and high dislocation, patients initially had a six-week period of 
bed rest to achieve full graft incorporation before starting mobilization. 
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FIGURE 1.
In 29 of the 69 cases, a pre-operative bone stock deficiency on the acetabular side was present, 
which was classified according to the AAOS classification and treated with a cemented THA and 
IBG. 
FIGURE 2.
Acetabular reconstruction in a 27-year-old woman with secondary osteoarthritis due to 
congenital hip dysplasia. Preoperative (A), immediately postoperative (B), and 12 years 
postoperative (C).
The anteroposterior pelvic and lateral hip radiographs of all hips were analysed on a 
consensus basis by two of the authors (MWJLS and BWS). Follow-up radiographs were 
complete for all hips, except for the two patients lost to follow-up. Graft incorporation was 
determined as the manifestation of a regular radiodensity and trabecular bone structure 
throughout the graft and host bone with a continuous trabecular pattern according to 
Conn et al.27 Radiolucent lines were described if they were more than 2 mm wide and 
69 consecutive THA’s performed
cemented THA without IBG (n=40)cemented THA and IBG (n=29)
no pre-operative bone stock deficiency (n=40)
pre-operative bone stock deficiency (n=29)
- Type I AAOS defect (n=5) 
- Type II AAOS defect (n=16) 
- Type III AAOS defect (n=8)
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were defined as stable or as progressive lines in time. The criteria of DeLee and Charnley 
were used to identify acetabular zones.28 Radiographic failure was defined as radiolucent 
lines in all three zones and/or migration of 5 mm or more in any direction on the AP-
pelvic view relative to the interteardrop line. The classification of Brooker et al. was used 
to describe heterotopic ossification 29. Polyethylene wear was calculated using the method 
of Dorr and Wan.30 On the femoral side, the Gruen classification was used to determine 
radiolucent zones.31 Femoral prosthetic subsidence was considered if it was more than 2 
mm32 while definite loosening of the stem was defined as the appearance of a radiolucent 
line in all Gruen zones that did not exist on the immediate postoperative radiographs, or 
as a crack in the cement or fracture of the stem.33 The Harris Hip Score and Oxford Hip 
Score were determined at each follow-up visit to evaluate clinical results, as were the VAS 
scores (on a scale of 1 to 100) for pain during rest and activity as well as the VAS score for 
satisfaction about the hip function (on a scale of 1 to 100).
Cemented total hip arthroplasties with acetabular IBG were used in al revision 
procedures. In case of femoral bone deficiency, we performed femoral IBG.34 
For this study, no ethical approval was required by the local ethical committee. 
Statistical analysis
Kaplan-Meier survival analysis were used to determine the survivorship of the primary 
hip implant for the endpoints revision of one or both components for 1) any reason, 2) 
aseptic loosening and 3) radiographic failure. In addition to analysis for the total group, 
hips with and without acetabular IBG were also analysed separately. The HHS and OHQS 
were evaluated in 3 categories: 1) after 2 to 5 years follow-up, 2) after 5 to 10 years follow-
up and 3) after more than 10 years follow-up. A ‘last observation carried forward analysis’ 
was done to determine the mean HHS and OHQS scores for the total group of surviving 
hips. VAS scores regarding pain in rest, pain during activity and overall satisfaction were 
determined. In addition to the results of our primary total hip arthroplasties, a Kaplan-
Meier survival analysis was performed for the revisions in our group. HHS and OHQS, 
as well as VAS-scores were also calculated for the revised total hip arthroplasties. All 
calculations were made with SPSS 18.0.2 and SAS for Windows 9.2. 
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RESULTS
Clinical results
Mean duration of follow-up of all 69 primary total hips was 11.5 years (range, 7 to 23 
years). During follow-up, 5 patients died (7 hips), two patients were lost to follow-up (3 
hips) and 13 hips were revised for several reasons. The average pre-operative HHS score 
was 47.0 (range 15 to 81) (n=30), and the average pre-operative OHQS was 43.2 (range 
34 to 52) (n=9). At review the mean HHS of the 49 surviving hips was 88.3 (n=48) (range 
55 to 100) and the mean OHQS was 17.5 (range, 12 to 34) (n=49) after a mean follow-up 
of 11.6 (range 3.0 to 22.0). The mean VAS score for pain in rest and during activity on a 
scale from 0-100 after a mean follow-up of twelve years were 5.5 and 16.0, respectively. 
VAS score for overall satisfaction was 88.8. 
Revisions and complications
Three total revisions for septic loosening were performed at 4.8, 5.7 and 6.1 years after the 
index surgery. All were treated with a two stage treatment protocol and all components 
were exchanged. One patient, originally planned for a one-stage cup revision after 13 
years for aseptic loosening had positive cultures at revision, suggesting septic loosening. 
This patient was treated during 3 months with antibiotics and despite partial revision, 
no relapse occurred. Nine cups had been revised because of aseptic loosening at 2.3, 3.0, 
4.1, 4.9, 7.6, 8.6, 13.6, 14.3 and 23.6 years. Except for the three stems revised for septic 
loosening, no additional stems had failed. One highly polished stem had to be exchanged 
for a same size stem using the cement in cement technique during a cup revision due 
to damage to the taper caused during that cup revision. This case was scored as a re-
operation but this stem exchange is not considered as a stem failure. 
In addition to these revisions mentioned, one early re-operation after a primary THA 
was necessary due to a suspected infection. The patient recovered after débridement and 
antibiotic therapy without implant revision. Two early dislocations were seen. In one case 
an open reduction was needed. One partial femoral nerve deficit was seen, and despite 
surgical release, recovery was incomplete. One periprosthetic fracture, type Vancouver B1 
occurred, fifteen years after the primary surgery for which open reduction and internal 
fixation was necessary without exchange of the implant. Other complications and their 
outcomes are listed in Table IV. 
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TABLE IV. 
Complications of the 69 primary total hip arthroplasties, excluding the 13 revisions.
Complications N Outcome
Early reoperation due to suspicion of deep infection 1 Fully recovered
Dislocation 2 One successful closed reduction, however one disloca-
tion in a multi trauma patient needed surgical reduction 
Neurological deficit 1 Femoral nerve exploration; incomplete recovery
Periprosthetic Fracture Vancouver B1 1 Plate osteosynthesis with cable grip plate system. No 
revision of the implant
Radiographic results
Radiolucent lines around the cup were observed in 18 of the 56 surviving hips, which 
were progressive in 6 hips. Osteolysis was seen in different zones on the acetabular side as 
well as on the femoral side. The complete detailed radiographic characteristics found in 
the 56 non-revised total hip arthroplasties are shown in Table V. 
Survivorship analysis
Regarding the endpoint revision for any reason of both cup and stem, the 10-year survival 
rate for the primary total group was 86% (95% CI: 74 - 92) and the 15-year survival rate 
was 75% (95% CI: 59 - 86) (Table VI). For endpoint revision for aseptic loosening, the 
10- and 15-year survival rates for the total group were 90% (95% CI: 79 - 96) and 82% 
(95% CI: 65 - 92), respectively (Table VI and Figure 3). Of the 9 revisions for aseptic 
loosening, 7 were primary cemented hips without IBG while there were only 2 revisions 
in the IBG group. The 15-year survival rate for the primary cemented hips was 80% (95% 
CI: 60 - 91) for endpoint aseptic loosening, whereas this was 86% (95% CI: 48 - 97) for 
the total hips that were combined with IBG group. This was not statistically different (p 
= 0.30). Survival curves for each type of implant separately did not show any significant 
differences.
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TABLE V. 
Radiographic characteristics of 56 primary total hip 
arthroplasty patients that were not revised at last follow-up
Radiographic characteristics
Acetabular radiolucent lines 18
Progressive
Stable
6
12
Osteolysis 9
Zone I 3
Zone II 3
Zone III 2
Zone I+II 1
Socket migration -
Progressive tilting of the cup -
PAO’s 13
Brooker class II  9
Brooker class III 4
Polyethylene wear > 2 mm 3
Femoral radiolucent lines 3
Zone 7 1
Zone 3 and 5 1
6 out of 7 zones 1
Rounding off of the calcar 8
Cortical atrophy 2
Zone 4 1
Zone 7 1
Cortical hypertrophy 5
Zone 3 1
Zone 4 3
Zone 5 1
Osteolysis of femoral component 7
Zone 1 1
Zone 4 1
Zone 5 1
Zone 7 1
Zone 1 and 7 4
Note: multiple radiographic characteristics per patient are possible
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TABLE VI. 
The 10-year and 15-years survivorship with the 95% confidence intervals (CI) for the three 
endpoints (revision for any reason, revision for aseptic loosening, radiographic failure) of the 
69 hips including 29 total hip arthroplasties with impaction bone grafting (IBG) and 40 primary 
cemented total hip arthroplasties
Category of patients Proportion revision 
free for any reason
Proportion revisions 
free for aseptic  
loosening
Proportion free of  
radiographic failure
10-year 
(95% CI)
15-year 
(95% CI)
10-year  
(95% CI)
15-year  
(95% CI)
10-year  
(95% CI)
15-year  
(95% CI)
All hips (n=69) 86%  
(74 to 92)
75%  
(59 to 86)
90%  
(79 to 96)
82%  
(65 to 92)
90%  
(80 to 96)
82%  
(65 to 92)
Primary cemented hips (n=40) 81%  
(64 to 91)
71%  
(50 to 84)
86%  
(70 to 94)
80%  
(60 to 91)
86%  
(70 to 94)
80%  
(60 to 91)
Acetabular IBG (n=29) 93%  
(74 to 98)
83%  
(49 to 95)
96%  
(77 to 99)
86%  
(48 to 97)
96%  
(77 to 99)
86%  
(48 to 97)
FIGURE 3.
Kaplan Meier estimated survival of the total of sixty-nine hips regarding endpoint revision for 
aseptic loosening.
Outcome of the thirteen revisions 
All 13 failed primary hips were revised in our institution and the reasons for revision have 
been explained previously. In all 3 septic loosenings, acetabular bone impaction grafting 
and a cemented implant was used in the second stage. Additionally, in 2 of the stem 
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revisions femoral bone impaction grafting was used. No relapse of infection occurred. 
In the 9 isolated cup revisions, acetabular bone impaction was used in combination with 
a cemented cup. In one case the new cup was simply re-cemented. The 12 defects seen 
on the acetabular side were five segmental defects (AAOS type I), two cavitary defects 
(AAOS type II) and five combined defects (AAOS type III). All of the segmental defects 
were reconstructed using a wire mesh. Of the cavitary defects, one did not need any 
mesh while the other was reconstructed with a medial and a rim mesh. Of the combined 
defects, 2 received only a rim mesh and three received both a rim and a medial mesh. 
The mean follow-up of the 13 revisions after the surgery was seven years (range, 1 to 15 
years). Remarkably, the only re-revision in this study was performed 13 years after cup 
revision without acetabular bone impaction grafting. One patient had a partial lesion of 
the femoral nerve after a cup revision, which recovered partially without any invasive 
treatment. 
Of the twelve non re-revised cups, we collected the postoperative HHS and OHQS 
after a mean follow-up of 7 years (range, 0.5 to fifteen years), which were 82.7 (range 49 to 
100) and 22.3 (range 12 to 52), respectively. Further analysis of these scores revealed that 
two patients had strikingly disappointing HHS and OHQS scores. One of the patients has 
a history of sclerodermia, M. Crohn, and recently received a stoma. The second patient 
post-operatively experienced problems of the femoral nerve which influences his activity 
and pain scores. This explains the differences of the HHS and OHQS scores between 
the primary and revision total hip arthroplasties. VAS scores of the twelve patients after 
revision for pain during rest and activity were 11.7 (range, 0-80) and 36.7 (range, 0 to 
100), respectively. The mean VAS satisfaction score was 68.3 (0 to 100). The Kaplan Meier 
survival curve of our revisions with endpoint revision for any reason showed a 100% 
survival at 10 years. 
DISCUSSION
Very young patients with osteoarthritis of the hip are still a challenge for orthopaedic 
surgeons. Frequently, due to the underlying pathology, an acetabular bone stock 
deficiency in this group is seen. Often large sized cups are used in order to cover this 
defect, without restoring the bone stock. However, in these younger THA patients, future 
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revisions will be inevitable. It is therefore of extreme importance to create an optimal 
bone stock situation in order to prepare future (re)-revisions. We have described both 
the technique and outcome of the reconstruction of acetabular defects with IBG in young 
patients up to the age of 50 before.25, 35, 36 
Although it is not very common in young patients, we have always used cemented 
total hip arthroplasties and cemented revisions in this young population. Furthermore, 
we used bone grafts in all cases with bone stock loss, thereby facilitating a biological 
reconstruction. Our 10 year Kaplan Meier estimated survival for endpoint aseptic 
loosening of 90% (95% CI: 79 to 96) is within the NICE criteria.37 Our 15 year estimated 
survival of 82% is still acceptable in these very young patients but needs to be monitored 
closely over the next years.
At review of the literature in March 2011, there was only limited literature available 
regarding the survival and complications of a total hip arthroplasty after a mean follow-up 
of 10 years or more in patients under 30 years. None of the reports included the outcome 
of their revisions in the same report as well. It should be noted that for young patients 
both outcome of the primary and revision THA, are equally important. Moreover, we 
assume that the outcome of the revision THA can be influenced by the primary THA 
procedure. Our results are at least comparable to the cohorts treated with a cemented 
THA, mentioned in table 1. Compared to the studies reporting on cohorts of the same 
size there seems to be a trend that the survival rates we obtain by using the biological IBG 
technique are more favourable, as can be seen in table 1. For the non-cemented total hip 
arthroplasty, only Wangen et al.16 reported the survival rates in patients less than 30 years 
old after a mean follow-up of more than 10 years. They reported 24 acetabular revisions 
in 49 hips at a mean follow-up of 13 years. McCullough et al. reported the survival rates 
in patients with a mean age of 24 years (range, 11 to 35) and showed a survival rate for 
the THA of 71% at 13 years.13 Both these studies do not equal our satisfying long-term 
survival rates. Over time, other techniques like the resurfacing prosthesis and large head 
metal-on-metal THA, have been introduced to treat young people with osteoarthritis. 
Unfortunately, the resurfacing prosthesis has shown its limitations, even before a large 
number of long-term follow-up studies were finished.38 A higher revision risk for younger 
female patients is observed, possibly related to their lower neck-head ratio, restricting 
the indications to younger males.39 Furthermore, the formation of pseudotumors and 
elevated ion levels which have been described for large head Metal-on-Metal THA as 
well, cause limitations to the application of these types of arthroplasties.40 
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The study of Girard et al. shows a very acceptable 10-year survival rate of 94.5% (95% 
CI: 80 - 98.6) for the non-cemented total hip arthroplasty with metal-on-metal bearings 
in patients younger than 30 years at time of surgery, but includes only 28 mm heads.22 
In our study we observed 13 revisions. Reasons for failure, in addition to the 4 septic 
revisions (3 complete revisions and one cup revision), are speculative and probably 
multifactorial. Two of our aseptic failures experienced a fall that could have caused 
accelerated loosening. 
One cup that was part of a total hip arthroplasty revision for septic loosening performed 
thirteen years earlier was re-revised. All other twelve revised hips were reconstructed 
on the acetabular side with IBG. All of them are still in situ and none of them show 
radiographic loosening. No femoral revisions for aseptic loosening were performed, 
emphasizing the good results of the cemented femoral component in this specific young 
population. The 100% survival of our revisions at ten-year follow-up is a promising result 
for young people. The outcome of the primary prosthesis and the subsequent revision 
outcome are equally important to determine the best solution in young patients.
IBG was associated with attractive survival results both in primary THA and revisions. 
Of the 9 primary total hip arthroplasties that needed a revision for aseptic loosening, only 
2 had received IBG. The results as shown in table 5 clearly outpoint a trend that IBG 
shows better results compared to non-IBG. Even after 15 years of follow-up, the survival 
rate for endpoint revision for any reason is still 83% (95% CI: 49 - 95) and for aseptic 
loosening even 86% (CI: 48 - 97). 
The number of hips in this study is acceptable regarding the longterm follow-up. 
In addition, the outcome of all revisions is known. In all patients, the same philosophy 
was used. As a referral centre we have included all indications except oncologic cases, 
which makes this an unique cohort. However, this study has some limitations. First, 
two patients were lost to follow-up. Often patients lost to follow-up are presented as 
censored cases. But as described by Murray, this might underestimate the revision rate.41 
Secondly, several different implants are used in our relatively small group of patients, 
however, all were cemented and all patients were treated in the same way according to 
our protocol. Survival curves for each type of implant separately showed no significant 
differences, and two of the components are still widely used (Exeter and Müller, 
Table 2).42 Furthermore, when reporting on surgery performed over a period of time, the 
use of different implants is almost inevitable. One can argue that 26 of our patients were 
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treated for rheumatic diseases and therefore may be low-demand patients. However, most 
series on hip arthroplasty outcome in very young patients include a significant number of 
patients with rheumatic disease. Lastly, it would be interesting to have more information 
about the activity level of all patients in addition to the collected HHS, OHS and VAS 
scores, as these scores might not completely satisfactorily describe level and duration 
for sport activity etc. In addition, as this study is performed in a consecutive series of 69 
THA’s performed in the period 1988-2004 it is not possible to retrospectively collect more 
information about the difference in pre- and postoperative activity level. 
CONCLUSIONS
The 10- and 15 year survival rates for endpoint aseptic loosening of cemented total hip 
arthroplasty in patients younger than 30 years are promising and indicate that this is a 
satisfying option for young people suffering of degenerative cartilage disease. IBG can be 
used to reconstruct the acetabular bone deficiency in primary as well as revision total hip 
arthroplasty. In our cohort none of the subsequent revisions was revised within 10 years. 
Particularly for young patients, reporting the survival of primary total hip arthroplasties 
and reporting the survival results of the revisions of the same cohort are equally important.
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ABSTRACT
Aims: This study was performed to update the long term results of the cemented 
Exeter stem in patients under 40 years at a mean follow-up of 13.6 years (10 – 20 
years). 
Methods: We included our original cohort of 104 cemented Exeter stems in 
78 consecutive patients with a mean age of 31 years (16 to 39). One patient was 
radiographically lost to follow-up.
Results: Six patients (eight hips) had died, none were related to their surgery. In 
addition to our earlier results, one traumatic periprosthetic fracture after a fall 
occurred and one stem broke. No revisions for aseptic loosening were performed 
during the whole study period, but 11 stems showed progressive radiolucent lines 
in one or more zones. The Kaplan Meier survival with endpoint revision for any 
reasons at 10 and 17 years was 97.1% (95% CI: 91.3-99.1) and 92.1% (95% CI: 74.1-
97.8), and 100% for aseptic loosening (95% CI: 83.8-100) both at 10 and 17 years. No 
additional stem was classified as radiographically loose. 
Conclusions: The clinical and radiographical results of the Exeter stem in young 
patients are satisfying up to 17 years after surgery. 
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INTRODUCTION
The Exeter Universal femoral component has been used in total hip arthroplasty 
(THA) since 19881. In 2008, we reported the clinical and radiographic outcome of 104 
consecutive primary cemented Exeter components in 78 patients under the age of 40 
years at time of surgery.2 In that review, which had a mean follow-up of 6.2 years (2 to 
13), the Kaplan-Meier survival analysis showed a probability of survival of the femoral 
component of 95.8% (95% CI 86.7 - 98.7) with revision for any reason as the endpoint, 
100% for aseptic loosening, and 96.7% (95% CI 86.1 - 99.3) for radiological failure. Three 
femoral components had been revised due to infection. 
Although the results of our previous study were promising, the question remains as to 
whether young patients with osteoarthritis of the hip should be treated with a cemented 
or an uncemented femoral component.3,4 Currently, there is a trend towards the use of 
uncemented implants. However, only by long-term follow-up studies can act as proof of 
concept for any hip implant to be established.
The purpose of the present study is to update results of our previous report to a mean 
follow-up of 13.6 years (10-20), emphasizing on the clinical and radiographic results of 
the cemented Exeter stem to prove if this cemented stem has an acceptable outcome for 
younger people. 
PATIENTS AND METHODS
The index primary arthroplasties were carried out between October 1993 and May 2004, 
during which time we performed 104 primary THAs in 78 consecutive patients using 
the Exeter Universal femoral component (Stryker Ltd, Newbury, United Kingdom). All 
patients were younger than 40 years at the time of surgery.
The cohort included 34 men (44%) and 44 women (56%) with a mean age of 31 years 
(range 16 to 39 years). Of these, 26 patients underwent bilateral procedures, resulting in 
50 left and 54 right THAs. Six patients (eight femoral components) had died of whom 
three patients (four stems) have been described in the previous report.2 These hips were 
followed until the patient died at 4.4, 5.3, 6.9, 7.5, 8.5, 8.6, 15.8, and 15.8 years respectively 
from causes not related to the surgery. Data of all deceased patients are included. The 
indications for the THR placement are summarised in Table І.
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TABLE І. 
Diagnosis at primary THA surgery (n=104)
Indication Number (%)
Congenital hip dysplasia 30 (28.8%)
Corticosteroid induced avascular necrosis 23 (22.1%)
Rheumatoid Arthritis 13 (12.5%)
Idiopathic avascular necrosis 5 (4.8%)
Perthes’ disease 5 (4.8%)
Post-traumatic arthritis 5 (4.8%)
Slipped capital femoral epiphysis 4 (3.9%)
Morquio’s disease 4 (3.9%)
Various diagnoses 15 (14.4%)
The posterolateral approach was used in all cases except one. In this case, the patient 
underwent trochanteric osteotomy, as the surgeon decided to carry out a THA instead of 
the planned Sugioka osteotomy.5 All femoral components were inserted using the third 
generation cementing technique with antibiotic loaded Simplex® Bone Cement (Stryker 
Ltd, Newbury, United Kingdom). 
Various acetabular components were used in this cohort: Charnley Elite cup 
(Depuy, Leeds, U.K.), the Exeter low profile cup (Stryker Newbury, UK) and the 
Exeter Contemporary cup (Stryker, Newbury, UK). The cups used in this cohort were 
produced of traditionally polyethylene. The newer used Contemporary cups, which were 
used in large numbers were made of Duration crosslinked polyethylene. All of them 
were cemented (fig 1). The peri-operative care and follow-up of the patients has been 
previously described.2 Their clinical and radiographic follow-up was biennial. At follow-
up, all patients were evaluated clinically using the Harris Hip Score (HHS)6, the Oxford 
Hip Score (OHS)7, and Visual Analogue Scales (VAS), graded 1-100, for pain in rest, 
pain during activity and overall satisfaction. In case of incomplete data collection at each 
review point, patients were contacted by telephone or mail for the missing data.
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FIGURE 1.
Radiographs showing the left Exeter femoral component in a 32-year-old man with 
corticosteroid induced avascular necrosis. A) pre-operative anteroposterior view of the left 
pelvis. B) left hip immediately post-operatively and c) 13 years post-operatively, with a stable 
prosthesis. 
Radiographic analysis was performed while using the anteroposterior and the faux profile 
view of all femoral components. Radiolucent lines were graded according to the 14 zones 
as described by Gruen et al.8 and femoral loosening was scored using the criteria as 
described by Harris et al.9 The cementation grade was classified according to Barrack et 
al.10 Subsidence (mm) was measured for all femoral implants according to Loudon and 
Olders’ method.11 Heterotopic ossification was classified according to Brooker et al.12 All 
femurs were assessed for cortical hypertrophy and/or atrophy, rounding-off of the calcar, 
and cement fractures. Acetabular inclination (°) was measured on the immediate post-
operative radiographs and the radiographs at last follow-up or the last radiograph prior 
to revision.13 Wear of the acetabular component was measured using Dorr and Wan’s 
method.14 
Kaplan-Meier survival analysis including 95% confidence intervals (CI) was 
performed for four different endpoints; revision of the femoral component for any reason, 
aseptic loosening of the femoral component, septic loosening and radiographic failure. 
Furthermore, an overall Kaplan-Meier survival analysis was calculated with revision of 
any hip component (acetabular or femoral) for any reason as the endpoint. All statistical 
analyses were performed using SPSS IBM Statistics 22 (IBM, Armonk, New York,) and 
SAS 9.2 (SAS institute, Inc, Cary, North Carolina).
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RESULTS
At final review, four femoral components had been revised during the total study period, 
leaving 100 femoral components in 76 patients available for evaluation. Three had been 
revised because of infection after 2.2, 3.4, and 6.1 years, as we described in our previous 
report. One further femoral component had been revised for fracture of the prosthesis 
after 16.5 years. This component was removed and a cement in cement revision was 
carried out using again an Exeter stem. At final review, no femoral component had been 
revised for aseptic loosening. 
Functional outcome
Clinical scores were available in 99 out of all cases. The preoperative median HHS was 
50 points (interquartile ranges 39-63), which improved to a median postoperative score 
of 93 points (interquartile ranges 77 to 98) at latest review. The median postoperative 
OHS was 18 points (interquartile ranges 12 to 24). The median VAS in rest was 0 points 
(interquartile ranges 0 to 20), during activity 0 points (interquartile ranges 0 to 30) and 
for satisfaction 90 points, (interquartile ranges 80 to 100) (table II). 
TABLE ІІ. 
Clinical scores presented as mean (range)
Preoperative score 
(range)
Postoperative score 
at previous report 
(range) 
Postoperative score 
at current update 
(range) 
HHS 51 (15 – 77) 89 (55 – 100) 85 (36 – 100)
OHS 39 (28 – 52) 19 (12 – 45) 19 (12 – 38)
VAS rest 7 (0 – 75) 10 (0 – 70)
VAS physical activity 19 (0 – 90) 19 (0 – 90)
VAS satisfaction 87 (20 – 100) 85 (0 – 100)
Scores include the mean Harris Hip Score (HHS), mean Oxford Hip Score (OHS) and mean Visual Analogue Scale (VAS) scores 
for pain in rest, during physical activity and satisfaction. The mean was used to compare the scores of the current update to 
the mean scores published in the previous report. 
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Radiological outcome
Radiographs were complete except in the case of one patient. The femoral component was 
implanted in more than 3° varus in 12 hips and and in more than 3° valgus in 11 hips.
In the 100 unrevised hips, radiolucent lines were seen in 40 different Gruen zones 
in 16 stems. In 11 hips, the radiolucent lines were progressive and in five they were not. 
As described in our previous report one hip was considered radiographically loose with 
lucent lines in all Gruen zones except for zones 3, 4 and 5. However, the prosthesis was 
still in place at final follow-up, the radiolucent lines had not progressed and the patient 
remained asymptomatic. Osteolytic areas were seen in five hips in a total of seven zones. 
Subsidence of more than 2 mm was seen in 34 hips (table III) of which one was 
considered a radiological failure. In this case a Vancouver type B2 periprosthetic 
fracture had occurred 11 years postoperatively, this was treated by plate fixation but 
without revision of the stem, resulting in subsidence of more than 5mm. Some cortical 
hypertrophy was seen in eight hips over a total of 15 zones, predominantly in zones 3,4 
and 5 (87%). Cortical atrophy was only encountered in one hip in zone 7. Rounding-off of 
the calcar was observed in 16 hips. Overall, 11 out of 104 cups showed more than 2 mm 
of polyethylene wear at final follow-up or at time of revision. 
TABLE III. 
Subsidence at latest follow-up by categories (n=103, 1 periprosthetic 
fracture excluded)
Subsidence Number of cases 
≤ 2 mm 70 (including 4 revisions)
>2 - ≤3 mm 23
>3 - ≤4 mm 8
>4 - ≤5 mm 2
Complications and reoperations unrelated to the femoral component
In total, 14 acetabular components were revised, three as a part of a revision total hip 
arthroplasty due to septic loosening, one because of recurrent dislocations and one for 
loosening following injury. The other nine components were revised for aseptic loosening.
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Previously we reported three patients with a deep infection and three hips with a superficial 
infection. Dislocation occurred in 12 hips, nine of which were treated conservatively 
and three underwent re-operation. The mean acetabular inclination immediately post-
operative was 46,0° (range 34.1-66.2) in the non-dislocated hips (n=89 ) and 46,6° (range 
25.7-57.2) in the hips that dislocated afterwards (n=12). Three were not measurable due 
to the mesh reconstruction. No additional dislocations in time after our previous report 
were observed. Detailed information regarding diagnosis and cup positioning in these 
dislocating hips is displayed in table IV. Heterotopic ossifications was seen in a total of 31 
patients; 12 were grade I, 13 grade II, and 6 grade III. 
Survival analysis
Kaplan-Meier survival analysis for the femoral component at up to 17 years follow-up 
showed survival rates of 92.1% (95% CI: 74.1-97.8) for revision for any reason (fig 2), 
100% for aseptic loosening (95% CI: 83.8-100) (fig 3), and 91.3% (95% CI: 71.5-97.6) for 
radiographic loosening (table V). The overall Kaplan-Meier survival was 87.4% (95% CI: 
79.3-92.5) at ten years and 75.7% (95% CI: 58.2-86.6) at 17 years with revision of any hip 
component for any reason as the endpoint. 
TABLE V.
Kaplan-Meier survival analysis for all Exeter femoral components
Revision for  
any reason  
(95% CI)
Revision for 
aseptic loosening 
(95% CI)
Revision for  
septic loosening  
(95% CI)
Failure for  
radiographic loosening 
(95% CI)
10-year survival 97.1% (91.3 - 99.1) 100% (96.7 - 100) 97.1 (91.3 - 99.1) 98.0 (92.3 - 99.5)
17-year survival 92.1% (74.1 - 97.8) 100% (83.8 - 100) 97.1 (91.3 - 99.1) 91.3 (71.5 - 97.6)
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FIGURE 2.
Stem survival for the endpoint revision for any reason.
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FIGURE 3.
Stem survival for the endpoint aseptic loosening.
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DISCUSSION
In this study we report the outcome of a series of all-cemented THA using the Exeter 
Universal cemented femoral component in patients under the age of 40 at time of their 
primary arthroplasty. Survival of the femoral component remained at 100% for aseptic 
loosening, with only one additional revision for fracture of the femoral component. 
This specific patient who weighed > 75 kg, had a very narrow femoral canal and a short, 
35.5 mm offset Exeter stem was implanted. However, these small components are rather 
slim proximally and we recommend they are not used in patients with a weight over 60 
kilograms (Exeter, Newburry, UK). At revision the distal part of the fractures prosthesis 
was easily removed and we re-implanted a new Exeter femoral component. One further 
complication, a periprosthetic fracture from a fall, was treated by plate fixation. The mean 
clinical scores remained satisfying over this period of follow-up and interestingly they are 
almost identical to our previous report, showing no significant decline between a mean 
follow-up of six and 13 years. The outlier functional and patient-reported outcome scores 
can be explained by co-morbidities, for example severe rheumatic arthritis, which limits 
overall function. One patient had an outlier VAS score for satisfaction of 0, caused by 
neurogenic defunctioning of his hip abductor muscles. 
There are some limitations to our study. The clinical scores of 20 patients were 
completed after their visit to the outpatients clinic, either by telephone or by mail. One 
patient was lost to radiological follow-up after six years, but clinically continued to report 
no concerns with their hip, suggesting that aseptic loosening is unlikely. Unfortunately, 
although we used standard hip scores, we did not actively collect data about sports 
activities, which may be of interest when treating younger patients. 
Some further radiological changes were noted at final follow-up, including an increase 
in radiolucent lines. This highlights the need for ongoing follow-up of younger patients. 
As illustrated in Table VI, most femoral components had radiolucent lines in only one 
or two Gruen zones. The 16% of hips with radiolucent lines in the 100 unrevised cases 
is higher than the 9.8% reported by Lewthwaite et al,15 in their study using the Exeter 
Universal femoral component and the 8.5% reported by Carrington et al16 at 15.7 years. 
This last study included patients of all ages. None of our patients had a Barack cementing 
C cement mantle and 11 of the 16 patients with radiolucent lines, subsidence of the 
component was 2 mm or less. There was no relationship between femoral component 
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subsidence and radiolucent lines in our study. On hip showed radiological signs of 
loosening of the femoral component, which were probably related to technical problems 
during the surgery because the centralizer was accidently not inserted. This patient did 
not show any radiological signs of acetabular component wear. Overall, we did not find 
any correlation between acetabular wear and the presence of femoral radiolucent lines. 
Only four of the 16 hips that had radiolucent lines around the femoral component had 
evidence of polyethylene wear of more than 2 mm.
TABLE VI. 
Displaying the number of patients with radiolucent lines including 
the Gruen Zones involved.
Gruen Zones with Radiolucent lines Number of cases (n)
0 84
1 2
2 1
7 3
8 1
12 1
13 1
1+8 2
8+14 1
9+10+11 1
1+6+7+8+9 1
1+7+10+11+12+13 1
1+2+6+7+8+9+10+11+12+13+14 1
Loudon and Older11 described femoral subsidence of more than 2 mm as abnormal. 
Williams et al1 reported that subsidence occurred in all Exeter components and 
Carrington et al16 showed a slow progressive increase in subsidence over time without 
clinical consequences. They stated that the definition of loosening as described by Harris 
et al9 is not appropriate to describe polished femoral components as their fixation is based 
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on the taper slip principle.17 Component subsidence slows with time in RSA studies and 
subsidence occurs within the cement mantle. This results in continuous compression of 
the cement and a bone-cement interface that maintains the secure fixation. This mode 
of action is completely different from other cemented designs such as the Charnley or 
Charnley Elite, which are not tapered and function as a “force closed” femoral component. 
They are not designed to subside: any subsidence takes place at the bone-cement interface 
which affects the stability of the implant.18
An alternative method of measuring subsidence was described by Fowler et al19. Some 
authors now define subsidence of >5 mm to be abnormal or even do not use subsidence 
as a criterion for defining radiological failure.15,20
In this study we found no difference in subsidence using either method. Only one 
femoral component migrated more than 5 mm and this was due to periprosthetic fracture. 
We did not find a strong relationship between the Barrack cement grading and 
subsidence, except for a relative higher number Barrack B cement mantles in stems with 
3mm to 4 mm subsidence. 
We noted an increase in femoral cortical hypertrophy in eight hips, in the distal Gruen 
zones. This appearance may indicate that the femoral component is loading the femoral 
shaft distally. The mean subsidence in these eight hips was 1.78, compared with 1.70 mm 
for the whole group, and did not reach significance. 
A number of dislocations were seen during the analysis, as we described in our 
original report. No further dislocations had occurred at final review. The reasons for 
dislocation remain unclear. Often patients with dislocations have had previous surgery, 
including osteotomies, or have abnormal anatomy of the hip, e.g. dysplasia. Alignment of 
the femoral component does not appear to affect this. 
The inclination of the acetabular component in patients with instability are shown in 
Table IV. The mean values show no difference to the cohort as whole. The design of the 
acetabular component used in the early part of the study may have had some bearing 
on outcome. A relatively high number of dislocations were seen with designs which 
had an elevated posterior rim (Contemporary hooded component, traditional Exeter 
components). This has been previously reported.21
Cemented femoral components in young patients have given results varying from 
poor to excellent.1,15,16,22-33 Uncemented femoral components have become increasingly 
popular.4,34-38 The literature comparing uncemented with cemented implants includes 
Cemented total hip arthroplasty and impaction bone grafting in young patients
82
4
reports in which obsolete cementing techniques or the use of a particular implant have 
been associated with a poorer outcome.3,34,35,37 The longer-tem survival of cemented 
implants has been improved substantially since third generation cementing techniques 
were introduced,15 and results are comparable with those of uncemented components.
Kim et al 39 reports a survival of cemented femoral components of 96% (95% CI 91-
100) at 26.1 years and 95% (95% CI 90-100) for uncemented stems at 26.1 years. Another 
of their series showed almost no difference between the Charnley Elite or Elite Plus stem 
and the cementless Profile stem at 20 years follow up with survival for any reason of 97% 
(95% CI 91-100) and 96% (95% CI 93-100) respectively.4 Factors contributing to these 
improved results for both cemented and noncemented stems in this study are the better 
cementation technique, better surgical skills regarding the uncemented implants and the 
improved designs of the femoral component. That is confirmed by Callaghan et al40 who 
noted a 5% femoral revision rate at 23.3 years patients whose average age was 42 years. 
When performing the cemented technique, polished tapered stems are nowadays widely 
used and have been reported frequently in literature.20,24,41 
Regarding in detail series of patients under 40 years, both cemented and uncemented 
femoral components seem to be an acceptable solution. In our former report we already 
mentioned Joshi et al, reporting a 97% survival at ten years with revision due to aseptic 
loosening as the endpoint for the original Charnley component and Chmell et al28 
reporting a survival rate of 95% at ten years with a variety of femoral components in 
patients under the age of 35. Garcia-Cimbrelo et al27 reports the survival of the Charnley 
flatback stainless steel stem inserted with a finger packing technique resulting in 5-, 15-, 
and 24-, year survival rates of 97%, 82%, 74%. Lampropoulou et al42 describes an overall 
probability of survival of 41 consecutive Charnley low-friction arthroplasty, with failure 
for aseptic loosening as the endpoint, of 95.1% (95% CI 91.75-98.45) at 10 years, 77.1 
(95% CI 73.9-803) at 20 years. Simon et al23 shows no revisions of the in total 34 polished 
triple tapered cemented MS-30TM and the polished double tapered cemented ExeterTM 
after a mean FU of 10.9 years in patients with avascular necrosis of the femoral head. In 
57 hips in patients with inflammatory arthritis no revision of the femoral component 
(inserted with hand mixed cement) was needed after a mean FU of 12.2 years (range 
7-19).25 For 49 uncemented stems Wangen et al43 reported at a minimum follow up of ten 
years that all fully coated with HA straight stems were well integrated, and no revisions 
were performed. Kim et al44 shows no aseptic loosening for their IPS femoral component 
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(DePuy, Leeds, united Kingdom) after a minimum of ten years and Girard et al45, reports 
a 100% survival in a cohort combining both cemented and uncemented stems at a mean 
of 108 months. 
In conclusion, we present an update of a cohort of young patients with hip osteoarthritis 
who all were treated with the Exeter cemented stem under the age of 40 years. In time we 
saw in 10% of the stems an increase in radiolucent lines, but no increase in radiographic 
loosening. In the future monitoring of these radiolucent lines will be necessary. The 
survival of this femoral component for aseptic loosening remained satisfying with a 100% 
survival at 17 years of follow-up, and the overall survival only slightly declined because 
of one stem fracture. The clinical outcome remained good. Therefore we think the use of 
cemented femoral components is an acceptable treatment option in very young patients. 
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ABSTRACT
We currently present the update of the 19 acetabular reconstructions that were 
still in situ at our previous report. All were performed with a cemented total 
hip arthroplasty and impaction bone grafting. At a mean follow-up period of 30 
years (range, 27 to 35 years) no additional patients were lost to follow-up during 
the current follow-up. Two additional patients (3 reconstructions) died. None of 
these were related to the surgery. An additional 5 reconstructions in 5 patients were 
revised, 4 for aseptic loosening and 1 for septic loosening, after a mean of 24 years 
(range 22 to 27 years), leaving 11 surviving hips in 11 patients which were clinically 
and radiographically evaluated. 
Kaplan-Meier survival at 30 years for the acetabular reconstructions regarding 
endpoints revision for any reason and aseptic loosening were 0.40 (95% CI: 0.23-
0.56) and 0.56 (95% CI: 0.35-0.73) respectively. Competing risk analysis showed 
that Kaplan-Meier overestimates the revision risk by 18% and 22%, respectively. 
Regarding radiographic loosening, survival was 0.53 (95% CI: 0.33-0.69) at 30 years.
In conclusion, cemented impaction bone grafting can be used as a reasonable 
long-term solution for demanding primary and revision acetabular reconstructions 
in young patients with acetabular bone defects. 
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BACKGROUND
There are no literature data available of the survival of acetabular reconstructions in young 
patients at 30 years or more after surgery. Only a few long term reports are available, 
which all describe a significant shorter duration of follow-up1-3. 
Therefore, we update the long-term outcome of our original cohort of 42 consecutive 
acetabular reconstructions with impaction bone grafting using morselized cancellous 
bone graft and a cemented cup 4, 5. The patient demographics have been displayed in Table 
I. We used impaction bone-grafting as a biological technique to reconstruct acetabular 
deficiencies in these younger patients. This consecutive cohort consisted of 23 primary 
and 19 revision acetabular reconstructions in 37 patients. Mean age was 37 years (range, 
20 to 49 years) at the time of surgery.
TABLE I. 
Patient Demographics
Patients (n) (%) Reconstructions (n) (%)
In series 37 100 42 100
Sex
F 22 60 24 57
M 15 40 18 43
Type of defects according to AAOS classification
Segmental 1 2
Cavitary 27 64
Combined 14 33
Deaths during follow-up period 7 19 9 21
Lost to follow-up 1 3 1 2
Revisions during follow-up 21 50
Due to septic loosening 3 7
Due to aseptic loosening 12 2
Due to wear 4 10
During stem revision 2 5
Six surgeons were involved in this single center study. Clinical and radiographical data 
were collected prospectively. In our first paper the minimum follow-up was 15 years; 1 
patient was lost to follow up (1 reconstruction) and 4 patients (5 reconstructions) had 
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died. Four primary and 4 revision reconstructions were (re-)revised. The acetabular 
revision for any reason Kaplan-Meier analysis revealed a 20-year survival rate of 0.80 
(95% confidence interval, 0.67-0.94) as can be seen in Table II. 
The average follow-up of the next update report was 23 years (range, 20 to 28 years)4. 
One more patient had died and another 8 cups had to be revised resulting in a total of 
16 (re)revisions (7 primary and 9 revisions), leaving 19 surviving reconstructions in 17 
patients. The Kaplan-Meier analyses showed a survival of the acetabular component at 25 
years of 0.52 (95% confidence interval, 0.35 to 0.72) with endpoint removal of the cup for 
any reason (Table II).
The purpose of the present study was to update the clinical and radiographic results of 
the 19 surviving reconstructions of our previous report after a mean follow-up of 30 years 
(range, 27 to 35 years) in these young patients.
MATERIALS AND METHODS
In this update, 19 surviving reconstructions in 17 patients are presented. This includes 10 
primary reconstructions and 9 revision reconstructions in 5 male and 12 female patients. 
All had received the combination of a cemented cup and IBG which was the only technique 
used in our department to treat acetabular bone stock loss. A posterior approach was 
used and after resection of the femoral head or removal of the failed component the IBG 
technique was performed as previously described4, 5. In short, segmental defects were 
reconstructed with use of a metal mesh or a solid graft.
The femoral head was used as autograft or autogenous bone from the iliac crest was 
used. In case of revision surgeries fresh frozen non-irradiated femoral head allografts 
were used, while in case of revision surgeries performed after hip resurfacing arthroplasty, 
reconstructions with use of the femoral head, the iliac crest or autogenous bone from 
the iliac crest combined with a femoral allograft were performed. After lavage, the grafts 
were impacted and the defect was reconstructed layer-by-layer using a trial acetabular 
prosthesis and a mallet. In 16 of these 19 reconstructions a thin Vitallium wire mesh 
(Mecron, Berlin, Germany) was used to cover the graft. After pressurization of the bone 
cement, a 32 mm all-polyethylene cup was inserted. Eleven of the original 25 Muller 
and 8 of the original 17 Allopro cups (Sulzer, Winterthur, Switzerland) were reviewed. 
Further details have been described in our previous reports4, 5. 
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All reconstructions were prospectively followed clinically and radiographically, annually 
or biennially for a minimum of 27 years or until revision or death. 
As in our prior publications, acetabular defects were classified by the AAOS 
classification system 6 (Table I). Anteroposterior and lateral radiographs were reviewed for 
radiographic evidence of graft incorporation7, osteolysis and radiolucent line formation8, 
heterotopic ossification9 and linear polyethylene wear10. 
At final review all patients with surviving hips were seen for clinical and radiographic 
review and their Harris hip score (HHS) and the Oxford Hip Questionnaire Score11 
were again obtained. All patients who died during the follow-up period were followed 
until their death. Their data including revisions and radiographical examinations were 
included in this report. 
Survival analyses were performed for 3 endpoints: revision of the acetabular 
component for any reason, revision for aseptic loosening, and radiographical failure. 
The latter was defined as radiolucent lines in all 3 zones of Charnley and DeLee or a 
migration of 5 mm or more in any direction relative to the interteardrop line as seen on 
the anteroposterior radiograph.
In the presence of a competing risk such as death, the standard Kaplan-Meier method 
will always overestimate the true revision rate12-15. Due to the long term follow-up and 
the increasing number of patients who died throughout the study period we calculated 
not only Kaplan-Meier survival estimates but also took into account the competing risk 
of death. 
Standard Kaplan-Meier survival analysis was used to estimate the survival percentage 
(KM) for each of the 3 endpoints. The estimated percentage of procedures revised was 
calculated as 1 – estimated survival percentage (1-KM).
To take into account the competing risk of death, the cumulative incidence function 
(CIF) of revisions in the presence of death was used. Analyses were performed for 
the whole group of reconstructions and stratified by primary and revision acetabular 
reconstructions. Log-rank tests were used to test differences between Kaplan-Meier 
estimates of primary and revision acetabular reconstructions, Gray’s (log-rank) tests were 
used to test differences in CIF between groups.
Kaplan-Meier and cumulative incidence function estimates were reported with their 
95% confidence intervals (CIs). Statistical analyses were performed using R (version 
3.2.4) with packages ‘rms’ and ‘cmprsk’16-18. 
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RESULTS
Clinical results
Of the 19 reconstructions in 17 patients which were available for this update report, no 
additional patients were lost to follow-up during the current follow-up. Two additional 
patients (3 reconstructions) died. None of these were related to the surgery. An additional 
5 reconstructions in 5 patients were revised after a mean of 24 years (range 22 to 27 
years), leaving 11 surviving hips in 11 patients which were clinically and radiographically 
evaluated after a mean follow-up period of 30 years (range, 27 to 35 years). All of them 
were able to attend our outpatient clinic for review. The mean Harris hip score of these 
surviving hips was 88 (range, 59 to 100) and the mean Oxford Hip Questionnaire Score 
was 20 (range, 12 to 40).
Regarding the entire group of 42 reconstructions in 37 patients, 1 patient (1 
reconstruction) has been lost to follow-up already since the first report. 7 patients (9 
reconstructions) died.
Revisions
Four out of 5 additional revisions presented in this updated review of the acetabular 
reconstructions were revised for aseptic loosening, which in one case occurred a few 
weeks after a traumatic event. One additional reconstruction was revised showing 
culture-proven coagulase negative staphylococcus septic loosening at 22.5 years. In this 
update, no additional revisions for wear or osteolysis were performed.
Revisons entire original cohort
Overall, 21 out of 41 acetabular reconstructions of the original whole cohort have been 
revised for any reason after minimal 27 years of follow-up. Of these 21 revisions, 12 were 
performed because of aseptic loosening after mean 19.8 years (range, 6.4 to 27.0 years): 
7 originally had a cavitary defect (type-2) and 5 a combined defect (type-3). Six were 
primary reconstructions, and 6 were revision reconstructions. Four reconstructions were 
revised because of wear and osteolysis after a mean of 18.8 years (range, 8.9-23.2 years), 
showing no intra-operative or radiographical loosening. Three reconstructions were 
revised because of culture-proven septic loosening after 3, 14.5 and 22.5 years. Another 
2 reconstructions had been revised at 12.3 and 18.3 years during a revision of the stem 
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because of persistent instability and matching problems. These 2 reconstructions were 
both intra-operatively and radiographically well fixed.
Radiographic results of the non-revised reconstructions
Six of the 11 surviving acetabular reconstructions showed radiolucent lines in 1 or 2 
zones of Charnley and DeLee. All of them were stable and had not shown any progression 
since the last update in 2011. No osteolysis was seen around these eleven reconstructions. 
None of the 11 surviving cups showed radiographic loosening. Six reconstructions 
showed periarticular ossifications Brooker grade I, one grade II and one grade III. The 
mean polyethylene wear for all surviving implants was 2.3 mm (range, 1.2 to 4.2 mm). 
We also studied the 9 non-revised reconstructions in the 7 deceased patients. One 
patient (1 reconstruction) has not been able to attend the outpatient clinic in one 
of our previous reports due to dementia over the last years before she died. We used 
her last available radiograph available from 2005. For another 2 deceased patients (3 
reconstructions) radiographic data were incomplete. With these limitations, none of the 
reconstructions was radiographically loose, 2 showed a progressive line in one acetabular 
zone and two showed a non-progressive radiolucent line in one acetabular zone. None 
showed osteolysis.
Radiographic Results of the revised reconstructions
Of the entire original cohort of 21 revised reconstructions, 15 showed definitive 
radiographic loosening of the cup (Table III). Nine had radiolucent lines in all three 
zones, 3 cups migrated more than 5 mm. Of the other 6 revised reconstructions, 3 showed 
radiolucent lines in one zone and 1 showed radiolucent lines in two zones. Two of them 
showed osteolysis in one zone. The mean polyethylene wear of the revised reconstructions 
up to last follow-up was 2.3 mm (range, 0 to 4.2 mm).
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Additional reoperations and 
complications
Since our previous update, 1 additional stem 
revision has been performed in the patients who 
did not undergo a revision of the acetabular 
reconstruction. Two other additional stems were 
revised with a cemented stem at time of the 
revision of the acetabular reconstruction.
One of these patients also developed a 
cerebrovascular accident immediately post-
operatively and anti-coagulation therapy was 
started immediately. Symptoms including the 
paresis of his arm and leg recovered fully the 
following days. 
Survivorship Analysis
The Kaplan Meier survival of the acetabular 
reconstruction for the different endpoints are 
displayed in Table IV. The Kaplan Meier survival 
with revision for any reason as the endpoint 
was 0.40 at 30 years (95% CI: 0.23-0.56) (Figure 
1), so the cumulative proportion of procedures 
revised (1-KM) was 0.60 (95% CI: 0.44-0.77). The 
competing risk analysis showed the cumulative 
incidence function of revision in the presence of 
death (CIF) was 0.51 (95% CI: 0.33-0.65) at 30 
years (Table IV). Figure 2 shows the overestimation 
of revision by 18% of the KM-analysis for revision 
for any reason after a follow-up of 30 years taking 
into account the competing risk of death. The 
Kaplan Meier survival with revision for aseptic 
loosening as the endpoint was 0.56 (95% CI: 0.35-
0.73) at 30 years, resulting in a cumulative failure 
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incidence (1-KM) of 0.44. The competing risk analysis for endpoint revision for aseptic 
loosening showed a cumulative failure incidence of 0.36 (95% CI: 0.17-0.51) at 30 years. 
At time of review none of the surviving reconstructions showed complete radiographic 
loosening. Comparison of survival rates of primary and revision reconstructions did not 
show any statistically significant differences. 
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FIGURE 1.
The Kaplan Meier survival proportion of the acetabular reconstructions (KM) for the endpoint 
revision for any reason.
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FIGURE 2.
The cumulative proportion of procedures revised (1-KM) and the competing risk analysis 
showing the cumulative incidence function (CIF) for all acetabular reconstructions and their 
upper and lower 95% confidence intervals with revision of the acetabular component for any 
reason as the endpoint. 
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CONCLUSIONS
This long-term follow-up study has been conducted to study if the results of impaction 
bone grafting can be used to perform a biological repair of acetabular bone defects and 
hence facilitate future revisions in younger patients. We still use this acetabular bone 
impaction technique in complex primaries and revision surgery. 
Compared to our last update, 5 additional revisions have been performed, of which 
3 were already reported to be radiographically loose in our last update. The survival has 
further declined at a reasonable constant rate over time. However, the results of 70% 
survival at 25 years and 56% at 30 years for endpoint revision for aseptic loosening are 
still acceptable19 as we used the technique in demanding primary total hip arthroplasties 
and acetabular revisions. As shown in other studies13, 14, 20, 21, the Kaplan Meier estimation 
ignores death as competing risk leading to biased estimations of the probability of 
revision surgery. In our study, we see an overestimation of 18% for endpoint revision for 
any reason at 30 years follow-up. Interestingly, at current review none of the surviving 
implants were radiographically loose, and therefore no accelerated decline of survival is 
expected. Furthermore, no osteolysis was seen around these reconstructions, supporting 
the fact that this technique both in primary and revision reconstructions can make these 
reconstructions last for over 30 years. Another advantage of this technique is that in case 
of failure of the reconstruction, again a cemented cup and IBG can be used to perform 
a (re-)revision (Figure 3). In those cases we used an allograft. Technically this can be 
perfectly performed as the remaining bone stock after reconstruction with IBG can be 
used to again perform a reconstruction with cement and IBG.
There are a few reports on acetabular reconstructions in younger patients, all 
describing a shorter duration of follow-up than we report in the current study. Kim et 
al2 reported a 15-year Kaplan Meier survival rate for the revised acetabular components 
of 93% using revision or radiological evidence of loosening of implant failures as the 
endpoint. Their data are comparable to our outcome at 15 years. Comba et al1 report a 
seven year survival of 30 acetabular revisions in patients under 55 years old, performed 
with impaction bone grafting and cemented cups, with need for revisions as the endpoint 
of 89% (CI 95% 71.9-96.4%). Lee et al3 reports the results of 181, mostly uncemented 
revisions (109 complete revisions), combined if necessary with use of structural and 
morselized allografts in 102 patients aged 50 years or younger after a mean follow-up of 
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eleven years. Twenty-seven patients were lost to follow-up before minimum survival of 2 
years. The 25-year survival for endpoint re-revision for any reason was 33%. To the best 
of our knowledge, no other studies reporting an over 25 year survival of primary and 
acetabular reconstructions are available. 
Our results support the fact that the technique of impaction bone grafting can be a 
reasonable long-term solution in young patients with acetabular bone defects.
FIGURE 3.
An example of a female who received a revision reconstruction at the age of 36. At the age of 
63 her reconstruction was re-revised. A) immediately post-operatieve revision reconstruction in 
1985. B) pre-operative radiograph showing tilting of the cup in 2011. C) the reconstruction which 
has been revised in 2011 is still in situ in 2016. 
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ABSTRACT
Despite the worldwide usage of the cemented Contemporary acetabular component 
(Stryker), no published data are available regarding its use in patients aged < 50 
years. We undertook a mid- to long-term follow-up study, including all consecutive 
patients aged < 50 years who underwent a primary total hip replacement using 
the Contemporary acetabular component with the Exeter cemented stem between 
January 1999 and January 2006. There were 152 hips in 126 patients, 61 men and 
65 women, mean age at surgery 37.6 years (16 to 49 yrs). One patient was lost to 
follow-up.
Mean clinical follow-up of all implants was 7.6 years (0.9 to 12.0). All clinical 
questionnaire scores, including Harris hip score, Oxford hip score and several visual 
analogue scales, were found to have improved. The eight year survivorship of all 
acetabular components for the endpoints revision for any reason or revision for 
aseptic loosening was 94.4% (95% CI: 89.2-97.2) and 96.4% (95% CI: 91.6-98.5), 
respectively.
Radiological follow-up was complete for 146 implants. The eight year survival for 
the endpoint radiological loosening was 93.1% (95% CI: 86.2-96.6). Three surviving 
implants were considered radiologically loose but were asymptomatic. The presence 
of acetabular osteolysis (n = 17, 11.8%) and radiolucent lines (n = 20, 13.9%) in the 
144 surviving cups indicates a need for continued observation in the second decade 
of follow-up in order to observe their influence on long-term survival.
The clinical and radiological data resulting in a ten-year survival rate > 90% in 
young patients support the use of the Contemporary acetabular component in this 
specific patient group.
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The results of cemented primary total hip replacement (THR) have been excellent over 
the recent decades, with national joint registries reporting revision-free survival rates 
between 90% and 98.2% at ten years.1-3 In addition, Callaghan et al4 described a survival 
rate of 88% for cemented Charnley (Thackray Limited, Leeds, UK) THRs after 30 years. 
Unfortunately, in patients aged < 50 years results have been less encouraging. This has 
created a shift towards uncemented designs and the use of other bearings in this group of 
patients.5 However, based on recent long- term results of cemented THR using modern 
cementing techniques,6-8 and the unexpected and ongoing problems with metal-on-
metal articulations,9 the discussion regarding hip replacement in this group of young 
patients has been re-opened. In particular the authors suggest that in current orthopaedic 
practice, attention has been drawn to the importance of surveillance of newly introduced 
implants, as well as ongoing long-term results of implants that are currently in use all over 
the world.
The cemented Contemporary acetabular component (Stryker-Howmedica, Newbury, 
United Kingdom), which has been available for nearly 20 years, has been used in young 
patients at our institution for over 15 years. Registry data reveal it to be a commonly used 
component in primary THR over the last decade.1-3,10
The registries of England and Wales, Australia, and New Zealand report a cumulative 
revision rate of the Contemporary acetabular component of 6.1% (95% CI: 4.4-8.5) 
after ten years,10 of 1.26% (95% CI: 1.10-1.44) at five years1 and a revision rate per 100 
component-years of 0.64 (95% CI: 0.56-0.73), respectively.3 The Danish and Swedish 
registries found the survival rate of this acetabular component to be 96.0% (95% CI: 95.2-
96.8) at five years11 and 97.3% (95% CI: 95.3-99.3) at six years, respectively.2 There are 
no reports of ten-year survival, radiological and clinical outcomes of the Contemporary 
component in primary THR in young patients. We report the mid-term clinical and 
radiological results of this device in primary THR in patients aged < 50 years.
Cemented total hip arthroplasty and impaction bone grafting in young patients
108
6
PATIENTS AND METHODS
Conventionally our department performs cemented THR regardless of the patients’ 
age. Between January 1999 and January 2006, all consecutive patients aged < 50 years 
undergoing primary THR received the Contemporary acetabular component. In total, 
152 such components were used as part of a primary THR in 126 consecutive patients, 
of whom 61 (48.4%) were men. The mean age at operation was 37.6 years (16 to 49). 
There were 73 THRs (48.0%) inserted on the right side and 26 patients had a bilateral 
procedure. The mean body mass index (BMI) was 25.5 kg/m2 (15.2 to 42.0). The primary 
indications in the majority of cases were developmental dysplasia of the hip (n = 33 hips, 
21.7%) and corticosteroid induced avascular necrosis (n = 29 hips, 19.1%) (Table I). Only 
THRs performed for oncological reasons were excluded.
TABLE I.
Indications for primary total hip replacement.
Indications N (%)
SOA due to CHD 33 21.7
Corticosteroid induced AVN 29 19.1
Primary osteoarthritis 15 9.9
SOA due to rheumatoid arthritis 11 7.2
SOA due to Perthes’ disease 11 7.2
SOA due to epiphyseal dysplasia 9 5.9
Posttraumatic osteoarthritis 8 5.3
AVN of unknown origin 6 3.9
SOA due to ankylosing spondylitis 5 3.3
Neonatal septic coxitis 5 3.3
Epiphysiolysis 5 3.3
SOA due to posttraumatic AVN 4 2.6
Morquio’s disease 4 2.6
Polycystic hip disease 2 1.3
Osteogenesis imperfecta 2 1.3
SOA due to protrusio acetabuli 1 0.7
Alcohol induced AVN 1 0.7
Pigmented villonodular synovitis 1 0.7
Total 152 100.0
SOA: secondary osteoarthritis, CHD: congenital hip dysplasia, AVN: avascular necrosis
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The cemented Contemporary acetabular component has four PMMA cement spacers 
which are intended to ensure a cement mantle of 2 mm to 3mm,12 and is available in a 
hooded and flanged version. We used a hooded device in 126 (82.9%) THR and a flanged 
version in 26 (17.1%). The component was manufactured from ultra high molecular 
weight polyethylene (UHMWPE) and combined in all cases with the cemented Exeter 
femoral stem (Stryker-How- medica). In 2001, the morse taper of the Exeter stem was 
changed, resulting in a cemented Exeter stem with a conventional trunnion being used 
in 40 hips and a V40 trunnion in 112 hips. Only 28 mm diameter metal heads were 
used to match the 28 mm inner diameter of the acetabular component; the median outer 
diameter was 52 mm (48 to 60). The posterolateral approach was used in all cases, with 
the operations performed by senior orthopaedic surgeons (JWMG, BWS).
Deficiencies in acetabular bone stock were present in 63 hips (41.4%) and classified 
according to the classification of the American Academy of Orthopaedic Surgeons.13 
There were 16 segmental defects, 25 cavitary defects and 22 combined deficiencies. All 
defects were reconstructed with impaction bone-grafting (IBG)14 using an autograft in 
49 cases, an allograft in four and a combination of an auto- and an allo- graft in ten hips. 
Wire meshes were used in 41 hips (27.0%).
Components were implanted using a third generation technique including optimal 
cement preparation, pulsatile lavage, pressurising and the use of spacer to guarantee an 
even cement mantle thickness and antibiotic loaded cement (Surgical Simplex; Stryker-
Howmedica). The mean operating time was 128 minutes (65 to 320) and mean length of 
stay after THR was 11.4 days (5 to 33). Each patient received 2 g intravenous cefazolin 
as antibiotic prophylaxis pre-operatively. Post-operatively, patients were treated with 
subcutaneous low-molecular-weight heparin for six weeks. In order to prevent heterotopic 
ossification, non-steroidal anti-inflammatory drugs (NSAIDs) were used during the first 
post-operative week. When NSAIDs were contraindicated, patients received a single dose 
of 7 Gy radiation pre- operatively.
Clinical and radiological data were collected prospectively at routine review at six 
weeks, three and six months and one year after surgery. Follow-up visits were annually 
or biannually. Patients who were unable to attend for follow-up had radiographs taken 
in another hospital, which were sent to our institution for analysis. Anteroposterior 
(AP) radiographs of the pelvis were evaluated on a consensus basis by three authors 
(MWJLS, CT and BWS). Evaluation of the radiographs included loosening of the 
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acetabular component, osteolysis and radiolucent lines (RLLs), component migration, 
cysts, fractures, tilting of the component, polyethylene wear and the presence of hetero- 
topic ossification. Loosening was defined as migration > 5 mm or tilting of the implant 
> 5°, both measured in relation to the inter-teardrop line.15 RLLs with a demarcation > 2 
mm were recorded. Osteolysis and RLLs were assessed according to the zones described 
by DeLee and Charnley16 for the acetabular component. Periarticular ossifications were 
classified according to Brooker et al.17 Linear wear was calculated using the method of 
Dorr and Wan.18
Clinical and functional evaluation was performed by independent researchers at our 
outpatient clinic. This included the Harris hip score (HHS),19 Oxford hip score (OHS),20 
and visual analogue scales for pain at rest (VAS rest) and during physical activity (VAS 
activity). The VAS scale ranged from 0 (no pain) to 100 (unbearable pain). A VAS for 
satisfaction was also included (VAS satisfaction) ranging from 0 (not satisfied at all) to 
100 (complete satisfaction).21
Statistical Analysis 
Kaplan–Meier survival analyses with 95% confidence intervals (CIs) were performed for 
all acetabular components, with end-points including revision for any reason, revision 
for aseptic loosening, revision for septic loosening and survival up to the identification of 
radiological loosening. We also calculated a worst-case scenario, defining revision, lost to 
follow-up or radiological failure as a collective endpoint. Time to revision was defined as 
the time between the date of implantation of the THR and the date of revision. Patients 
without revision were censored at the date of the last radiological or clinical follow-up or 
at death. To indicate significant differences in survival between groups we used the log-
rank test. A linear model was used to assess whether the HHS and OHS scores differed 
between patients with a surviving implant and patients with a revision. All calculations 
were made with SPSS v18.0.2 (SPSS Inc., Chicago, Illinois) and SAS v9.2 (SAS Institute 
Inc, Cary, North Carolina). A p-value < 0.05 was considered significant.
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RESULTS
During follow-up, nine patients (13 hips) died at a mean follow-up of 4.2 years (1.1 to 
7.8) for reasons not related to the THR and none of them had required revision of their 
THR. These patients had all been followed up to the point of their death and so their 
data are included. Mean clinical follow-up of all acetabular components (n = 152) was 
7.6 years (0.9 to 12.0). Three patients (six hips) had no recent radiograph. One patient 
(two hips) was lost to follow-up after 3.6 years with a radiological follow-up of only one 
month. The second patient was pregnant at the time of review and had a clinically well-
functioning prosthesis, whereas the third patient agreed to visit our outpatient clinic but 
did not attend her appointment. On telephone interview she had no complaints regarding 
her hip prosthesis. Their most recent available radiographs were used in the radiological 
evaluation.
The median pre- and post-operative available HHS, OHS and VAS scores after median 
follow-up are illustrated in Table II. Post-operative complications, excluding those 
resulting in revision, are listed in Table III. In total, 18 post-operative complications were 
seen in 16 patients, of which seven resulted in surgical intervention. One periprosthetic 
fracture occurred in femoral Gruen zone I 6.4 years after primary THR.22 The fracture 
was secured with a plate and cerclage wires and the patient was functioning well at final 
follow-up, 3.5 years after fixation of the fracture. Overall, eight hips had one or recurrent 
dislocations resulting in a dislocation rate of 5.3%. No venous thromboembolic (VTE) 
complications were noted.
TABLE II. 
Pre- and post-operative Harris hip score (HHS), Oxford hip score (OHS) and visual analogue 
scales (VAS) for pain at rest, pain during activity and satisfaction. Based on all available scores of 
patients up to their last visit or revision of their acetabular component.
Median score (Range)
Preoperative scores N Postoperative scores N Follow-up in years
HHS 51 (15 to 81) 73 94 (41 to 100) 149 6 (0.3 to12)
OHS 38 (24 to 57) 59 16 (12 to 49) 149 6.5 (0.5 to12)
VAS rest 45 (0 to 100) 59 0 (0 to 90) 150 7 (0.5 to12)
VAS activity 72 (18 to 100) 59 75 (0 to 100) 150 7 (0.5 to 12)
VAS satisfaction 11 (0 to 50) 42 90 (10 to 100) 145 6.3 (0.5 to 12)
HHS: Harris Hip Score, OHS: Oxford Hip Score, VAS: Visual Analogue Scale
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TABLE III.
Post-operative complications, excluding complications leading to revision
Complication N
Complications requiring surgery
Permanent femoral nerve palsy 1
Peri-prosthetic fracture 1
Recurrent dislocation 1
Fascia repair 1
Debridement of excess cement 1
Removal of heterotopic ossifications 1
Debridement under suspicion of deep infection, negative for infection 1
Complications not requiring surgery
Urinary tract infection 1*
Post-operative haematoma 1†
Single dislocation 2*
Recurrent dislocation 2
Retention bladder 1
Pneumonia 1†
Haemolysis 1
Complaints of pain, recovering fully 1
Transient sensory obturator nerve palsy 1
*One patient had a urinary tract infection and a single dislocation. 
† One patient had a post-operative haematoma and developed a pneumonia post-operatively.
A total of eight acetabular components were subsequently revised: five due to aseptic 
loosening after 1.1, 2.5, 3.1, 5.0 and 6.0 years post-operatively, respectively. One hooded 
implant was revised for recurrent subluxation at 3.5 years and one acetabular component 
showed loosening after 4.3 years following trauma. One hooded implant without IBG 
was revised as part of a complete revision for septic loosening at 0.9 years. One further 
stem was revised for septic loosening without removal of the acetabular component after 
5.6 years, despite this partial revision the infection could be cured. Two modular femoral 
heads were exchanged following recurrent subluxations one week and one month after 
surgery, respectively. No stems were revised for aseptic loosening.
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TABLE IV. 
Radiological evaluation of the surviving acetabular components, based on their last available 
radiograph, and revised implants, based on their last radiograph before revision.
Surviving implants (n=144) Revised implants (n=8)
Stable Radiologically loose Stable Radiologically loose
Total (n=152) 141 3 3 5
Radiolucent lines
Immeasurable 0 0 0 1
None 123 1 1 1
Yes 18 2 2 3
Zone(s)
I 9 0 1 0
II 2 0 0 0
III 3 0 1 0
I + II 1 0 0 0
II + III 2 0 0 0
I + III 1 0 0 0
I + II + III 0 2* 0 3†
Stability
Progressive 8 1 1 2
Stable 10 1 1 1
Osteolysis
None 124 3 3 5
Yes 17 0 0 0
Zone(s)
Zone I 9 0 0 0
Zone II 2 0 0 0
Zone III 4 0 0 0
Zone I + II 1 0 0 0
Zone II + III 1 0 0 0
Cysts
None 140 3 3 5
Yes (zone II) 1 0 0 0
Migration >5mm
Immeasurable 0 0 0 1
No 141 3 3 3
Yes 0 0 0 1†
Wear
Immeasurable 6 0 0 2
<2mm 130 2 3 2
>2mm 5 1 0 1
Tilting
<5° 141 1 3 2
> 5° 0 2* 0 3†
Periarticular ossifications
None 102 3 3 4
Brooker grade I 26 0 0 1
Brooker grade II 8 0 0 0
Brooker grade III 5 0 0 0
Brooker grade IV 0 0 0 0
* One component showed lines in all three zones and tilting. 
† One cup showed lines in all three zones, migration and tilting.
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Radiographs of all 144 surviving acetabular components, including three hips with 
an incomplete follow-up, were available for review. Due to extensive acetabular 
reconstructions using metal meshes, linear wear could not be measured accurately in six 
hips. A typical case is shown in Figure 1. A total of three surviving acetabular components 
were considered radiologically loose after 1.4, 7.8 and 8.0 years of follow-up (Table IV). 
These patients were clinically asymptomatic and functioning well after 8.3, 11.0 and 8.9 
years, respectively.
FIGURE 1.
Anteroposterior pelvic radiograph of a man with Perthes’ disease, treated with several 
osteotomies of the femur and pelvis, including a Chiari osteotomy, before receiving a THA with a 
Contemporary cup at the age of 30. At final follow-up, 6.6 years post-surgery, we were unable to 
determine whether wear was present, due to a superolateral rim defect that was reconstructed 
with IBG and a rim mesh.
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An example of a radiologically stable, surviving acetabular component is shown in Figure 
2. Of the 141 surviving stable implants, 18 (12.8%) showed RLLs, most frequently in zone 
I (Table IV). All lines emerged in the interface between bone and cement. All grafts were 
fully incorporated. UHMWPE wear of more than 2 mm was present in five out of 130 
hips (3.8%) (Table IV). These five hips had a mean radiological follow-up of 9.1 years (8.0 
to 10.6).
FIGURE 2.
A 43-year old female with developmental dysplasia of the left hip. Preoperative AP radiograph 
(a), two months post-operative AP radiograph (b) showing the THA with Contemporary cup and 
10 years post-operatively (c) with no signs of radiographic loosening or wear of the cup.
At time of revision, five out of eight revised acetabular components were considered 
radiologically loose after 2.2, 2.4, 2.8, 2.9 and 4.3 years. Results of radiological evaluation 
at time of revision can be found in Table IV. Kaplan–Meier survivorship of the 
Contemporary acetabular components with revision for any reason as the endpoint was 
94.4% (95% CI: 89.2-97.2) at eight years, survivorship for aseptic loosening was 96.4% 
(95% CI: 91.6-98.5) (Fig. 3). The eight-year survival was 93.1% (95% CI: 86.2-96.6) with 
radiological loosening of the acetabular component as the endpoint (Fig. 3).
Survival with revision for aseptic loosening at five years was 97.6% (95% CI: 92.6-
99.2) for the hooded and 100% (95% CI: 86.7-100) for the flanged implants (Table V). 
However, this difference in survival was not significantly different (log rank, p = 0.332).
Survivorship with revision for aseptic loosening was 98.5% (95% CI: 89.6- 99.8) for 
the components implanted with IBG and 94.8% (95% CI: 86.8-98.0) for those implanted 
in the absence of IBG at eight years. This difference in survival between the two groups 
was not statistically significant either (log-rank, p = 0.270).
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FIGURE 3.
Survival curves with asymmetrical 95% confidence-intervals for the endpoints revision for any 
reason (a), revision for aseptic loosening (b) and radiographic loosening (c).
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TABLE V. 
Survival for all Contemporary components (n=152), and the flanged (n=26) and hooded 
(n=126) implants separately, for different endpoints, including a worst case scenario (NE, not 
estimable).
Survival (%, 95% CI)
5 years (%) 8 years (%)
5 years 8 years Flanged Hooded Flanged Hooded
Revision for any 
reason
95.9%  
(91.2-98.2)
94.4%  
(89.2-97.2)
100.0%  
(86.7-100.0)
95.1%  
(89.5-97.8)
NE 93.4%  
(87.2-96.6) 
Number 135 71 21 114 70
Revision for  
aseptic loosening
98.0%  
(93.8-99.3)
96.4%  
(91.6-98.5)
100.0%  
(86.7-100.0)
97.6%  
(92.6-99.2)
NE 95.8%  
(90.1-98.2)
Number 135 71 21 114 70
Revision for  
septic loosening
99.3%  
(95.4-99.9)
99.3%  
(95.4-99.9)
100.0%  
(86.7-100.0)
99.2%  
(94.5-99.9)
NE 99.2%  
(94.5-99.9)
Number 135 71 21 114 70
Radiographic  
loosening
95.7%  
(90.7-98.0)
93.1%  
(86.2-96.6)
96.0%  
(74.8-99.4) 
95.7%  
(90.0-98.2) 
NE 93.1%  
(85.8-96.7) 
Number 124 68 17 107 68
Worst case scenario* 93.1%  
(87.6-96.2)
89.9%  
(82.8-94.1) 
n=68
96.0%  
(74.8-99.4) 
92.6%  
(86.3-96.1) 
NE 89.3%  
(81.6-93.8) 
Number 125 68 17 108 68
* worst case scenario represents all the acetabular component failures, including radiological failures and the patient lost to 
follow-up (two hips).
DISCUSSION
Our study shows that very good results in young patients can be obtained by using the 
cemented Contemporary UHMWPE acetabular component. The eight-year survivorship 
with the endpoint revision for aseptic loosening for the entire cohort was 96.4% (95% CI 
91.6-98.5).
These survival rates are similar to those reported by registries (Table VI),1,2,10,11 but 
these do not enable comparisons based on age, radiological results or clinical outcomes 
such as the HHS, OHS and VAS scores. Therefore, we compared our results with different 
cohort studies that also used some of these widely used acetabular components.23-26 
Studies reporting the mid- to long-term survival of these implants are summarised 
in Table VII.27-29 Overall, these results are comparable with the current results of the 
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Contemporary acetabular component, whilst the primary indications for the THR and 
reasons for revisions in these studies are varied. The calculated survival rates in our 
cohort of young patients are very satisfying, especially considering that younger patients 
generally have lower survival rates compared with elderly patients.1,3,10,30,31
TABLE VI. 
Comparison of data on widely used cups in several national joint registries.
Implant
Registry/Rate Trident Pinnacle Birmingham 
Hip Resurfacing
Contemporary
Denmark12
Number used in 2010 363 1880 72 302
5-year survival rate (95%CI) 97.6 (96.4 to 98.8) * 95.6 (94.6 to 96.6) † - 96.0 (95.2 to 96.8) ‡
New Zealand3
Number used in 2010 606 1363 - 379
Revision rate/100 compo-
nent-years (95% CI)
0.66 (0.57 to 0.76) 0.87 (0.71 to 1.06) 1.46 (0.67 to 2.78) 0.64 (0.56 to 0.73)
Sweden2
Number used in 2010 201 130† 137 7993‡
Survival rate (95%CI) 97.9 (96.8 to 98.9) 
at 6 years
- 97.8 (95.3 to 100) at 
9 years
97.3 (95.3 to 99.3) 
at 6 years
England and Wales 11
Number used in 2010 NA NA NA NA
5-year revision rate 2.35 (1.83 to 3.02) * 2.29 (2.04 to 2.57) † 3.44 (3.12 to 3.79) 1.26 (1.10 to 1.44) ¶
Australia1
Number used in 2010 6106 5059 587 289 (hooded);  
380 (Flanged)
10- year cumulative  
proportion revised
4.2 (3.8 to 4.7) 6.3 (5.3 to 7.4) 6.1 (4.4 to 8.5);  
7.3 (4.5 to 12.0)
* combined with Symax stem 
† combined with Corail stem 
‡ combined with Exeter stem 
§ combined with Accolade stem 
¶combined with Exeter V40 stem
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TABLE VII. 
Comparison of results of the current study with cohort studies reporting survival rates of other 
widely used acetabular designs. 
Implant/Study†
Characteristics* Trident29 Pinnacle27 BHR29 Contemporary 
(current study)
Hips 209 95 3095 152
Mean follow-up (yrs) (range) 4.2 6 8 (0.7 to 13) 7.6 (0.9 to 12.0)
Mean age (yrs) (range) 52 53.5 (34 to 70) 53 (13 to 86) 37.6 (16 to 49)
Mean BMI (kg/m2) (Range) - 29.3 (19.5 to 45.9) - 25.5 (15.2 to 42.0)
Indication (%)
OA 81 91.6 100 9.9
AVN 11 4.2 - 23.7
CHD - 1.1 - 21.7
RA - 2.1 - 7.2
Other 7.5 1.1 - 37.5
Survival any reason 98.1% (96.2-99.9) 
at 5 years
100%  
at 7 years
96%  
at 13 years
94.4% (89.2 to 97.2)  
at 8 years 
Main reasons for revision Recurrent sublux-
ations (n=2)
- Femoral head 
collapse (n=25)
Aseptic loosening 
(n=5)
Osteolysis (%) No osteolysis No osteolysis - 11.8
Radiolucent lines (%) 1.7% - - 13.9
PAO - - 15.3 27.0
Mean Harris hip score 
(range)
pre-operatively - 43.4 (20-68) - 51 (15-81)
post-operatively 96.6 98.3 (86-100) - (41-100)
*BMI, body mass index; OA, osteoarthritis: AVN, avascular necrosis; CHD, congenital hip dysplasia; RA, reumatoid arthritis; 
PAO, periarticular ossification 
†BHR: Birmingham Hip Resurfacing 
The most common radiological signs seen in our cohort were peri-articular ossification 
(n = 39, 27.0%), acetabular osteolysis (n = 17, 11.8%) and RLLs (n = 20, 13.9%) in the 
surviving cups. D’Antonio et al29 and Kindsfater et al27 reported no osteolysis, and only 
D’Antonio et al29 mentioned RLLs in their study, with an incidence of 1.7%. A possible 
explanation for their low numbers was the strict inclusion criteria that they applied, 
as patients with a bone stock deficiency or using corticosteroids were excluded. Peri-
articular ossification was reported only by McMinn et al28 in 15.3% of cases. Other studies, 
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specifically in young patients, found osteolysis ranging from 0% to 34%, and RLLs in 7% 
to 47% of the acetabular components.7,32-35 These wide ranges illustrate the difficulties in 
comparing radiological outcomes, which may reflect not only differences in component 
designs but also the application of different criteria for reporting RLLs or osteolysis. We 
acknowledge that in young patients the outcome of the acetabular components in another 
ten years will be crucial, as RLLs and osteolysis might eventually progress to loosening. 
However, other cohorts of young patients have shown that the early signs of radiological 
failure do not inevitably result in impaired function or revision in their second decade.36,37 
Our study does not specifically assess high level function in young patients but pre- and 
post-operative HHS and OHS scores are similar to that reported by several cohort studies 
(Table VI).7,25-27,29,33-35
The Australian registry reported a cumulative revision rate at ten years of 6.1% (95% 
CI 4.4-8.5) for the Contemporary hooded, and 7.3% (95% CI 4.5-12.0) for the flanged 
implant.1 Our ten-year survival rate of the Contemporary hooded component of 93.4% is 
comparable (n at risk = 25), and this is satisfying considering the young age of the patients 
in our cohort. Because of the short follow-up and low numbers of Contemporary flanged 
components (n = 26) we were not able to calculate a representative survivorship after five 
years for this design, although there were no revisions in this group so far. The flanged 
implant was an evolutionary development that could improve cement penetration and 
reduce the incidence of loosening. At the same time it became apparent that a hooded 
implant might be associated with higher dislocation rates due to its design as described 
by Jameson et al.38 The hood consists of a large posterior elevation of the rim, intuitively 
intended to reduce the risk of posterior dislocation but in practice functioning as a source 
of impingement, resulting in a relatively high rate of dislocation, including anteriorly. Our 
department has since switched to the use of the Contemporary flanged component, due 
to the dislocation rate of 5.6% in the 126 hooded implants. At the time of our analysis the 
dislocation rate in our cohort did not differ significantly between the flanged and hooded 
implants. Analysis should however, ideally be performed for both designs separately, but 
our numbers did not allow this in any meaningful way on this occasion.
A limitation of the current study might be the diagnostic heterogeneity of our 
group, making it difficult to compare our data with other studies. Despite the variety of 
indications, we report a high survival rate of the acetabular component, which is often the 
weakest link of the THR in young patients.5 Another limitation was the difficulty of the 
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radiological evaluation of a number of hips that had required an extensive reconstruction 
of the acetabulum with IBG.
The Contemporary acetabular implant shows good results in our cohort of young 
patients. With revision for aseptic loosening as endpoint the survival rate was 96.4% (95% 
CI 91.6-98.5) at eight years in this challenging group of 126 consecutive patients aged < 
50 years. The clinical outcome of our patients is similar to that of other widely used THRs 
in several national joint registries and cohort studies, and those of other cohort studies 
with young patients. We believe the long-term clinical and radiological results, showing 
a ten-year survival of more than 90% in patients below 50 years of age, support the use of 
the cemented Contemporary acetabular component in this specific patient group.
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ABSTRACT
Background and purpose: Total hip arthroplasties (THAs) in younger patients are 
becoming increasingly popular. However, the outcome of subsequent revisions in 
younger patients is not well known and, therefore, their success (subsequent revision 
prosthesis survival) might be overestimated. We investigated available data on the 
outcome of primary- and subsequent revision THAs performed in the same cohort 
of patients who underwent primary THA before the age of 50 years old. 
Methods: Medline, Embase and the Cochrane Library (CENTRAL) were searched 
up until 13th April 2016 for studies that reported both the survival of primary- and 
subsequent revisions THA of single cohorts of patients younger than 50 years old. 
Eligible articles had to include Kaplan Meier analysis or competing risk analysis 
for survival of the primary THA at a mean follow-up of ten years, as well as for the 
subsequent revision THA within the same cohort. 
Results: We found 4,799 unique records; 43 of which were potentially eligible. Only 
one paper met our inclusion criteria. It reported on the survival of 69 primary 
prostheses at a mean of more than ten years follow-up and 13 subsequent revisions.
Conclusions: There is a clear lack of evidence about the outcomes of the revision 
arthroplasty in younger patients. Only one study reported the survival-rate of 
subsequent revision arthroplasty with the minimum ten-year survival rate of the 
original THA cohort. In the future, this serious lack of knowledge could result in a 
large number of patients with no further reconstructive options after failed THA, 
and a large medical burden for society.
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BACKGROUND
Total hip arthroplasty (THA) is one of the most successful and cost-effective operations 
in medicine.1 Due to its success in reducing pain and restoring mobility to near normal in 
older patients,2-6 THA is increasingly used in younger patients who suffer from primary- 
and secondary osteoarthritis.2, 5, 6 Survival of a THA is often expressed as the duration to 
failure of one or both components of the total hip prosthesis for any reason, including 
aseptic loosening, septic loosening, trauma, recurrent dislocations, or any other reason. 
Literature shows comparable early results of THA in young patients compared to older 
patients, but within ten years after surgery, a decline of the survival of the prosthesis 
in younger patients aged under 50 has been seen.2, 5 This less successful survival, in 
combination with the fact that many young patients will outlive their primary total hip 
implant due to their longer life-expectancy, makes high numbers of revisions in these 
younger patients inevitable.7 It is imperative that these younger patients are informed 
about the chances of revision, and on the outcome of these revisions.8-11 However, there 
is a serious lack of knowledge on the outcome of subsequent revisions in young patients. 
And, as more and more younger patients undergo operations, this could result in large 
numbers of patients who will have no further reconstructive options after failed hip 
arthroplasty in the future, which would present a large medical burden to society. 
Survival of primary THA in cohorts of younger patients has been widely 
published.2, 10, 12-22 Alongside this, there are reports on separate survival results of 
revision arthroplasties. However, most publications concerning revisions of THAs in 
younger patients include a number of revision cases performed over particular period 
of time. Results of these revisions are often published without detailed information on 
the characteristics of the patients and implants from the complete original or different 
primary cohorts, from which the revisions were reported. In these cases, it is unclear if 
the primary arthroplasty was easy to revise. And, therefore, the influence of the fixation of 
the primary implant and available bone stock after removal on the survival of the revision 
implant is unknown. This might result in selective outcome reporting for revision total 
hip arthroplasty which could lead to a worrisome situation; incomplete information on 
the success of total hip arthroplasty in younger patients; and inaccurate decision-making. 
When reporting on revision THA, the survival results and baseline characteristics of 
the complete primary THA cohort should be included to obtain accurate information 
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on which revision THA could be successful for an individual patient. The results of the 
primary hip prosthesis, the revisability of hip arthroplasties and survival of its subsequent 
revision should be investigated and presented together. In summary, we can state that 
in cases of total hip arthroplasty, any re-intervention on a hip, either to the cup or the 
femoral component should be considered as important, because for the patient, the 
overall number of re-operations and the revisability of the prosthesis are the outcome 
parameters that count. Therefore, survival of a prosthesis should be presented as survival 
of the whole construct (both acetabular- and femoral components). Furthermore, the 
influence of the primary construct on the revision construct should be taken into account 
when judging survival of total hip arthroplasty in younger patients. To the best of our 
knowledge, no systematic reviews are available on this topic. 
Therefore, we performed a systematic review of current literature regarding the 
available results of subsequent revision arthroplasties in cohorts of patients, who received 
their primary THA aged under 50 years old at the time of surgery, with a mean follow-up 
of ten years after primary hip arthroplasty.
PATIENTS AND METHODS
A systematic review of studies that evaluated the survival data of both primary- and 
revision hip arthroplasties in the same cohorts of patients who received their primary 
total hip implant under the age of 50 years old was performed. 
The review protocol and methodology were prospectively registered in PROSPERO 
(registration number CRD42016039602). The review was performed according to the 
PRISMA guidelines.
Eligibility criteria
To answer the research question and search for appropriate available literature that 
combined the results of primary- and revision total hip arthroplasties in younger patients, 
we used the following eligibility criteria:
1. studies that evaluated the survival data of both primary- and revision hip 
arthroplasties in the same cohorts of patients who received their primary total 
hip implant under the age of 50 years old;
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2. with a mean follow-up of ten years after primary total hip arthroplasty; and
3. that included both acetabular- and femoral components. 
Review articles and case reports were excluded. Studies that presented data on hemi-
arthroplasties and resurfacing arthroplasties were also excluded. Only total hip 
arthroplasty procedures were included. 
Our primary outcome was the survival of revision arthroplasties in cohorts of patients, 
from whom, the survival of all primary hip arthroplasties was also described. 
Survival was defined as the survival of the primary (or revision) arthroplasty, with 
endpoint as (re-) revision for aseptic loosening and/or any reason (including (re-)revision 
for aseptic loosening, septic loosening, luxation and other causes mentioned for (re-)
revision of one of the total hip components).
Only articles written in English, Dutch, German or French were considered eligible. 
Search strategy
Medline (PubMed), Embase and the Cochrane Library (CENTRAL) were searched (the 
last search was performed 13th April 2016) for articles that reported both the survival 
of primary prosthesis in cohorts of patients younger than 50 years old, as well as the 
survival of the subsequent revision THAs in the same cohort. Our search strategy was 
developed together with a medical information specialist from the Medical Library of 
Radboud university medical center in Nijmegen, the Netherlands. Keywords used to 
develop the search were ‘hip prosthesis’, ‘revision’, ‘young’ and ‘cohort’. The detailed search 
strategy is provided in Appendix 1. The Cochrane Library showed evidently fewer results 
compared to Medline and Embase, and, therefore, we omitted the search terms related 
to ‘cohort’ and ‘young’ to reveal as many possible eligible articles within the Cochrane 
Library database. 
Language limits were set to English, Dutch, German and French. The complete 
reference lists of the possible eligible papers were screened for potentially missed papers. 
Selection of studies
After removal of duplicates, articles were screened on title and abstract by two independent 
reviewers (MS and CT). Any discrepancies were resolved by discussion. 
Full text copies of eligible articles were assessed and included when they met our 
inclusion criteria. 
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Data collection process and items
Survival data of primary THA, as well as the survival of the revision THA within the same 
cohort, including estimated Kaplan-Meier survival or competing risk survival analysis, 
were extracted. In addition, the survival for aseptic loosening and/or any reason of both 
acetabular- and femoral components of the primary cohort were also extracted. Baseline 
characteristics including age, gender and body mass index (BMI) were collected, as well 
as fixation method (cemented, uncemented and hybrid) and indication at time of primary 
surgery. All of this was carried out by two independent reviewers (MS and CT).
Risk of bias assessment
Bias risk was assessed at study level and the quality of the included cohort studies was 
scored by two authors (CT, GH) using the Newcastle-Ottawa Scale (NOS) for assessment 
of the quality of non-randomised studies in meta-analysis23. A study could be awarded 
a maximum of one star for each of the four numbered items within the ‘Selection’ and 
‘Outcome’ categories. A maximum of two stars could be given for ‘Comparability’. 
In total, a maximum of eight stars could be received. We used the Newcastle-Ottawa 
scale, as it is one of the two most useful tools of the many instruments created to assess 
methodological quality of non-randomised studies of interventions, and reviewed 
systematically by Deeks et al.24, as described in the Cochrane Handbook for Systematic 
Reviews of Interventions25.
Subgroup analysis
If three or more comparable studies were available, subgroup analyses for fixation 
technique of the prosthesis (cemented, uncemented and hybrid) and for diagnosis at time 
of primary surgery were performed.
RESULTS
Search and summary of results
Our search strategy resulted in 4,799 unique records (Figure 1). The subsequent selection 
procedure resulted in 43 potentially eligible articles, of which one met the inclusion 
criteria and could be included. This paper describes one of our own studies that includes 
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patients younger than 30 years old, and reported on 13 revisions from a primary cohort 
of 69 primary THAs21. Index surgery was performed between 1988 and 2004, and analysis 
was carried out in 2011. Diagnosis at time of primary surgery was described for all 
cases. Mean age was 25 years (16-29) at primary implantation. Survival of the primary 
prostheses with aseptic loosening as reason for revision was 90% (CI 79-96) after ten 
years. All primary- and revision cases involved cemented implants. Mean follow-up of 
the primary cohort was 11.5 years (7-23). There were 13 revisions in this cohort. The 
diagnoses of these 13 hips at primary surgery were not clearly described. Three THAs 
were revised for septic loosening and ten acetabular components were revised; due to 
aseptic loosening, none of the stems were revised separately. Only one revision required 
a re-revision after 13 years, the reason for revision was not reported. Survival of the 
revision THAs was, therefore, 100% after ten years.
FIGURE 1.
Flow chart depicting the results of identifying eligible articles for review
Records identified through database 
searching: 
 Medline: 3.938 
 Embase: 3.184 
 Cochrane: 304 
 Total: 7.426
Records identified through other 
sources: 291
Records after duplicates 
removed 
(n = 4.799)
Records screened 
(n = 4.799)
Full text articles assessed 
for eligibility 
(n = 43)
Studies available for  
review 
(n = 1)
Records excluded 
(n = 4.756)
By title (n = 3.210) 
• No survival primary and revision (n = 2.023) 
• No cup and stem data (n = 1.142) 
• Review or case report (n = 45)
By abstract (n=1.546) 
• No survival primary and revision (n = 1.477) 
• No cup and stem data (n = 37) 
• Follow-up <10 years (n = 30) 
• Review or case report (n = 2)
Full-text articles excluded 
(n = 42)
• No survival primary and revision (n = 42)
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Quality assessment
According to the Newcastle-Ottawa Scale (NOS), three out of four stars were awarded 
for ‘selection’. ‘Comparability’ was not applicable, as no comparison of cohorts was 
performed. Regarding ‘outcome’, three out of three stars were awarded. 
Subgroup analysis
Subgroup analysis was not performed, as only one study could be included.
DISCUSSION
Comparison to literature
We identified only one study reporting on revisions, whilst reporting on the survival 
of the primary THA cohort in patients under 50 years old. This is a striking result, as 
we know from studies including patients of all ages that it is important to be familiar 
with the effect of the primary implant and the fixation technique used on the results of 
revision. For example, Lie et al26 reported on 78,534 primary operations that included 
people of all ages with a median follow-up of 5.6 years, and found the probability of 
requiring revision surgery within ten years for all primary operations to be 11.4% (95% 
CI: 11.3-11.4). Whereas for the subsequent revisions, with no infection, the ten-year risk 
of failure was 25.6% (95% CI: 24.8-26.4), which emphasises the higher failure risk of 
revisions compared to primary prosthesis. Both acetabular- and femoral components 
showed different survival rates per revision technique, which stresses the importance 
of obtaining more knowledge on the influence of the primary implant and its fixation 
technique in success of the final revision. Although total hip arthroplasty for younger 
patients has been acclaimed as a reliable solution, one might say that this is still based on 
incomplete data that lacks subsequent revision outcomes. 
Remarkably, there is a growing body of literature that has reported on cohorts 
of total hip arthroplasties in younger patients with primary outcomes,2, 12, 14, 15, 17, 27-
31 even including follow-up of more than 25 years.16, 18, 19 Overall, there are also a few 
studies that report on revision total hip arthroplasty in younger patients. Such studies 
are of clinical importance and do meet some of our inclusion criteria, however, none 
report data on revision arthroplasty in combination with results of the primary THA 
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cohort.8, 9,11,32-36 Often, the authors solely present a subgroup of their cohort and the primary 
survival data are omitted. The characteristics of the original primary THA, including 
the type of component, fixation technique and baseline characteristics of patients are 
omitted. Furthermore, information on the survival of the primary component that was 
revised is not complete. For example, it is important to know if the primary component 
already failed before it even reached a follow-up of ten years, or, in cases of an acetabular 
component revision, it is useful to know if the femoral component was also exchanged 
in the meantime. 
 So, the literature on revisions in younger patients appears to be selectively reported. 
This selective reporting of revision total hip arthroplasty outcome is alarming, as we 
cannot determine which of the revised patients had a durable primary implant and what 
patient characteristics and fixation techniques might have contributed to the reported 
survival results. Survival data of THA in younger patients have also been published in 
National Joint Registries,2, 5, 37 and can be helpful to indicate trends or record differences 
in outcomes with otherwise extremely low incidence.37-40 However, these registers also 
often do not reveal complete information about the initial diagnosis, survival of the 
primary implant or the radiographical images at time of revision.41 
Possible explanations
One possible explanation of the lack of information available could be the use of the 
resurfacing prosthesis. After its re-introduction in the 1990s, the resurfacing prosthesis 
became quite popular, especially for use in the younger patient, and this could have 
impacted the number of cohorts of younger patients receiving THA. An additional 
explanation for our findings could be that collecting data such as primary- and subsequent 
revision arthroplasty outcomes requires strict and intensive follow-up of young patients, 
as also suggested by others.8-11 As revisions are often performed in specialised referral 
centres, practice can lead to mixed cohorts, or a number of patients lost to follow-up. 
On the other hand, primary cohorts of patients that have been described already years 
ago in literature should be described again somewhere in time to present their revision 
outcome as well. Even though these results might show varying success rates or include 
old techniques, the information can help in defining the best treatment options for 
younger patients suffering from osteoarthritis, especially when radiographic follow-up 
is complete. It should be emphasised that THA in young patients is often a continuous 
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process of multiple surgeries, and that we currently miss essential ‘pieces of the puzzle’ in 
the literature. 
Limitations 
There are some limitations to our study that should be discussed. Firstly, as we included 
studies that reported on patients of 50 years old and younger at the time of primary 
surgery, we might have excluded studies that have reported on patients aged <65 years or 
older and might include subgroups of younger age. Secondly, by including only cohorts 
that present at least a mean follow-up of ten years of their primary prosthesis, we might 
have excluded some useful articles that presented revision data. Furthermore, one must 
realise that revision rates capture not all the implants that clinically fail but have not been 
treated surgically. We consider that with the currently available results of hip arthroplasty, 
presenting results at shorter follow-up would not yield any representative and useful 
results for clinical practice. Thirdly, by including articles reporting on both components, 
we might have excluded those reporting on only acetabular - or femoral components. The 
reason for this is that the results of only one component are of lower clinical relevance to 
patients in discussing survival. Lastly, we have appraised the quality of our own study. We 
have performed this as accurately and completely as possible. 
CONCLUSION
There is this little information available on the revisability of hip prosthesis in young 
patients. 
We should be aware of selective outcome reporting in younger patients in treating 
those patients with end-stage osteoarthritis, as we cannot currently adequately inform 
younger patients on their future survival expectations regarding different total hip 
arthroplasty techniques. This could potentially lead to large numbers of patients with 
hips that cannot be reconstructed and can generate high medical costs for societies.
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APPENDIX 1: 
Detailed search strategy Medline
1) “Hip Prosthesis”[Mesh] OR “Arthroplasty, Replacement, Hip”[Mesh] OR Hip 
Replacement Arthroplasty[tiab] OR Hip Replacement Arthroplasties[tiab] OR 
Hip Prosthesis Implantation[tiab] OR Hip Prosthesis Implantations[tiab] OR Total 
Hip Replacements[tiab] OR Total Hip Replacement[tiab] OR Hip Prostheses[tiab] 
OR Hip Prosthesis[tiab] OR (“arthroplasty”[tiab] AND “replacement”[tiab] AND 
“hip”[tiab]) OR (“total”[tiab] AND “hip”[tiab] AND “arthroplasty”[tiab]) OR total 
hip[tiab]
2) Revision OR Revisions
3) Adolescents[tiab] OR Adolescent[tiab] OR Teens[tiab] OR Teen[tiab] OR 
Teenagers[tiab] OR Teenager[tiab] OR Youth[tiab] OR Youths[tiab] OR Young[tiab] 
OR Adolescence[tiab] OR Adult[tiab] OR Adults[tiab] OR Middle-age[tiab] OR 
Middle-aged[tiab] OR Child[tiab] OR Children[tiab] OR “Adolescent”[Mesh] OR 
“Adult”[Mesh:noexp] OR “Middle Aged”[Mesh] OR “Young Adult”[Mesh] OR 
“Child”[Mesh]
4) Cohort OR Concurrent Studies OR Concurrent Study OR Incidence Studies OR 
Incidence Study OR Follow-Up OR Follow up OR Longitudinal OR Prospective OR 
Retrospective OR “Cohort Studies”[Mesh]
Detailed search strategy Embase
1) exp hip prosthesis/ OR exp hip arthroplasty/ OR Hip Replacement Arthroplasty.
ti,ab. OR Hip Replacement Arthroplasties.ti,ab. OR Hip Prosthesis Implantation.
ti,ab. OR Hip Prosthesis Implantations.ti,ab. OR Total Hip Replacements.ti,ab. OR 
Total Hip Replacement.ti,ab. OR Hip Prostheses.ti,ab. OR Hip Prosthesis.ti,ab. OR 
(“arthroplasty”.ti,ab. AND “replacement”.ti,ab. AND “hip”).ti,ab. OR (“total” AND 
“hip” AND “arthroplasty”) ti,ab OR total hip.ti,ab.) 
2) (Revision or Revisions).mp.
3) (Adolescents OR AdolescentOR Teens OR Teen. OR Teenagers OR Teenager 
OR Youth OR Youths OR Young OR Adolescence OR Adult OR Adults.ti,ab. OR 
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Middle-age.ti,ab. OR Middle-aged.ti,ab. OR Child.ti,ab. OR Children).ti,ab. OR exp 
adolescent/ or adult/ or exp child/ or middle aged/)
4) (Cohort or Concurrent Studies or Concurrent Study or Incidence Studies or Incidence 
Study or Follow-Up or Follow up or Longitudinal or Prospective or Retrospective).
mp. OR cohort analysis/)
Detailed search strategy Cochrane
#1 MeSH descriptor: [Hip Prosthesis] explode all trees
#2 MeSH descriptor: [Arthroplasty, Replacement, Hip] explode all trees
#3 Hip Replacement Arthroplasty or Hip Replacement Arthroplasties or Hip Prosthesis 
Implantation or Hip Prosthesis Implantations or Total Hip Replacements or Total 
Hip Replacement or Hip Prostheses or Hip Prosthesis or (“arthroplasty” and 
“replacement” and “hip”) or (“total” and “hip” and “arthroplasty”) or total hip:ti,ab,kw 
(Word variations have been searched) 
#4 #1 or #2 or #3 
#5 revision or revisions:ti,ab,kw (Word variations have been searched)
#6 #4 and #5 
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ABSTRACT
The cup survival in patients under 50 years is the weakest link in total hip arthroplasty 
(THA), both in cemented and uncemented prostheses. We hypothesized that the 
application of acetabular impaction bone grafting (IBG) in primary cemented THAs 
will improve the bone cement interdigitation in these patients and will improve the 
cup survival, even in the absence of acetabular bone stock loss.
However, the application of an additional layer of impacted bone grafts in non 
deficient acetabula might introduce an additional failure mechanism. Therefore, 
we compared the early revision rates and complications between two cohorts of 
patients: hips without an acetabular defect, that received a straightforward cemented 
cup (non-IBG group, n= 30) and hips that received a cemented cup after a layer 
of impacted bone grafts (IBG group, n=29). Mean age at index surgery was 36.2 
(15.3-49.4) years. The minimal follow-up was 2 years. Radiological and clinical 
parameters were assessed. Kaplan-Meier survival analyses were used to determine 
the survivorship of the acetabular component. There were no specific per- or 
postoperative complications for the IBG procedure, although the additional surgical 
time was 8 minutes. 
Survival for endpoint revision for any reason for the non-IBG group and 
IBG group was 96.7% (95% CI: 78.6-99.5) and 93.1% (95% CI: 75.1-98.2) at two 
years, respectively, due to three revisions for recurrent dislocations and one septic 
loosening. The two-year acetabular survivorship with endpoint revision for aseptic 
loosening was 100% in both the non-IBG and IBG group. There was one radiological 
failure in the non-IBG group, and none in the IBG group. 
Acetabular IBG during primary cemented THA in young patients without an 
acetabular defect might be an attractive technique to improve the cup survival in 
this demanding group. Based on already available long-term reports of the survival 
of cemented cup after IBG in bone deficient cases, mechanical failure after a stable 
initial situation is uncommon and full incorporation after 2 years can be expected.
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INTRODUCTION
Total hip arthroplasties (THA) in patients less than 50 years of age remain a challenge 
in orthopedic surgery. Initially, predominantly cemented implants were used, but the 
outcomes of these cemented cups at longer follow-up appeared inferior in young patients 
compared to older patients. Over the past years mainly uncemented primary THA 
designs have been used and although the designs have improved in the course of years, 
the outcomes of uncemented cups in young patients is also still not satisfying1. On the 
long term, the weakest link of a THA in these young patients remains the acetabular side 
for both cemented and uncemented techniques.2-12 
Since 1979 we have been using acetabular impaction bone grafting (IBG) in complex 
primary THA and revision THA to reconstruct acetabular bone loss.13 We previously 
evaluated the outcome of this technique in patients under 50 years and realized that, 
even at a long follow-up, the results were very acceptable, certainly when the complexity 
of these cases is taken into account.14 The often very sclerotic subchondral bone plate 
in young patients at the primary THA makes it is more difficult to create an optimal 
cement-bone interdigitation, especially in absence of acetabular bone defects. Based on 
this observation, we implemented a new surgical protocol in this patient group.
From 2008, acetabular IBG in primary THA is applied in all patients under 50 years 
old, whether an acetabular defect is present or not. Our hypothesis is that the application 
of IBG in cases without acetabular defects will improve the bone-cement interdigitation 
and subsequently benefit the fixation of the cemented cup on the long-term. 
In this preliminary report, we present the short-term outcomes at a minimum of two 
years follow-up in patients under 50 years without an acetabular bone stock defect, who 
received a primary cemented THA with acetabular IBG and compared this group to a 
similar cohort in which the cups were directly cemented without IBG. The aim is to focus 
on the intra- and early postoperative complications related to the IBG-technique when 
using this new approach. 
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METHODS
Study group
All consecutive young patients (< 50 years) that received a primary cemented THA from 
1-1-2006 up to 1-1-2010 in our institution and had no pre-existing acetabular bone defect 
based on pre-operative radiographs and intraoperative findings, were included. Patients 
who had a THA for oncologic indications were excluded. From 1-1-2006 up to 2008, we 
included all patients who received a directly cemented total hip without acetabular IBG 
(non-IBG group). Per 1-1-2008 we implemented our protocol and performed acetabular 
IBG in all patients under 50 years. Thus, those young patients that received a THA from 
1-1-2008 up to 2010, without an acetabular defect and with IBG, were included (IBG 
group). The total population consisted of 59 hips in 53 patients; 30 (51%) hips in the 
non-IBG group and 29 (49%) hips in the IBG group. Patient characteristics per group are 
listed in table I. The primary diagnoses per group are listed in table II. 
TABLE I.
Patient characteristics
Total group non-IBG IBG p-value
Gender, n (%) 0.12
Male 29 (49) 18 (62) 11 (38)
Female 30 (51) 12 (40) 18 (62)
Age, mean (range) 36.5 (15.3-49.4) 38.1 (18.0-49.4) 34.9 (15.3-48.1) 0.33
THA side, n (%) 0.61
Left 29 (49) 16 (55) 13 (45)
Right 30 (51) 14 (47) 16 (53)
Bilateral, n (%)* 10 (19) 6 (60) 4 (40)
Follow-up, mean (range)** 3.5 (0.2-6.2) 4.9 (0.2-6.2) 2.8 (0.5-4.1) <0.01
* Number of patients who received a contralateral THA during the inclusion period of the study 
** Until revision of any component 
P-values for differences between IBG and non-IBG were calculated using the Fisher exact test in case of 2*2 tables and the 
Mann-Whitney test in case of continuous outcome.
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TABLE II. 
Indications for primary total hip arthroplasty
Indication Total group, n (%) non-IBG (n) IBG (n)
Corticosteroid induced AVN 18 (30.5) 14 4
Posttraumatic osteoarthritis 9 (15.3) 4 5
AVN of unknown origin 8 (13.6) 5 3
Primary osteoarthritis 5 (8.5) 1 4
SCA due to Perthes’ disease 4 (6.8) 0 4
SCA due to CHD 3 (5.1) 1 2
SCA due to rheumatoid arthritis 3 (5.1) 2 1
SCA due to protrusio acetabuli 2 (3.4) 0 2
Epiphysiolysis 2 (3.4) 0 2
SCA due to Bechterew’s disease 1 (1.7) 0 1
SCA due to posttraumatic AVN 1 (1.7) 1 0
SCA due to osteonecrosis in sicklecell anaemia 1 (1.7) 1 0
Coxitis 1 (1.7) 0 1
Other 1 (1.7) 1 0
Total 59 (100) 30 29
SCA = secondary coxarthritis, AVN = avascular necrosis, CHD = congenital hip dysplasia
Surgical technique
All surgeries were performed by three orthopedic surgeons and a posterolateral approach 
was used in all cases. All patients received two grams intravenous cefazolin pre-operatively. 
To optimize direct cementation (non-IBG group) or to stimulate vascularisation of the 
graft (IBG group), the acetabular bone bed was prepared with multiple two-millimeter 
drill-holes. Next the acetabulum was washed and dried and the cups of the non-IBG 
group were directly cemented onto this surface. In the IBG group, the patient’s femoral 
head was morsellised with a rongeur to provide cancellous bone chips with a diameter 
of 0.7-1.0 centimeters. However, as the femoral head was affected and sclerotic in some 
cases, a femoral head allograft from the bone bank was obtained. Autografts only were 
used in 21 (72.4%) hips, a combination of autografts and allografts was used in 5 (17.2 
%) hips and allografts only in 3 (10.4%) hips. The bone chips were impacted with metal 
impactors and a mallet. The last metal impactor was at least two millimeters larger than 
the cup in order to facilitate a sufficient cement mantle. Vacuum-mixed cement loaded 
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with antibiotics (Surgical Simplex®, Stryker Howmedica, Newbury, UK) was pressurized 
directly into the host bone (non-IBG group) or the impacted grafts (IBG group).15-18 
Next, the polyethylene cup was inserted followed by a cemented femoral component (fig 
1). The acetabular components used in both groups are displayed in table III. For the 
femoral component, an Exeter® stem (Stryker Howmedica, Newbury, UK) was used in 
all cases. 
FIGURE 1.
Acetabular impaction bone grafting in hips without acetabular bonedefect. 
Impaction bone grafting technique: a) no acetabular bone defects are seen and no mesh is used. 
b) The femoral head was morselized with a rongeur to provide cancellous bone chips with a 
diameter of 0.7-1.0 centimeters. In case the femoral head was affected and sclerotic, a femoral 
head allograft from the bone bank was obtained. c) With a hammer and metal impacter, the 
bone chips are compressed tightly. d) Bone cement is introduced in a relatively viscous state and 
is pressurized to force bone cement into the graft before placement of the cup.
TABLE III. 
Types of acetabular component
Type of acetabular implant Total group, n (%) non-IBG (n) IBG (n)
Exeter/ContemporaryTM* 53 (90) 24 29
Müller®/Allopro® cup# 6 (10) 6 0
*Stryker Howmedica, Newburry, UK, # Zimmer, Winterthur, Switzerland
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Postoperative treatment
Thrombosis prophylaxis with low-molecular-weight heparin (LMWH) was given 
during six weeks postoperatively in both groups. Patients were mobilized according to a 
standardized protocol under the supervision of a physiotherapist: immediate full weight 
bearing with crutches for six weeks was allowed in the non-IBG group, whereas patients 
in the IBG group were allowed 10% of partial weight bearing during the first six weeks, 
followed by another six weeks of 50% weight bearing.
Clinical and radiographic analysis
Clinical failure of the cup was defined as revision for any reason. For the radiographic 
analysis, anteroposterior radiographs of the pelvis and lateral radiographs of the hip were 
used. Radiographic evaluation was performed by three of the authors (MWJLS, EC, BWS) 
and classified on a consensus base. The following parameters were scored: cup position, 
graft incorporation,19 migration of either component, and radiolucent lines more than 
two millimeters wide in one of the three zones of DeLee and Charnley.20 Radiographic 
failure was defined as presence of radiolucent lines in three zones of DeLee and Charnley 
or migration of five millimeters or more in any direction. 
Statistical analysis
Kaplan-Meier survival analyses were used to determine the survivorship of the primary 
hip implant for the endpoints revision of the cup for 1) any reason, 2) aseptic loosening 
3) septic loosening and 4) radiographic failure. P-values for differences in patient 
characteristics between the non-IBG and IBG group were calculated using the Fisher 
exact test and the Mann-Whitney U test. The Log-rank test was used to determine any 
statistical differences between the survival of the non-IBG and IBG group. Statistical 
analysis was performed using statistical software package (SAS version 9.2, SAS Institute 
Inc, Cary, NC, USA).
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RESULTS
The two study groups showed no statistical difference in patient characteristics (table I). 
At the time of review, one patient (non-IBG group) was lost to follow-up after 0.47 years 
due to emigration and could not be contacted. None of the patients died, and every other 
non-revised patient had a minimum follow-up of two years. 
No intraoperative complications related to the placement of the cups occurred. The 
mean operation time was 105 minutes in the non-IBG group and 113 minutes in the IBG 
group. There was no difference in revision rate between the two methods due to a failure 
mechanism. During follow-up one reconstruction (IBG group) was revised for an early 
postoperative septic failure after 0.5 years, resulting in an infection rate of 1.7% in the 
whole cohort.
There were no technique-related failures in both groups. However, three acetabular 
components were revised due to recurrent dislocations (one in the non-IBG group and 
two in the IBG group). All three patients had early osteoarthritis after a pelvic trauma: 
one patient suffered from a Pipkin fracture and two patients had an acetabular fracture. 
All three underwent previous surgeries after their initial trauma. At revision surgery, the 
acetabular component was stable in all three hips. In one hip the dislocation problem 
was solved by converting the original 28 mm cup into a 32 mm design. In the other two 
cases an Avantage cup was inserted. No further dislocations occurred in these cases. No 
reoperations other than the revision surgeries were performed. 
The two-year survivorship rates of the cups of both groups are presented in table IV. 
For endpoint revision for any reason, the two-year estimated Kaplan-Meier survival of 
the non-IBG group was 96.7% (95% CI: 78.6-99.5), whereas this was 93.1% (95% CI: 
75.1-98.2) for the IBG group. This difference was not statistically significant (log-rank, 
p = 0.157). The survival regarding the endpoint revision for aseptic loosening of any 
component was 100% in both the non-IBG and IBG group. 
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TABLE IV.
The percentage revision free survival after two years and 95% confidence intervals (CI) for the 
endpoints revision for 1) any reason, 2) aseptic loosening and 3) septic loosening.
Percentage revision free for All cups (n=59) non-IBG (n=30) IBG (n=29)
Any reason 94.9 (84.9-98.3), n=54 96.7 (78.6-99.5), n=28 93.1 (75.1-98.2), n=26
Aseptic loosening 100 (94.6-100), n=54 100 (89.9-100), n=28 100 (89.1-100), n=26
Septic loosening 98.2 (88.2-99.8), n=54 100 (89.9-100), n=28 96.6 (77.9-99.5), n=26
Radiographic results
Follow-up radiographs were complete for all patients (59 THAs). Of the 55 non-revised 
cups, none of the cups reconstructed with IBG were radiographically loose, in contrast 
to one cup in the non-IBG group which showed radiological loosening due to migration 
two years postoperatively. However, the position of the cup is stable and the patient 
experienced no complaints at the latest follow-up at 4.7 years. Fifty-one of a total of 55 
non-revised cups were radiographically well incorporated and showed no radiolucent 
lines at final follow-up. One cup in the non-IBG group showed a non-progressive line 
which was present immediately post-operatively (zone 1, bone-cement interface) and 
two cups of the IBG group showed progressive radiolucent lines in one zone (one in the 
bone-cement interface in zone 1, the other in the bone-graft interface in zone 2), which 
were visible at 1 year and 1.5 years postoperatively, respectively. All three patients were 
doing clinically well. There were no radiographs showing osteolysis or migration in either 
group. 
DISCUSSION
Based on our satisfying long-term experience with acetabular IBG in patients with 
bone defects,13, 14, 21-23 we realized that this technique might be an option to improve cup 
survival in young patients in acetabula without a bone defect as well. Although also some 
bone stock is reconstructed using these bone grafts, this was not the initial goal of the 
procedure, since none of these acetabula had pre-existing bone stock defects. 
None of the cups in the IBG group showed significant migration or aseptic loosening 
within two years postoperatively. There was one septic loosening in the whole group, and 
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although it occurred in the IBG group, there is no suggestion of a relation between the 
use of the IBG technique and increased infection rates as this patient had received an 
autograft.22, 24 At two years, all cups except one (non-IBG) were radiographically stable.
The current study is based on prospectively collected data, comparing two cohorts 
of young patients. The same surgeons were involved in both study groups, using the 
same implants and techniques. Additionally, follow-up radiographs were available for all 
patients. 
Unfortunately, this study is not a randomized trial, although the patient groups are 
comparable. The addition of a third control group of uncemented primary cups with IBG 
would certainly be of additional value to compare the treatments. In our institution we 
have no experience with uncemented prostheses and we therefore decided not to include 
this option in the current study. However, recent publications on uncemented THA’s in 
combination with IBG showed acceptable results as well.25, 26
There are potential drawbacks when applying this technique; a longer surgical time 
might be expected since IBG is an additional step during surgery. The surgical time 
was prolonged (on average 8 minutes) but within acceptable limits. Secondarily, early 
mechanical loosening of the cup that is cemented on top of the bone graft layer and poor 
incorporation of the bone grafts can occur. However, there were no revisions in the IBG 
group that were related to the IBG technique within two years. From histological studies 
it is known that these (auto)grafts tend to incorporate quickly,27-30 so after the period of 
two years it is not likely to expect problems of mechanical loosening.
The slightly prolonged postoperative rehabilitation time can be considered as a 
disadvantage as well. Based on our historical experience patients were allowed to 10% 
weight bearing the first six weeks postoperatively followed by six weeks of 50% weight 
bearing. These patients had larger acetabular reconstructions and the weight bearing 
limitation was necessary to allow the reconstruction to become stable. Realizing that 
the reconstructions in the current study are smaller, we have changed the postoperative 
weight bearing protocol in the meantime to immediate 50% weight bearing during the 
first six weeks.
The weight bearing limitations in the IBG group did not have any influence on the 
use of LMWH which was prescribed for 6 weeks in both groups and no deep venous 
thrombosis or pulmonary embolism were observed in any of the groups. 
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In the study, a relatively high number of revisions was performed due to recurrent 
dislocations. However, all three patients suffered from posttraumatic osteoarthritis 
and it is known that due to the trauma and previous surgeries, the soft tissues are 
not optimal, causing an impaired abductor muscle mechanism.31, 32 In addition, these 
patients are usually not familiar with limited hip joint excursions, and can subsequently 
be less cautious with postoperative movement restrictions. Perhaps, larger femoral head 
prostheses might solve this problem in this patient group.
Acetabular impaction bone grafting in cases without a bone stock defect during 
the primary cemented THA is a new approach in an attempt to improve the cemented 
primary hip arthroplasty in young patients. In several studies, good long-term outcomes 
of acetabular IBG in both primary and revision THA have been reported. It is known 
both from animal studies and human clinical biopsies taken after IBG on the acetabular 
side that these grafts incorporate very well. In studies with less satisfying outcomes, the 
problematic cases were always the more demanding cases with segmental and cavitary 
defects. And although this approach is based on a new idea, the used technique itself is 
well-proven with published long term outcome data by several study groups. The focus 
of this extremely preliminary report was to report the complications of this technique 
within the first two years after implantation, as this method can result in a higher 
complication rate compared to the traditional method with direct cementation, which 
was not the case in this study group. This study emphasizes the fact that we will need to 
monitor the follow-up of this cohort closely in order to see if the results can match the 
results of our historical cohorts with acetabular defects on the long-term. Prospective 
randomized studies comparing the techniques, with maybe even comparing uncemented 
and cemented cups with bone impaction in young patients, are needed to further analyze 
this new surgical protocol. 
Cemented total hip arthroplasty and impaction bone grafting in young patients
156
8
REFERENCES
1. Eskelinen A, Remes V, Helenius I, Pulkkinen P, Nevalainen J, Paavolainen P. Uncemented 
total hip arthroplasty for primary osteoarthritis in young patients: a mid-to long-term follow-
up study from the Finnish Arthroplasty Register. Acta Orthop 2006; 77: 57-70.
2. Duffy GP, Berry DJ, Rowland C, Cabanela ME. Primary uncemented total hip arthroplasty in 
patients <40 years old: 10- to 14-year results using first-generation proximally porous-coated 
implants. J Arthroplasty 2001; 16: 140-144.
3. Joshi AB, Porter ML, Trail IA, Hunt LP, Murphy JC, Hardinge K. Long-term results of 
Charnley low-friction arthroplasty in young patients. J Bone Joint Surg Br 1993; 75: 616-623.
4. Kim YH, Park JW, Patel C, Kim DY. Polyethylene wear and osteolysis after cementless total hip 
arthroplasty with alumina-on-highly cross-linked polyethylene bearings in patients younger 
than thirty years of age. J Bone Joint Surg Am 2013; 95: 1088-1093.
5. Lewthwaite SC, Squires B, Gie GA, Timperley AJ, Ling RS. The Exeter Universal hip in patients 
50 years or younger at 10-17 years’ followup. Clin Orthop Relat Res 2008; 466: 324-331.
6. Makela KT, Eskelinen A, Pulkkinen P, Paavolainen P, Remes V. Results of 3,668 primary total 
hip replacements for primary osteoarthritis in patients under the age of 55 years. Acta Orthop 
2011; 82: 521-529.
7. McAuley JP, Szuszczewicz ES, Young A, Engh CA, Sr. Total hip arthroplasty in patients 50 
years and younger. Clin Orthop Relat Res 2004: 119-125.
8. Pedersen AB, Mehnert F, Havelin LI, Furnes O, Herberts P, Karrholm J, et al. Association 
between fixation technique and revision risk in total hip arthroplasty patients younger than 
55 years of age. Results from the Nordic Arthroplasty Register Association. Osteoarthritis 
Cartilage 2014; 22: 659-667.
9. Shia DS, Clohisy JC, Schinsky MF, Martell JM, Maloney WJ. THA with highly cross-linked 
polyethylene in patients 50 years or younger. Clin Orthop Relat Res 2009; 467: 2059-2065.
10. Sochart DH, Porter ML. The long-term results of Charnley low-friction arthroplasty in 
young patients who have congenital dislocation, degenerative osteoarthrosis, or rheumatoid 
arthritis. J Bone Joint Surg Am 1997; 79: 1599-1617.
11. Torchia ME, Klassen RA, Bianco AJ. Total hip arthroplasty with cement in patients less than 
twenty years old. Long-term results. J Bone Joint Surg Am 1996; 78: 995-1003.
CHAPTER 8
A new approach to improve cemented cup survival in primary 
total hip arthroplasty in young patients: acetabular impaction bone grafting
157
8
12. Wroblewski BM, Siney PD, Fleming PA. Charnley low-frictional torque arthroplasty in young 
rheumatoid and juvenile rheumatoid arthritis: 292 hips followed for an average of 15 years. 
Acta Orthop 2007; 78: 206-210.
13. Slooff TJ, Huiskes R, van Horn J, Lemmens AJ. Bone grafting in total hip replacement for 
acetabular protrusion. Acta Orthop Scand 1984; 55: 593-596.
14. Busch VJ, Gardeniers JW, Verdonschot N, Slooff TJ, Schreurs BW. Acetabular reconstruction 
with impaction bone-grafting and a cemented cup in patients younger than fifty years old: a 
concise follow-up, at twenty to twenty-eight years, of a previous report. J Bone Joint Surg Am 
2011; 93: 367-371.
15. Askew MJ, Steege JW, Lewis JL, Ranieri JR, Wixson RL. Effect of cement pressure and bone 
strength on polymethylmethacrylate fixation. J Orthop Res 1984; 1: 412-420.
16. Azuma T, Yasuda H, Okagaki K, Sakai K. Compressed allograft chips for acetabular 
reconstruction in revision hip arthroplasty. J Bone Joint Surg Br 1994; 76: 740-744.
17. Krause WR, Krug W, Miller J. Strength of the cement-bone interface. Clin Orthop Relat Res 
1982: 290-299.
18. MacDonald W, Swarts E, Beaver R. Penetration and shear strength of cement-bone interfaces 
in vivo. Clin Orthop Relat Res 1993: 283-288.
19. Conn R A PLFA, Stauffer R N, Ilstrup D. Management of acetabular deficiency: long-term 
results of bone grafting in the acetabulum in total arthroplasty. Trans Orthop Res Soc 1985; 
9: 451-452.
20. DeLee JG, Charnley J. Radiological demarcation of cemented sockets in total hip replacement. 
Clin Orthop Relat Res 1976: 20-32.
21. de Kam DC, Gardeniers JW, Hendriks JC, Veth RP, Schreurs BW. Cemented polyethylene 
cups in patients younger than 40 years. Clin Orthop Relat Res 2009; 467: 1753-1764.
22. Schreurs BW, Slooff TJ, Gardeniers JW, Buma P. Acetabular reconstruction with bone 
impaction grafting and a cemented cup: 20 years’ experience. Clin Orthop Relat Res 2001: 
202-215.
23. Schreurs BW, van Tienen TG, Buma P, Verdonschot N, Gardeniers JW, Slooff TJ. Favorable 
results of acetabular reconstruction with impacted morsellized bone grafts in patients younger 
than 50 years: a 10- to 18-year follow-up study of 34 cemented total hip arthroplasties. Acta 
Orthop Scand 2001; 72: 120-126.
Cemented total hip arthroplasty and impaction bone grafting in young patients
158
8
24. Welten ML, Schreurs BW, Buma P, Verdonschot N, Slooff TJ. Acetabular reconstruction with 
impacted morcellized cancellous bone autograft and cemented primary total hip arthroplasty: 
a 10- to 17-year follow-up study. J Arthroplasty 2000; 15: 819-824.
25. Lee JM, Nam HT. Acetabular revision total hip arthroplasty using an impacted morselized 
allograft and a cementless cup: minimum 10-year follow-up. J Arthroplasty 2011; 26: 1057-
1060.
26. Palm L, Jacobsson SA, Kvist J, Lindholm A, Ojersjo A, Ivarsson I. Acetabular revision with 
extensive allograft impaction and uncemented hydroxyapatite-coated implants. Results after 
9 (7-11) years follow-up. J Arthroplasty 2007; 22: 1083-1091.
27. Buma P, Donk S, Slooff TJ, Schreurs W. Bone graft incorporation after reconstruction of 
bony defects with impacted morselized bone graft. Histology of animals and patients. 
Ortop Traumatol Rehabil 2001; 3: 41-47.
28. Garcia-Cimbrelo E, Cruz-Pardos A, Garcia-Rey E, Ortega-Chamarro J. The survival and fate 
of acetabular reconstruction with impaction grafting for large defects. Clin Orthop Relat Res 
2010; 468: 3304-3313.
29. Schimmel JW, Buma P, Versleyen D, Huiskes R, Slooff TJ. Acetabular reconstruction with 
impacted morselized cancellous allografts in cemented hip arthroplasty: a histological and 
biomechanical study on the goat. J Arthroplasty 1998; 13: 438-448.
30. van der Donk S, Buma P, Slooff TJ, Gardeniers JW, Schreurs BW. Incorporation of morselized 
bone grafts: a study of 24 acetabular biopsy specimens. Clin Orthop Relat Res 2002: 131-141.
31. Schreurs BW, Zengerink M, Welten ML, van Kampen A, Slooff TJ. Bone impaction grafting 
and a cemented cup after acetabular fracture at 3-18 years. Clin Orthop Relat Res 2005: 145-
151.
32. Makridis KG, Obakponovwe O, Bobak P, Giannoudis PV. Total hip arthroplasty after 
acetabular fracture: incidence of complications, reoperation rates and functional outcomes: 
evidence today. J Arthroplasty 2014; 29: 1983-1990.
CHAPTER 8
A new approach to improve cemented cup survival in primary 
total hip arthroplasty in young patients: acetabular impaction bone grafting
159
8

CHAPTER 9
Summary and general discussion
Cemented total hip arthroplasty and impaction bone grafting in young patients
162
9
SUMMARY
The number of total hip arthroplasties performed in very young patients is increasing.1, 2 
Over the last decade, different arthroplasty techniques have been used to treat these young 
patients, who mostly suffer from secondary osteoarthritis. Non-cemented, cemented, 
hybrid and reversed hybrid techniques are used and investigated. In addition, different 
bearings, including: metal-on-polyethylene; metal-on-metal; ceramic-on-ceramic; and 
ceramic-on-polyethylene have been used. Furthermore, an increasing number of young 
patients received a resurfacing hip arthroplasty. In contrast to conventional total hip 
arthroplasties (THA), the proximal femoral bonestock is preserved in resurfacing hip 
arthroplasty. The different techniques used in young patients have shown varying success 
rates. It is important in THA for very young people to use hip implants with a proven long-
term outcome, as they will probably outlive their implant.3 Choosing an implant with 
an excellent and very reliable long-term outcome is one step to prevent early revisions. 
Alongside this, it must be kept in mind that most young people will inevitably face one or 
more revisions in their lifetime, due to their long life-expectancy. Therefore, the implant 
must also be revisable to avoid the creation of large bone stock deficiencies during revision 
surgery that involves attempts to remove the failed prostheses. Furthermore, outcome of 
the revision THA is thus influenced by the primary type of implant and the primary THA 
procedure. Respecting the bone stock, or even enhancing the amount of bone at time of 
the primary THA is of great importance for the future of the implant and any subsequent 
revisions in the young patients. Hence, both survival of the primary and subsequent 
revision THA and revisability of the implant are important outcome measurements in 
these young patients.
The main objective of this thesis was to evaluate the long-term results of the cemented 
primary and revision total hip arthroplasty in young patients under 50 years old. 
Furthermore, the long-term results of impaction bone grafting (IBG) in acetabular 
reconstructions in these young patients were evaluated. This technique includes 
reconstruction of the acetabulum with the help of auto- or allograft bone chips that are 
impacted with a metal hammer into the acetabular defect. 
Moreover, the next step of the application of impaction bone grafting was introduced. 
Nowadays, at Radboud university medical center (Radboudumc), Nijmegen, the 
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Netherlands, IBG is also used in young patients without pre-existing bone deficiencies to 
enhance their cement-bone fixation by using an additional layer. Early results are analysed 
to evaluate the use of this technique in young patients without acetabular bone stock 
deficiency. Finally, literature was studied to investigate the amount of reliable information 
available regarding the long-term outcome of primary THA and the subsequent revision 
arthroplasty outcome in cohorts of younger patients. 
In order to reach the objective of this thesis, research questions were formulated and 
answered in the next chapters. 
1. Resurfacing hip arthroplasty in younger patients: what is the state-of-the-art and 
what should we advise patients under 55 years of age?
Chapter 2 describes the developments, results and complications of the hip resurfacing 
arthroplasty. Hip resurfacing arthroplasty was re-introduced as an alternative to the 
conventional THA. Conventional THA showed suboptimal results in younger patients 
compared to elderly patients. This led to the demand and search for other solutions in 
this specific patient category. The resurfacing technique was widely adopted as the best 
solution for younger patients and its application enormously increased by the beginning 
of the 21st Century. A literature search, which we carried out in 2011, indicated that, at 
the time, not one randomised controlled trial with a minimum follow-up of 10 years, 
comparing hip resurfacing to conventional hip replacement, had been conducted in 
patients under 55 years of age. Independently, Australian- and United Kingdom Hip 
Registries demonstrated high revision rates for some brands of resurfacing implants after 
just five years. In addition to these disappointingly early revision rates, complications 
were increasingly reported, such as aseptic lymphocytic vasculitis, which was caused 
by a local tissue reaction evoked by metal particles. The resurfacing procedure received 
negative media attention in the Netherlands, leading to confusion and concern amongst 
patients. In response to this, the Netherlands Orthopaedic Association (NOV) applied 
a moratorium that advised members not to use these implants until the status of these 
devices was clearer. The same advice was also given for large head metal-on-metal 
articulations in conventional THA. To reduce patient uncertainty in this kind of situation, 
it is important to provide information about the specific type of implant used in their case.
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2. What is the long-term outcome of a cemented total hip arthroplasty in patients 
under 30 years, and what is the outcome of subsequent revisions in this group of 
patients?
Resurfacing hip prostheses have never been used at Radboudumc. A cemented THA is 
our standard procedure for all cases, with additional bone impaction grafting used in 
the presence of acetabular bone stock deficiencies. This standard procedure is performed 
even in very young patients aged less than 30 years old at time of primary surgery.
In Chapter 3, we present the long-term outcome of the primary prosthesis in patients 
less than 30 years of age, along with the outcome of their subsequent revisions. This is an 
update of a series that was initiated in 1988. The study reports on 48 consecutive patients 
(69 hips), which were all treated with a cemented primary total hip prosthesis between 
1988 and 2004.4 The mean age at time of surgery was 25 years (range 16 to 29 years).The 
mean follow-up of the primary THA was 11.5 years (range 7 to 23 years). In addition to 
the results of our primary total hip arthroplasties, a Kaplan-Meier survival analysis was 
conducted for the revisions in this group. During follow-up, 13 revisions were performed; 
in three cases a two-stage total revision was performed for septic loosening, in one case 
originally planned for one stage cup revision, positive cultures were found during cup 
revision and another nine cups were revised for aseptic loosening. Of these nine cups, 
seven were primary cemented hips without IBG, while there were only two revisions in 
the IBG group. All revisions required in this cohort were also executed with a cemented 
implant, and in all cases, except one, IBG was carried out. No aseptic stem revisions were 
performed. The 10- and 15-years survival rates with endpoint revision for aseptic loosening 
of the primary THA were 90% (95% confidence interval (CI): 79-96) and 82% (95% CI: 
65-92) respectively. The 13 revisions that were performed had a mean follow-up of seven 
years (range one to 15 years), and only one re-revision was performed 13 years after cup 
revision. Cemented total hip implants in patients under 30 years had an encouraging 
outcome at 10- and 15-years after surgery in these young patients. Combining this with 
IBG provides a durable and revisable solution for these very young patients, who will 
probably need future revisions, because they are likely to outlive their prostheses. 
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3. Can the cemented highly polished Exeter stem be used as a long-term solution in 
patients under 40 years old?
Chapter 4 describes the long-term results of the ExeterTM (Stryker-Howmedica, Newbury, 
UK) cemented femoral component. This component has been used frequently since 1991 
at Radboudumc, and from 1998 onwards, it is the standard stem used in every patient. 
We investigated all 104 cemented stems in 78 consecutive patients under the age of 40, 
who received a primary THA replacement between October 1993 and May 2004.5 The 
Exeter stems were combined with different types of cemented polyethylene acetabular 
components, and in case of an acetabular bone stock defect, IBG was performed. In one 
case, femoral IBG was added. Radiographic analyses showed that femoral radiolucent 
lines increased over time, but no relation to acetabular wear was found. At final follow-
up, 16 out of 100 non-revised stems showed stable radiolucent lines in one or more Gruen 
zones. There was no increase in the number of radiographically loose femoral components 
and, therefore, only one of the surviving stems was considered radiographically loose. In 
total, three stems were revised for septic loosening after 2.2 years, 3.4 years and 6.1 years. 
In one patient, a stem fracture occurred after 16.5 years. The broken implant was removed 
and a new cemented stem was implanted. This same patient also suffered a contra-lateral 
Vancouver B1 peri-prosthetic fracture after a fall, 11.2 years post-surgery, which was 
treated with cable grip and plating. 
No revisions for aseptic loosening were performed for any of the stems during the full 
study period. This resulted in an estimated Kaplan-Meier survival at 10-years and 17-years 
of 97.1% (95% CI: 91.3-99.1) and 92.1% (95% CI: 74.1-97.8) for endpoint revision for any 
reason and 100% for aseptic loosening (95% CI: 83.8-100) both at 10-years and 17-years. 
The clinical outcome remained good. Therefore, we conclude that the use of cemented 
Exeter femoral components is an acceptable treatment option for very young patients.
4. What are the 30-year radiographic and clinical outcomes of primary and revision 
acetabular reconstructions with impaction bone grafting in patients aged less than 
50 years old?
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In Chapter 5, the update of 42 acetabular primary and revision reconstructions with IBG 
and a cemented cup is presented, as performed in 37 patients under 50 years old, now at 
27-years to 35-years follow-up.6 
No other studies on acetabular reconstructions in young patients presenting minimal 
25-year follow-up are known in literature. Between 1979 and 1987, we performed 42 
consecutive acetabular reconstructions (23 primary, 19 revisions) using the IBG technique 
and cemented cups. Radiographic and clinical parameters, including the Harris Hip Score 
(HHS) and the Oxford Hip Questionnaire Score (OHS), were collected prospectively. 
In the Kaplan-Meier survival estimation, we treat death as a censored observation. 
However, in fact, death is another competing endpoint, alongside revision. During long-
term follow-up over 35 years, the number of patients who died throughout the study 
period, of course, increased. Therefore, the competing risk of death was incorporated by 
performing competing risk analyses (cumulative incidence function). To compare the 
cumulative incidence function of revision with the Kaplan-Meier survival analyses, we 
first calculated the estimated percentage of procedures revised as 1 – estimated survival 
percentage (1-KM). At a mean follow up of 30.3 years (range 27-35), one patient was lost 
to follow-up and seven patients died (nine hips). Radiographically, six of the 11 surviving 
acetabular reconstructions showed radiolucent lines in one or two zones of DeLee and 
Charnley. All of them were non-progressive and none of the 11 surviving reconstructions 
showed radiographic loosening. The mean HHS at time of review was 88 (range 58-99) 
and mean OHS was 20 (range 12-40).
The Kaplan-Meier survival with revision for any reason as the end-point was 40% at 
30 years (95% CI: 23-56), so the cumulative percentage of procedures revised (1-KM) 
was 60% (95% CI: 44-77). The competing risk analysis showed the cumulative incidence 
function of revision in the presence of death (CIF) was 51% (95% CI: 33-65) at 30-years. 
This illustrates that the Kaplan-Meier survival analysis results in an overestimation of 
revision for any reason at 30-years follow-up by 18%. The Kaplan-Meier survival with 
revision for aseptic loosening as the end-point was 56% (95% CI: 35-73) at 30-years, 
resulting in cumulative failure incidence (1-KM) of 44%. The competing risk analysis 
for end-point revision for aseptic loosening showed a cumulative failure incidence of 36% 
(95% CI: 17-51) at 30-years. 
These long-term results illustrate that this technique shows acceptable results when 
used in demanding primary THA and acetabular revisions and supports the use of IBG 
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as a long-term solution in young patients with acetabular bone defects. The study also 
shows that a competing risk analysis is a better method to calculate the risk for patients 
of having future revisions in the very long-term follow-up studies. 
5. What are the clinical- and radiographical outcomes of the Contemporary acetabular 
component in patients under 50 years old, with and without IBG?
Over the past few years, increased attention has been drawn to the importance of a strict 
follow-up of newly introduced implants, as well as to the long-term results of implants 
that are currently used all over the world. One of these implants is the polyethylene Exeter 
Contemporary cup (Stryker -Howmedica, Newbury UK), which has been on the market 
for nearly 20 years, and has been used in young patients at our institution for over 15 
years. This cup has two subtypes: the Contemporary hooded and the Contemporary 
flanged cup. No long-term results for young patients are described in the literature. In 
Chapter 6, we report the mid-term clinical- and radiographical results of the cemented 
polyethylene Contemporary cup in primary THA in patients aged less than 50 years old. 
In the period between January 1999 and January 2006, 152 polyethylene Exeter 
Contemporary cups were used, with and without acetabular IBG, in 126 patients aged 
less than 50 years old. At mean follow-up of 7.6 years (0.9 to 12.0), one patient was lost to 
follow-up. All clinical questionnaire scores (HHS, OHS and Visual Analogue Scale scores 
for pain in rest, pain during activity and satisfaction) had improved. Radiological follow-
up was complete for 146 implants and showed an eight-year survival for the endpoint 
radiological loosening of 93.1% (95% CI: 86.2-96.6). Eight cups were revised: five due 
to aseptic loosening after 1.1 years, 2.5 years, 3.1 years, 5.0 years and 6.0 years post-
operatively. One Contemporary hooded cup was revised for recurrent luxations at 3.5 
years and one cup showed post-traumatic loosening after 4.3 years. One Contemporary 
hooded cup without IBG was revised as part of a complete THA revision for septic 
loosening at 0.9 years. This resulted in a survival of the cups with revision for any reason 
as the endpoint of 94.4% (95% CI: 89.2-97.2) at eight years, whereas the survival of the 
cups with reason for revision aseptic loosening was 96.4% (95% CI: 91.6-98.5). 
The high dislocation rate of 5.6% that was seen in the group of patients treated 
with the Contemporary hooded cups led Radboudumc to switch to the use of only the 
Contemporary flanged cups, as it became apparent that the hooded design might cause 
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more dislocations. The large posterior rim elevation seems to function as a source of 
impingement, resulting in a higher dislocation rate. It is remarkable that these cups, 
which were specifically designed with an elevated posterior rim in an attempt to reduce 
the dislocation rate, in fact, generated more dislocations. 
6. What is known of both the survival data of primary THA and the survival of the 
subsequent revisions within the same cohorts of patients under 50 years of age?
Chapter 7 describes the results of a systematic review of the available reports in literature 
that describe cohorts of patients with both their survival of the primary implant reported 
at a mean follow-up of ten years, as well as the results of subsequent revisions of these 
same patients. In young patients it is very important to know the influence of the 
outcome of primary arthroplasty on the outcome of subsequent revision arthroplasty 
and the expected survival of these revision arthroplasties. So far, most publications 
concerning revisions of THA in younger patients include selectively included revision 
cases performed during a particular period of time. Results of these revisions are often 
published without detailed information on the characteristics of the patients and primary 
implants within the patient cohort. Furthermore, often only survival of one component 
is presented which does not reflect the total risk of re-operation for a patient. This can 
result in selective outcome reporting for revision THA, which might lead to incomplete 
information of the success of THA in younger patients and inaccurate decision-making. 
When reporting on revision THA, one should include the survival results of both 
THA components and baseline characteristics of the complete primary THA cohort 
to gain accurate information on which revision THA could be most successful for an 
individual patient. A literature search was performed to check for the availability of this 
kind of information. The study was performed according to the PRIMSA guidelines. 
Medline, Embase and the Cochrane Library were searched up to the 13th of April 2016 
was performed to find any studies that reported both the survival of primary and the 
survival of subsequent revision THA in single cohorts of patients younger than 50 years 
old. Studies were eligible if they investigated and reported on cohorts of patients who had 
received their primary THA at an age of younger than 50 years old, and if they included 
the survival outcome of subsequent revisions of the same cohort. Two independent 
reviewers assessed study eligibility and quality. 
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Kaplan-Meier analysis or competing risk analysis for revision for any reason should be 
described both for the primary THA at a mean follow-up of 10-years and the subsequent 
revision total hip arthroplasties that were performed within the same cohort. A total of 
4,799 unique records were found, of which 43 were possibly eligible, but only one met 
our inclusion criteria. In conclusion, there is a clear lack of evidence for the revision 
arthroplasty outcome in young patients. With an increasing number of young patients 
receiving a THA nowadays, we might face large numbers of patients in the future, who 
have most likely not received optimal primary and revision treatment, and as a result, 
have no further reconstructive options after failed hip arthroplasty. This will leave society 
with an increasingly costly medical burden. 
7. Can we safely use impaction bone grafting in patients without an acetabular defect 
in order to improve future long-term outcome?
Finally, Chapter 8 focuses on a new concept aimed at improving cup survival in patients 
under 50 years old, as the cup remains the ‘weakest link’ in THA. Based upon the good 
clinical results of IBG seen in younger patients throughout the years, we introduced IBG 
in patients without an acetabular defect. We believe that the application of acetabular 
IBG in primary cemented THA’s will improve bone-cement interdigitation and, thereby, 
improve cup survival, even in absence of acetabular bone stock loss. Although also some 
bone stock is added using IBG, this is not the initial goal of the procedure.
The aim of the study described in chapter 8, was to evaluate the difference in revision 
rate and early complications between patients under the age of 50 years without an 
acetabular defect, who received a straightforward primary cemented THA without IBG 
or a cemented THA with acetabular IBG. Therefore we compared two cohorts of patients: 
hips without an acetabular defect, that received a cemented cup without IBG (non-IBG 
group, n = 30) in the period of 1-1-2006 up to 2008 and hips without an acetabular 
defect that received a cemented cup after a layer of impacted bone grafts (IBG group, 
n = 29) in the period from 1-1-2008 up to 2010. All surgeries were performed by three 
orthopedic surgeons and a posterolateral approach was used in all cases. To optimize 
direct cementation (non-IBG group) or to stimulate vascularisation of the graft (IBG 
group), the acetabular bone bed was prepared with multiple two-millimeters drillholes. 
After washing and drying of the acetabulum the cups of the non-IBG group were directly 
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cemented onto the surface of the acetabulum. In the IBG group, autografts of the patients’ 
femoral head, allografts or a combination was used to create bone chips (7-10 mm size) 
which were impacted with a metal impactor and mallet. Vacuum mixed cement was 
pressurized directly into the host bone or impacted grafts and the acetabular component 
was inserted. Patients were allowed 10% of partial weight bearing in the first 6 weeks, 
followed by 50% weightbearing in the next 6 weeks. The two cohorts of patients showed 
no statistical difference in patients characteristics. Mean age at index surgery was 36.2 
(15.3-49.4) years. At time of review one patient (non-IBG) was lost to follow-up after 0.47 
years due to emigration. None of the patients died and the minimal follow-up was 2 years. 
Radiological and clinical parameters were assessed. Kaplan-Meier survival analyses were 
used to determine the survivorship of the acetabular component. No intra-operatieve 
complications related to the placement of the cups occurred. The mean additional surgery 
time was 8 minutes in the IBG group. Survival for endpoint revision for any reason for 
the non IBG group was 96.7% (95% CI: 78.6-99.5) and for the IBG group 93.1% (95% 
CI: 75.1-98.2) at two years. Three acetabular components were revised due to recurrent 
dislocations (one in the non-IBG group and two in the IBG group). All three patients 
suffered from early osteoarthritis after a pelvic trauma. One revision (IBG group) was 
performed for septic loosening. The two-year acetabular survivorship with endpoint 
revision for aseptic loosening was 100% in both the non-IBG and IBG group. Of the 55 
non revised cups, one cup (non IBG group) showed radiological loosening. Furthermore 
in the non IBG group one cup showed a non progressive radiolucent line in acetabular 
zone 1, and 2 cups in de IBG group showed progressive lines in one acetabular zone. 
This new approach might be an attractive solution for younger patients suffering from 
end-stage osteoarthritis. Intensive monitoring will be necessary, however, to evaluate 
long-term results and to check for technical advantages during the revision surgery in 
the future. In addition, studies with larger numbers are needed. Prospective randomised 
studies comparing the technique are needed to further analyse the long-term advantages. 
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GENERAL DISCUSSION
There is a worldwide trend to implant more total hip arthroplasties in patients aged 
less than 50 years old. Whereas the number of cemented THA performed in these 
young patients is decreasing, the number of uncemented total hip arthroplasties 
performed is increasing7. High revision rates were seen for uncemented metal-on-metal 
bearings.8,9 However, for metal-on-polyethylene bearings, the survival results 
for the primary cemented and uncemented THA after 10 years are, in general, 
comparable.8, 10 What exactly happens after these first 10 years is unclear and information 
regarding technically demanding cases and subsequent revision outcomes is not widely 
available. 
In this thesis, the long-term results of a cemented THA and IBG after these first 10 
years were investigated. In the very young patients (under the age of 30), who received 
a cemented total hip and in case of a bone stock defect also received IBG, we found 
a 10-years and 15-years survival rate with endpoint revision for aseptic loosening of the 
primary total hip of 90% and 82%, respectively. This survival rate is still lower compared 
to the general survival rates seen in cemented- and uncemented THA in many Hip 
Arthroplasty Registries and the Orthopaedic Data Evaluation Panel (ODEP) criteria for 
THA in general, which also includes older patients,1, 7, 8, 10, 11 but is comparable to other 
data for these young patients. However, in addition to survival, one more important 
aspect that should be taken into account in treating the young patient: the revisability of 
the prosthesis.
Cemented total hip arthroplasties have acceptable long-term survival results in young 
patients that suffer from end-stage osteoarthritis, who require technically demanding 
reconstructions of the hip joint. Therefore, orthopaedic surgeons should be able to perform 
a well-cemented THA using the third generation technique. A reduction of the technical 
skills required to perform a proper cemented THA within the orthopaedic community 
would be regrettable. This thesis also proves that revision of cemented components can be 
well performed with re-cemented components, even in the case of technically demanding 
hips, as included in this thesis. Besides fixation technique, bone stock plays an important 
role in revisability of the prosthesis. 
The restoration of bone stock deserves attention. Young patients will most likely 
outlive their primary prosthesis and the residual bone stock left after removal of the 
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failed primary THA can influence the technical aspect and survival results of the revision 
procedure. In such cases, acetabular IBG is an attractive biological way to reconstruct 
the bone stock already at their primary total hip implant. To achieve satisfying results, 
attention must be paid during the procedure to use the adequate size of bone chips (8-
12mm) and to perform the correct technique of impacting the bone chips. Small variations 
on the original technique may lead to inferior clinical outcomes. In contrast to techniques 
that use large metal cups, metal wedges or large cages,12 it can be used in combination 
with thin metal wire meshes in almost all kinds of defects. The only exception mentioned 
in literature is for very large defects, which seem to have less successful results.13 Other 
techniques that can be used in the presence of a bone stock deficiency at the primary 
implantation like bulk grafts used during primary THA have also been described, but 
the outcome of revisions with such bulky grafts are not yet available.14 So far, it remains 
unclear if these reconstructions with bulk grafts really produce more bone and facilitate 
a further hip revision.
By restoring the bone stock in cases of primary- and secondary acetabular 
reconstructions, we try to optimise the bone-cement interface, but also to create an optimal 
situation for expected future revisions. In our primary- and revision reconstructions with 
a cemented THA and IBG in patients under 50 years old, 56% survival was seen for the 
endpoint aseptic loosening at 30-years of follow-up, which is a unique result. This thesis 
shows that revisions of cemented THA’s, with or without acetabular reconstruction, can 
be performed with a cemented THA and IBG. 
Even in the absence of a bone stock deficiency, IBG may still be added to the 
acetabular bone bed in order to enhance cement-bone fixation. Our cohort study showed 
no increased risk of early complications between both cohorts. No early aseptic loosening 
was seen on the radiographs in the IBG group. These are the first results of IBG and a 
primary cemented THA in young patients without an acetabular defect. Currently, we are 
collecting and evaluating results from a larger number of patients, and to determine the 
exact behaviour of the grafts in these patients, histological studies should be performed, 
as radiographic evaluation of the grafts is not always very reliable.
This thesis also aimed at careful evaluation of the presence of radiographical signs 
of loosening of the cemented components, such as radiolucent lines and osteolysis. In 
literature, the presence of radiolucent lines and osteolysis varies widely, illustrating the 
difficulty of comparing radiographic outcomes. These different observations might be 
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due to different cup designs, the use of other criteria for reporting radiolucent lines or 
osteolysis, or a missing number of recent radiographs. All of our studies have no- or 
low numbers of patients lost to follow-up, and the criteria for radiographic analysis have 
always been the same throughout the years. We realise that in some studies we reported 
relatively high numbers of radiographic signs, such as osteolysis and radiolucent lines, 
compared to others. Interestingly, those lines often become stable radiolucent lines 
and no accelerated decline in survival of both acetabular and femoral components was 
noticed after 10-years of follow-up. Regarding the Exeter femoral stem, we observed an 
evidently higher number of radiolucent lines around the femoral components, compared 
to the 9.8% mentioned by Lewthwaite et al15 in their cohort of Exeter Universal stems in 
young patients. However, these radiolucent lines were often present in only one or two of 
all Gruen zones, and none of them progressed further to aseptic loose components. No 
relation to wear of the polyethylene acetabular component was seen. Observations like 
these should be closely monitored in the future to check for any increase in radiographic 
loosening.
Another interesting aspect revealed in this thesis is the influence of the design of 
an acetabular component on the risk of luxation. This observation stopped us using 
Contemporary hooded cups in our patients. Such observations can only be performed 
by adequate monitoring of implants. This is another illustrative example of important 
information that can be collected from cohort studies. It confirms the important 
conclusion that newly introduced implants should be carefully monitored during early 
stages for their long-term results and revisability.
Overall, a cemented THA in combination with acetabular IBG results in a biological 
reconstruction of the bone stock, and in case of long-term failure, revision is possible 
with a cemented cup and IBG. 
CONCLUSION AND RECOMMENDATIONS
This thesis proves that satisfying long-term results of the cemented total hip arthroplasties 
in young patients can be expected, when performed with adequate third generation 
cementing techniques, and, if needed, in combination with IBG. Based on the results in 
patients with acetabular bone deficiencies, we expect that there might be an indication to 
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use the IBG technique, even in young patient cases without acetabular bone deficiencies, 
as it can improve the bone-cement interface. At short-term follow-up, no additional 
risks of adding IBG to the procedure in the absence of an acetabular bone deficiency 
were found. However, further research is needed to prove the expected increase of the 
long-term survival of these fixations in young patients without an acetabular defect. In 
addition, it would be interesting to know if this technique can improve long-term patient 
satisfaction. Lastly, this thesis introduced the first step towards reporting the results 
of THA in young patients in a new way. This includes combining the outcome of the 
primary arthroplasty and the outcome of subsequent revisions within the cohort, which 
is essential information for younger patients who will most likely outlive their prosthesis. 
Future research must put more emphasis on combining these results and try to identify 
factors that positively or negatively influence the results of revision surgery. We need the 
best evidence that we can get to inform young osteoarthritic hip patients as accurately as 
possible, before he or she receives a THA surgery. In the future, we propose that research 
should be focused on:
• the long-term survival of acetabular component in combination with impaction 
bone grafting in case of absence of an acetabular bone stock defect at primary 
surgery;
• ‘patient-reported outcome measurements’ (PROMs) including long-term 
satisfaction and activity levels of patients receiving impaction bone grafting 
without any acetabulary defect;
• cost-effectiveness analysis of adding impaction bone grafting to the total hip 
arthroplasty procedure in young patients without any acetabulary deficiency;
• the revisability of primary components and the influence of the bone stock 
available at revision surgery.
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SAMENVATTING
Het aantal totale heupprothesen dat geplaatst wordt bij jonge patiënten neemt toe. In 
de laatste decennia zijn verschillende prothesiologietechnieken gebruikt om deze 
jonge patiënten, met vaak secundaire artrose van de heup (coxartrose), te behandelen. 
Ongecementeerde, gecementeerde, hybride en omgekeerd hybride technieken zijn 
gebruikt en onderzocht. Ook werd er door de jaren heen gebruik gemaakt van 
verschillende articulaties zoals metaal op polyethyleen, metaal op metaal, keramiek op 
keramiek en keramiek op polyethyleen. Daarnaast werd er de laatste jaren in toenemende 
mate de zogenaamde ‘resurfacing prothesen’ geplaatst in de jonge patiënt. In tegenstelling 
tot de conventionele totale heupprothese (THP) wordt hierbij het proximale femur intact 
gelaten. De genoemde technieken hebben allen verschillende overlevingsduuruitkomsten. 
Het is bij jonge patiënten zeer belangrijk om implantaten met een bewezen goede 
langetermijnuitkomst te gebruiken. Gelet op de nog lange levensduurverwachting 
van de jonge patiënt dient men er tevens rekening mee te houden dat de patiënt vaak 
zijn implantaat overleeft. Om deze reden dient het implantaat niet alleen een lange 
levensduur te hebben maar ook makkelijk te reviseren te zijn, zonder grote botdefecten 
te veroorzaken. Bovendien worden de uitkomsten van het revisie-implantaat beïnvloed 
door het type primaire implantaat en de operatieprocedure. Het respecteren of, indien 
nodig, het herstellen van aanwezige botconfiguratie ten tijde van de primaire THP is 
belangrijk voor de toekomst van het implantaat en de revisie-operaties in de jonge patiënt. 
Zowel de overlevingsduur van het primaire implantaat als van het revisie-implantaat zijn 
dan ook samen bepalende uitkomst-parameters in deze jonge patiënten.
Het primaire doel van dit proefschrift was het evalueren van de langetermijnresultaten 
van gecementeerde primaire en revisie-THP in patiënten jonger dan 50 jaar. Daarnaast 
werden de resultaten van impaction bone grafting (IBG) in kaart gebracht. Met deze 
techniek wordt het acetabulum gereconstrueerd met behulp van autologe of donor 
spongieuze botsnippers welke worden geïmpacteerd. Bovendien werd de volgende stap 
in de toepassing van IBG beschreven. Sinds 2008 werd in het Radboudumc te Nijmegen 
de IBG techniek ook standaard toegepast bij patiënten jonger dan 50 die geen acetabulair 
botdefect hebben maar wel in aanmerking komen voor een THP. Het doel was de 
cement-botfixatie te verbeteren door deze extra laag geïmpacteerde botsnippers. De 
korte-termijnresultaten werden geanalyseerd om het gebruik van de techniek bij jonge 
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patiënten op deze wijze te evalueren. Ten slotte werd door middel van een literatuurstudie 
geïnventariseerd wat er reeds bekend is over de overlevingsresultaten van primaire THP’s 
gecombineerd met de overlevingsresultaten van de daaropvolgende revisie-THP’s in 
dezelfde patiënten.
Om het primaire doel te behalen werden onderzoeksvragen geformuleerd en 
achtereenvolgens in de beschreven hoofdstukken beantwoord:
1. De resurfacing prothese in de jonge patiënt: wat is de stand van zaken en wat 
kunnen we patiënten jonger dan 55 jaar adviseren?
De ontwikkelingen, resultaten en complicaties van de resurfacing heupprothese wordt 
beschreven in hoofdstuk 2. De resurfacing heupprothese werd geherintroduceerd 
als alternatief voor de totale heupprothese. In vergelijking met oudere patiënten, liet 
de conventionele THP bij jongere patiënten tegenvallende resultaten zien. Daardoor 
ontstond er vraag naar andere oplossingen voor de jongere patiënten. De resurfacing 
heupprothese werd al snel gezien als dé oplossing voor deze doelgroep en in het begin 
van de 21e eeuw werd deze dan ook in een sterk toenemende mate toegepast. Bij ons 
literatuuronderzoek in 2011 werd geen studie aangetroffen waarin de resultaten van de 
resurfacing heupprothese met de conventionele heupprothese werden vergeleken in een 
gerandomiseerd onderzoek met controlegroep bij patiënten jonger dan 55 jaar en een 
minimale follow-up-duur van 10 jaar.
Voorts lieten verschillende heupregistraties, waaronder het Australische en het Engelse 
heupregister, hoge revisie-aantallen zien van enkele typen resurfacing heupprothesen 
slechts 5 jaar na implantatie. Naast de tegenvallende overlevingsduur van enkele merken 
van dit type prothesen bleken er ook complicaties zoals aseptic lymphocytic vasculitis te 
ontstaan. Deze werden veroorzaakt door losse metaaldeeltjes afkomstig van de prothese 
die een lokale weefselreactie initieerden. In Nederland kwam de resurfacing prothese 
daardoor uiteindelijk negatief in het nieuws, leidend tot verwarring en ook zorgen 
onder patiënten. In reactie hierop heeft de Nederlandse Orthopaedische Vereniging 
(NOV) besloten haar leden het advies te geven deze prothesen niet meer standaard te 
gebruiken totdat er meer over dit type en mogelijke complicaties bekend zou zijn. Indien 
een dergelijke situatie zich voordoet is het van groot belang om de patiënt correct te 
informeren over het type implantaat dat bij hem of haar is gebruikt. 
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2. Wat is de langetermijnuitkomst van een gecementeerde totale heupprothese in 
patiënten jonger dan 30 jaar en wat is de uitkomst van de daaropvolgende revisie-
implantaten in deze groep patiënten?
In het Radboudumc is de resurfacing prothese nooit gebruikt. Door de jaren heen is de 
standaard techniek altijd een gecementeerde THP geweest. Indien tevens een acetabulair 
botdefect aanwezig was, werd aanvullend IBG toegepast. Ook in het geval van hele jonge 
patiënten (<30 jaar) is dit de standaardprocedure.
In hoofdstuk 3 evalueren we de langetermijnuitkomsten van de primaire THP bij 
patiënten jonger dan 30 jaar. Tevens presenteren we de uitkomsten van daaropvolgende 
revisie-implantaten bij dezelfde patiënten. De studie betreft een vervolgstudie van een 
onderzoekscohort dat werd gevolgd vanaf 1988. De studie includeert 48 opeenvolgende 
patiënten (69 heupen) die allemaal behandeld werden met een gecementeerde THP in de 
periode 1988-2004. De gemiddelde leeftijd ten tijde van de primaire operatie was 25 jaar 
(range 16 tot 29 jaar). De gemiddelde follow-up-duur van de primaire THP was 11.5 jaar 
(range 7 tot 23 jaar). Alle revisie-operaties die werden uitgevoerd in dit cohort, werden 
wederom uitgevoerd met een gecementeerde THP en in de meeste gevallen werd ook IBG 
toegepast. Er werd een Kaplan-Meier survival analyse verricht voor de overleving van 
zowel de primaire als de revisie-implantaten in dit cohort. Gedurende de follow-up-duur 
werden 13 revisie-operaties uitgevoerd: een drietal ‘two-stage’ totale revisie-operaties in 
verband met septische loslating, één geplande cuprevisie voor aseptische loslating waarbij 
toch positieve kweken werden gevonden tijdens cuprevisie en nog negen cuprevisies voor 
aseptische loslating. Zeven hiervan waren primaire heupprothesen zonder de toevoeging 
van IBG, terwijl bij slechts twee van deze revisie-operaties IBG was toegepast ten tijde 
van de primaire operatie. Er werden geen stelen voor aseptische loslating gereviseerd. 
De 10- en 15- jaars overleving voor het eindpunt revisie voor aseptische loslating van de 
primaire THP waren respectievelijk 90% (95% confidence interval (CI): 79-96) en 82% 
(95% CI: 65-92). De 13 revisie-operaties die werden uitgevoerd hadden een gemiddelde 
follow-up-duur van zeven jaar (range 1 tot 15 jaar). Slechts één re-revisie-operatie werd 
13 jaar na een eerdere cupvervanging uitgevoerd.
Gecementeerde THP’s in patiënten jonger dan 30 jaar laten goede resultaten zien na 
10 en 15 jaar. In combinatie met IBG kan een duurzame oplossing geboden worden aan 
de jonge patiënt die in de toekomst mogelijk nog een revisie-operatie moet ondergaan 
gezien zijn lange levensverwachting.
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3. Kan de gecementeerde gepolijste Exeter-steel gebruikt worden als een 
langetermijnoplossing in patiënten jonger dan 40 jaar?
Hoofdstuk 4 beschrijft de langetermijnresultaten van de gecementeerde ExeterTM steel 
(Stryker-Howmedica, Newbury, UK). Sinds 1991 werd deze femorale component vaak 
gebruikt in het Radboudumc te Nijmegen. Vanaf 1998 is het de standaard gebruikte 
femorale component voor iedere patiënt. Voor deze vervolgstudie werden alle 104 
gecementeerde stelen in 78 opeenvolgende patiënten die een THP kregen tussen 
oktober 1993 en mei 2004 onder de leeftijd van 40 jaar, geïncludeerd. De Exeter-steel 
werd gecombineerd met verschillende typen gecementeerde polyethyleen acetabulaire 
componenten en in het geval van een acetabulair botdefect, werd IBG uitgevoerd. 
Eenmaal werd ook femorale IBG toegevoegd. De röntgenopnamen lieten gedurende de 
follow-up-duur een toename van femorale radiolucente lijnen zien. Aan het einde van de 
follow-up-duur lieten 16 van de 100 niet-gereviseerde stelen stabiele radiolucente lijnen 
zien in één of meer Gruen zones. Deze vertoonden geen verband met het optreden van 
polyethyleen wear van de cup. Er was geen toename in het aantal radiografisch losse 
stelen ten opzichte van de eerdere studie en dus bleef het bij één radiologisch loszittende 
steel. Er werden in totaal drie stelen gereviseerd voor septische loslating en wel na 2.2, 
3.4 en 6.1 jaar. In één patiënt trad er een steelfractuur op na 16.5 jaar. Het gebroken 
implantaat werd verwijderd en een nieuwe steel werd geïmplanteerd. Dezelfde patiënt 
liep aan de contralaterale zijde een Vancouver B1 peri-prosthetische fractuur op na een 
val, 11.2 jaar na de operatie, welke werd behandeld middels een trochantergripplaat en 
kabels.
Er werden geen revisie-operaties voor aseptische loslating uitgevoerd gedurende 
de gehele follow-up-duur. Dit resulteerde in een geschatte Kaplan-Meier survival na 10 
en 17 jaar van respectievelijk 97.1% (95% CI: 91.3-99.1) en 92.1% (95% CI: 74.1-97.8) 
voor eindpunt revisie om welke reden dan ook en een 100% overleving voor aseptische 
loslating (95% CI: 83.8-100) zowel na 10 als 17 jaar. Ook de klinische uitkomsten bleven 
goed. Daarom concluderen we dat de gecementeerde Exeter femorale component een 
acceptabele behandelingsmogelijkheid is voor de jonge patiënt.
4. Wat zijn de radiologische en klinische uitkomsten van acetabulaire primaire en 
revisie reconstructies met IBG na 30 jaar follow-up-duur in patiënten onder de 50 
jaar?
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In Hoofdstuk 5 presenteren we de update van 42 acetabulaire primaire en revisie-
reconstructies met IBG en een gecementeerde cup, uitgevoerd in 37 patiënten jonger dan 
50 met een follow-up-duur van 27 tot 35 jaar.
Er zijn geen andere studies bekend waarin de uitkomsten van acetabulaire 
reconstructies in jonge patiënten na een minimale follow-up-duur van 24 jaar worden 
beschreven. Tussen 1979 en 1987, werden in het Radboudumc 42 opeenvolgende 
acetabulaire reconstructies (23 primaire en 19 revisies) uitgevoerd met behulp van IBG 
en gecementeerde cups. De radiologische en klinische parameters inclusief de Harris 
Hip Score (HHS) en de Oxford Hip Questionnaire Score (OHS) werden prospectief 
verzameld. In de Kaplan-Meier survival analyse wordt overlijden als een censored event 
meegenomen. Maar eigenlijk is overlijden in feite een ander mogelijk competing eindpunt 
naast revisie van de prothese. Gedurende de lange follow-up-duur was uiteraard ook het 
aantal overleden patiënten toegenomen. Daarom werd naast de Kaplan-Meier survival 
analyse ook een competing risk analyse uitgevoerd (cumulative incidence function). 
Om de cumulative incidence function te kunnen vergelijken met de Kaplan-Meier (KM) 
survival analyse berekenden we eerst het geschatte percentage van gereviseerde prothesen 
als 1-KM. Na een gemiddelde follow-up-duur van 30.3 jaar (range 27-35 jaar) was er één 
patiënt lost-to-follow-up en waren zeven patiënten (negen heupen) overleden.
Radiologisch lieten zes van de 11 overlevende acetabulaire reconstructies radiolucente 
lijnen zien in éen of twee zones van DeLee and Charnley. Deze waren allemaal niet-
progressief en geen van deze 11 reconstructies liet radiografische loslating zien. De 
gemiddelde HHS ten tijde van review was 88 (range 58-99) en de gemiddelde OHS was 
20 (range 12-40).
De Kaplan-Meier overleving voor het eindpunt revisie om welke reden dan ook was 
40% (95% CI: 23-56) na 30 jaar. Het cumulatieve percentage gereviseerde prothesen (1-
KM) was dus 60% (95% CI: 44-77). De competing risk analyse liet zien dat de revisie-
vrije overleving gebaseerd op het cumulatieve revisie-risico voor het eindpunt aseptische 
loslating na 30 jaar 51% (95% CI: 33-65) was. 
De Kaplan-Meier overleving voor het eindpunt revisie voor aseptische loslating was 
56% (95% CI: 35-73) na 30 jaar. Dit resulteert in een cumulatief revisiepercentage (1-
KM) van 44%. De competing risk analyse voor het eindpunt aseptische loslating liet een 
cumulatief revisiepercentage zien van 36% (95% CI: 17-51) na 30 jaar. 
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Deze langetermijnresultaten illustreren dat deze techniek, welke wordt toegepast in 
uitdagende primaire THP’s en acetabulaire revisies, acceptabele uitkomsten laat zien. Ze 
ondersteunen het gebruik van IBG als een langetermijnoplossing in jonge patiënten met 
acetabulaire botdefecten. Ook laat deze studie zien dat de Kaplan-Meier survival analyse 
de kans op falen met 18% overschat voor dit eindpunt en dat de competing risk analyse 
in dergelijke situaties dus een geschiktere analyse is.
5. Wat zijn de klinische en radiologische uitkomsten van de Exeter Contemporary cup 
in patiënten jonger dan 50 jaar met en zonder IBG?
Gedurende de laatste jaren heeft het strikt vervolgen van nieuw geïntroduceerde 
implantaten in toenemende mate aandacht gekregen. Ook is er steeds meer aandacht voor 
de langetermijnresultaten van implantaten die momenteel wereldwijd gebruikt worden. 
Eén van deze implantaten is de polyethyleen Contemporary cup (Stryker - Howmedica, 
Newbury UK), welke al 20 jaar lang op de markt is en in het Radboudumc ten tijde van de 
studie al meer dan 15 jaar werd gebruikt. Deze cup kent twee varianten: de hooded en de 
flanged variant. In de literatuur zijn echter nog geen langetermijnresultaten beschreven 
van deze component in de jonge patiënt. In Hoofdstuk 6 beschrijven wij de klinische 
en radiologische middellangetermijnresultaten van de gecementeerde polyethyleen 
Contemporary cup in primaire THP in patiënten jonger dan 50. 
Bij 126 patiënten die in de periode 1999-2006 jonger dan 50 waren, werden 152 
polyethyleen Contemporary cups gebruikt, met en zonder acetabulaire IBG. Na een 
gemiddelde follow-up-duur van 7.6 jaar (0.9-12.0 jaar) was één patiënt lost-to-follow-
up. Alle klinische vragenlijstscores (HHS-, OHS- en Visueel Analoge Schaal-scores voor 
pijn in rust, pijn gedurende activiteit en de score voor tevredenheid) waren verbeterd. 
De radiologische follow-up was compleet voor 146 implantaten en liet een acht jaars 
overleving voor het eindpunt radiologische loslating zien van 93.1% (95% CI: 86.2-96.6). 
Acht acetabulaire componenten werden vervangen. Vijf vanwege aseptische loslating na 
1.1, 2.5, 3.1, 5.0 en 6.0 jaar na operatie. Eén Contemporary hooded cup werd gereviseerd 
vanwege recidiverende luxaties, 3.5 jaar na de operatie, en één cup liet posttraumatische 
loslating zien na 4.3 jaar. Eén hooded cup zonder IBG werd gereviseerd als onderdeel van 
een volledige revisie-THP in verband met septische loslating na 0.9 jaar. Dit resulteerde 
in een overleving van de cups met als eindpunt revisie om welke reden dan ook van 94.4% 
Cemented total hip arthroplasty and impaction bone grafting in young patients
186
10
(95% CI: 89.2-97.2) na 8 jaar, terwijl de overleving van cups met als eindpunt revisie voor 
aseptische loslating 96.4% (95% CI: 91.6-98.5) was.
Het hoge luxatie percentage van 5.6% dat werd vastgesteld in de groep patiënten die 
behandeld was met een Contemporary hooded cup, resulteerde in het Radboudumc in 
een stop van het gebruik van dit type cup en een switch naar het type flanged cup. De 
relatief grote verhoging van de posterieure rand van de Contemporary hooded cup lijkt 
te functioneren als een bron van ‘impingement’ waardoor er juist meer luxaties optreden. 
Dat is opvallend, aangezien dit type cup juist was ontworpen met een verhoogde 
posterieure rand om de luxatie-aantallen te verlagen.
6. Wat is er in de literatuur bekend over de overleving van primaire heupprothesen 
en de overleving van de daaropvolgende revisie-prothesen in datzelfde cohort van 
patiënten onder de 50 jaar.
Hoofdstuk 7 toont een systematische review van de beschikbare literatuur met betrekking 
tot cohorten waarbij in dezelfde slag een beschrijving plaatsvindt van zowel de overleving 
van de primaire implantaten na een gemiddelde follow-up-duur van 10 jaar als de resultaten 
van de daaropvolgende revisie-operaties. Dit is een belangrijk onderwerp aangezien het 
voor de jonge patiënt erg belangrijk is om de invloed van het type primair implantaat en 
fixatie op de daaropvolgende revisie te weten. Vergeleken met de oudere patiënt heeft de 
jonge patiënt door zijn langere levensverwachting ten tijde van de operatie een hogere 
kans op het moeten ondergaan van een revisie operatie tijdens zijn leven. Tot dusver 
worden in publicaties betreffende de revisie-THP-operaties bij jonge patiënten vaak 
geselecteerde cohorten van revisie-patiënten binnen een beperkt tijdsbestek weergegeven. 
Daarnaast worden de resultaten van deze revisie-operaties vervolgens vaak weergegeven 
zonder gedetailleerde informatie over de patiënt zelf en de primaire THP. Dit kan leiden 
tot het selectief rapporteren van uitkomsten wat kan resulteren in incomplete informatie 
over het succes van de primaire THP in de jonge patiënt en in inaccurate beslissingen. 
Daarom zou men in het geval van het rapporteren van uitkomsten van revisie-THP ook 
de uitkomsten van de primaire THP en de patiëntkarakteristieken moeten meenemen. 
We voerden een literatuur onderzoek uit om te zien in hoeverre revisie-uitkomsten op 
deze manier reeds gerapporteerd worden. Medline, Embase en de Cochrane Library 
werden daarom tot en met 13 april 2016 doorzocht op studies welke zowel de overleving 
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van de primaire THP in de jonge patiënt als de overleving van daaropvolgende revisie 
THP rapporteerden. Studies waren geschikt indien zij patiënten includeerden die hun 
primaire THP op een leeftijd jonger dan 50 jaar hadden ontvangen en daarbij zowel de 
cup- en steel-overleving van de primaire en de daaropvolgende revisie binnen hetzelfde 
cohort rapporteerden. Een Kaplan-Meier analyse of een competing risk analyse voor het 
eindpunt revisie om welke reden dan ook moest beschreven zijn voor zowel de primaire 
THP na een gemiddelde follow-up-duur van 10 jaar als voor de daaropvolgende revisies 
in hetzelfde cohort. Twee onafhankelijke reviewers beoordeelden of de studie voldeed aan 
de genoemde criteria en beoordeelden de kwaliteit van de studies. 
Er werden 4.799 unieke resultaten gevonden waarvan er 43 geschikt leken, maar 
waarvan er slechts één aan alle inclusiecriteria voldeed. Concluderend is er een duidelijk 
gebrek aan onderbouwend bewijs betreffende de uitkomsten van revisie-THP na 
primaire THP in de jonge patiënt. Met het toenemende aantal jonge patiënten dat een 
heupprothese ontvangt, kunnen we in de toekomst grote aantallen revisies verwachten 
waarbij mogelijk niet de optimale primaire en revisie-behandeling is uitgevoerd met als 
gevolg dat er voor een eventuele (re-)revisie geen goede reconstructieve mogelijkheden 
voor deze patiënten zijn. Dat zou een voor de maatschappij onwenselijke toename in 
medische zorg en kosten betekenen.
7. Kunnen we IBG veilig toepassen in patiënten zonder een acetabulair defect om op 
deze manier de langetermijnuitkomsten te verbeteren?
Deze laatste onderzoeksvraag wordt beschreven in Hoofdstuk 8 en richt zich op een 
nieuw concept om de cup-overleving in patiënten onder 50 jaar te verbeteren. Ten 
opzichte van de steel is de cup nog steeds de zwakke schakel binnen de THP. Gebaseerd 
op de goede klinische resultaten van IBG in jongere patiënten over de afgelopen jaren, 
hebben we IBG nu ook toegepast in jongere patiënten die geen acetabulair botdefect 
hadden. We denken dat door het toevoegen van IBG in primair gecementeerde THP’s 
de botcement-interdigitatie verbetert en daarmee ook de cup-overleving verlengd wordt, 
zelfs in de afwezigheid van het acetabulaire botdefect. Ook wordt de botconfiguratie van 
het acetabulum hersteld. Echter, dit is in dit geval niet het primaire doel van de procedure.
Het doel van de studie beschreven in hoofdstuk 8, was het onderzoeken of er een 
verschil is in het aantal vroege revisie-operaties en andere vroege complicaties tussen 
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patiënten jonger dan 50 jaar die een primair gecementeerde THP met of zonder IBG 
kregen in de afwezigheid van een acetabulair botdefect. Daartoe werden twee cohorten 
met elkaar vergeleken: heupen zonder een acetabular defect welke een gecementeerde 
cup zonder IBG ontvingen (non-IBG groep, n = 30) in de periode 1-1-2006 tot 2008 
en heupen zonder een acetabular defect welke een gecementeerde cup ontvingen nadat 
er eerst een laag botsnippers werd geïmpacteerd (IBG groep, n = 29) in de periode 
1-1-2008 tot 2010. De in totaal 59 operaties werden door 3 verschillende orthopedisch 
chirurgen uitgevoerd en in alle operaties werd de posterolaterale benadering gebruikt. 
Om het cementeren te optimaliseren (non-IBG groep) en om de vascularisatie van de 
graft (IBG groep) te bevorderen werd het acetabulaire botbed eerst voorbereid door er 
multipele 2 mm boorgaatjes in te maken. In de non-IBG groep werd na het spoelen en 
drogen van het botbed direct gecementeerd op het acetabulaire botoppervlak. In de IBG 
groep, werd een autograft van de oude heupkop van de patiënt, dan wel een allograft, dan 
wel een combinatie van beiden verwerkt tot botchips van 7-10 mm groot. Deze werden 
geïmpacteerd met een metalen impactor en een hamer. Het vacuüm gemixte cement 
werd onder druk direct of het bodbed dan wel op de geïmpacteerde grafts aangebracht. 
Vervolgens werd de cup werd geplaatst. Patiënten die een graft hadden ontvangen 
mochten de eerste 6 weken 10% belast mobiliseren gevolgd door 6 weken 50% belast 
mobiliseren. De twee cohorten verschilden voor wat betreft hun patiënt karakteristieken 
niet significant van elkaar. De gemiddelde leeftijd van de 59 patiënten gezamenlijk was 
36.2 (15.3-49.4) jaar. Ten tijde van review was één patiënt lost to follow-up nadat deze 
patiënt was geëmigreerd. Geen van de patiënten was overleden en iedereen had een 
minimale follow-up van 2 jaar. Radiologische en klinische parameters werden beoordeeld. 
Kaplan-Meier survival analyses werden gebruikt om de overleving van de componenten 
te bepalen. Er traden geen intra-operatieve complicaties gerelateerd aan plaatsing van de 
cups op. De operatieduur nam in de IBG –groep met gemiddeld 8 minuten toe. Voor de 
non-IB groep was de overleving na 2 jaar voor het eindpunt revisie om welke reden dan 
ook 96.7% (95% CI: 78.6-99.5) en voor de IBG groep was dit 93.1% (95% CI: 75.1-98.2). 
Drie cups werden vervangen vanwege recidiverende luxaties (één in de non-IBG groep 
en twee in de IBG groep). Bij alle drie de patiënten was er sprake van artrose op jonge 
leeftijd na een eerder trauma van het bekken. Eén revisie (IBG groep) werd uitgevoerd 
in verband met infectie. Voor het eindpunt revisie voor aseptische loslating werd in beide 
groepen een overleving van 100% na 2 jaar gezien. Van de 55 cups die niet gereviseerd 
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waren, liet 1 cup in de non-IBG groep radiologische loslating zien. Verder was er één cup 
in de non-IBG groep die een non-progressieve radiolucente lijn liet zien in zone 1 van het 
acetabulum. In de IBG-groep lieten 2 cups progressieve radiolucente lijnen zien, ieder in 
één acetabulaire zone. 
Deze nieuwe toepassing van IBG in jonge patiënten zonder acetabulair botdefect 
maar met uitgebreide (secundaire) coxartrose kan een aantrekkelijke oplossing zijn. 
Intensieve follow-up van deze groep is nodig om zowel de langetermijnresultaten 
te beoordelen als de technische voordelen ten tijde van eventuele revisie-operaties 
te kunnen bepalen. Daarnaast zijn er studies met grote aantallen patiënten nodig. 
Prospectieve gerandomiseerde studies betreffende dit onderwerp kunnen de data leveren 
om het antwoord op de volgende vraag te geven: “Levert deze techniek op lange termijn 
daadwerkelijk voordeel op voor deze specifieke groep patiënten?”
ALGEMENE DISCUSSIE
Wereldwijd worden er steeds meer THP’s in jonge patiënten geplaatst. Terwijl 
wereldwijd het aantal gecementeerde THP’s in de jonge patiënten afneemt, neemt het 
aantal ongecementeerde THP’s in deze groep juist toe. Hoge revisie-aantallen werden 
gezien voor ongecementeerde metaal-op-metaal articulaties, maar voor metaal-op-
polyethyleen articulaties zijn de 10-jaars-overlevingsresultaten voor gecementeerde en 
ongecementeerde THP’s vrijwel gelijk aan elkaar. Wat er na die eerste 10 jaar gebeurt 
is veel minder duidelijk. En informatie rondom technisch uitdagendere casuïstiek en 
rondom onvermijdelijke revisie-operaties is in verhouding summier. 
In dit proefschrift worden de langetermijnresultaten van de gecementeerde THP 
en IBG na deze eerste 10-jaar-follow-up-duur onderzocht. De hele jonge patiënten 
(jonger dan 30 jaar) die een gecementeerde THP ontvingen en waarbij in geval van een 
acetabulair botdefect ook IBG werd toegepast, lieten een 10- en 15-jaars overleving zien 
van respectievelijk 90% en 82% voor het eindpunt revisie voor aseptische loslating. Deze 
overleving is helaas nog wel lager dan de algemene overlevingspercentages voor zowel 
de gecementeerde als de ongecementeerde THP die worden gevonden in veel landelijke 
heupregisters waarin ook oudere patiënten zijn geïncludeerd. Ook de Orthopaedic Data 
Evaluation Panel (ODEP)-criteria verwachten een langere overlevingsduur van zowel 
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ongecementeerde als gecementeerde implantaten. Maar de resultaten zijn vergelijkbaar 
met die van de beschikbare data van jongere patiënten. Er is echter nog een aspect waar 
men rekening mee dient te houden in het geval van een jonge patiënt: de reviseerbaarheid 
van het implantaat.
De gecementeerde THP laat acceptabele langetermijn-overlevingsresultaten zien bij 
jonge patiënten met technisch uitdagende reconstructies van het aangedane heupgewricht 
dat onderhevig is aan eindstadium-artrose. Het is voor orthopedisch chirurgen daarom 
belangrijk om ook een goed gecementeerde prothese met behulp van de derde graads 
cementeringstechniek te kunnen uitvoeren. Het zou jammer zijn wanneer in de 
orthopedische wereld een verlies van de technische vaardigheden die nodig zijn voor 
het uitvoeren van een adequaat gecementeerde THP, zou optreden. Dit proefschrift laat 
ook zien dat een revisie-operatie van gecementeerde componenten goed uitgevoerd kan 
worden met opnieuw gecementeerde componenten, zelfs in deze soms technisch zeer 
uitdagende reconstructies zoals in dit proefschrift geïncludeerd. Naast de fixatie-techniek 
speelt ook de aanwezige botconfiguratie een belangrijke rol in het kunnen reviseren van 
een prothese.
Er dient aandacht te zijn voor het herstellen van de botconfiguratie. Jonge patiënten 
overleven vaak hun primaire prothese. Het botbed dat overblijft na het verwijderen van de 
gefaalde primaire prothese, kan van invloed zijn op de techniek en overlevingsresultaten 
van de revisie-procedure. In dergelijke gevallen is acetabulaire IBG een aantrekkelijke 
biologische manier om een eventueel aanwezig botdefect reeds ten tijde van plaatsing van 
het primaire implantaat te herstellen. Om de optimale resultaten te krijgen dient men goed 
te letten op de juiste keuze van de maat botsnippers (8-12 mm) en het correct uitvoeren 
van het impacteren van deze botsnippers. Kleine variaties binnen deze originele techniek 
kunnen tot inferieure klinische resultaten leiden. In tegenstelling tot technieken die grote 
metalen cups, metalen wigjes of grote cages gebruiken, kan IBG worden gecombineerd 
met dunne metalen meshes in ongeveer alle typen acetabulaire defecten. De enige 
uitzondering zijn de hele grote defecten. Hiervan wordt in de literatuur beschreven 
dat de uitkomst van IBG minder succesvol is. Andere technieken die in het geval van 
een botdefect ten tijde van plaatsing van de primaire THP ook gebruikt worden - zoals 
bulk grafts -, zijn wel beschreven, maar er is nog weinig bekend over de uitkomsten van 
revisie-prothesen waarbij opnieuw een dergelijke bulk graft gebruikt wordt. Tot dusver is 
het onbekend of deze reconstructies met een dergelijke bulk graft daadwerkelijk meer bot 
produceren en dus een volgende revisie-operatie vergemakkelijken. 
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Door de botvoorraad steeds weer te herstellen in het geval van zowel een primaire 
als een revisie-operatie, proberen we steeds de botcement-interface te optimaliseren, 
maar creëren we ook een optimale basis voor de verwachte toekomstige revisies. In onze 
primaire en revisie-reconstructies met een gecementeerde THP en IBG in patiënten 
jonger dan 50, zagen we na 30 jaar 56% overleving voor het eindpunt revisie voor aseptische 
loslating en 40% overleving voor het eindpunt revisie om welke reden dan ook, wat unieke 
resultaten zijn. Dit proefschrift laat zien dat revisie-operaties van gecementeerde THP’s 
met of zonder IBG, dus beide uitgevoerd kunnen worden met opnieuw een gecementeerde 
prothese en IBG.
Zelfs in de afwezigheid van een acetabulair botdefect kan IBG worden toegevoegd 
aan het acetabulaire botbed om zo de cement-botfixatie te bevorderen. Onze studie liet 
geen toegenomen risico op vroege complicaties zien. Ook werd er geen vroege aseptische 
loslating gezien op de röntgenfoto’s. Dit zijn de eerste resultaten betreffende IBG en een 
gecementeerde THP in jonge patiënten zonder acetabulair botdefect. Momenteel worden 
van een veel grotere groep patiënten de data verzameld en geanalyseerd. Om daadwerkelijk 
vast te stellen wat er met de grafts in de patiënten is gebeurd, zijn aanvullend histologische 
studies nodig aangezien radiologische beoordeling hiervan niet betrouwbaar genoeg is.
Het in dit proefschrift beschreven onderzoek is tevens gericht op een evaluatie van 
radiologische kenmerken die kunnen wijzen op radiologische loslating zoals radiolucente 
lijnen en osteolyse. In de literatuur wordt het optreden van radiolucente lijnen en osteolyse 
met zeer wisselende incidentie beschreven, wat illustreert hoe moeilijk het kan zijn om 
radiologische resultaten te vergelijken. De verschillende in de literatuur beschreven 
incidenties kunnen ook samenhangen met verschillende cup-designs, het gebruik van 
andere criteria voor het beschrijven van radiologische kenmerken of met het grote 
aantal ontbrekende röntgenfoto’s ten tijde van follow-up. Al onze studies hebben geen of 
lage aantallen patiënten die lost-to-follow-up waren en de criteria voor het beoordelen 
van röntgenfoto’s zijn door de jaren heen altijd dezelfde gebleven. We beseffen dat we 
in sommige studies vrij hoge aantallen radiolucente lijnen en osteolyse beschrijven in 
vergelijking met de aantallen beschreven in andere studies. Het is echter opvallend dat in 
onze cohorten deze radiolucente lijnen vaak stabiel blijven en er geen progressieve afname 
van de survivalcurven te zien is voor zowel de femorale als acetabulaire component na 
10 jaar als gevolg van aseptische loslating. Betreffende de Exeter steel zagen we een wat 
hoger aantal radiolucente lijnen rondom de femorale component dan het percentage 
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radiolucente lijnen (9.8%) dat door Lewthwaite et al werd beschreven in hun cohort van 
Exeter Universal stelen in jonge patiënten. Vaak waren de lijnen in onze groep aanwezig 
in slechts één of twee Gruen zones en resulteerde enige uitbreiding van radiolucentie 
rondom de steel niet in volledige radiologische loslating. Er werd geen relatie gevonden 
met het optreden van polyethyleen slijtage van de cup. Dergelijke observaties dienen in de 
toekomst goed vervolgd te worden om het eventueel alsnog optreden van radiologische 
loslating te kunnen evalueren. 
Een andere belangrijke les die geleerd werd uit één van de studies is dat het design 
van de acetabulaire component het risico op luxatie van de THP enorm kan beïnvloeden. 
Deze observatie zorgde ervoor dat we stopten met het implanteren van de Contemporary 
Hooded cups in onze patiënten. Dergelijke observaties kunnen alleen worden gedaan 
middels het adequaat vervolgen van patiënten en hun implantaten. Het illustreert hoe 
belangrijk de informatie is die men uit cohort studies kan verkrijgen. Het bevestigt, 
net als de problemen die we zagen rondom de resurfacing heupprothese, dat nieuw 
geïntroduceerde implantaten aandachtig dienen te worden geobserveerd in de vroege fase 
maar ook moeten worden beoordeeld op hun langetermijnresultaten en mogelijkheden 
tot revisie. 
Al met al resulteert een gecementeerde THP in combinatie met acetabulaire IBG in 
een biologische reconstructie. In het geval van falen is op lange termijn ook weer revisie 
mogelijk middels opnieuw een gecementeerde cup en IBG. 
CONCLUSIES AAN AANBEVELINGEN
Dit proefschrift laat zien dat acceptabele langetermijnresultaten van de gecementeerde 
THP in jonge patiënten verwacht kunnen worden indien deze middels de adequate 
derde generatie cementeringstechniek worden verricht en, indien nodig, IBG wordt 
toegepast. Gebaseerd op de resultaten in patiënten met acetabulaire botdefecten menen 
we dat er een indicatie is voor het gebruik van IBG, zelfs wanneer er geen botdefect 
aanwezig is. Het kan dan de bot-cement-interface verbeteren. In de eerste 2 jaar follow-
up werden er geen extra complicaties waargenomen welke veroorzaakt zouden kunnen 
worden door het toevoegen van IBG aan de standaardprocedure in afwezigheid van 
een acetabulair botdefect. Er is vervolg onderzoek nodig om de verwachte toename in 
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langetermijnoverleving van deze fixatie in jonge patiënten zonder acetabulair defect te 
bewijzen. Ook is het interessant om te weten of hierdoor de patiënttevredenheid kan 
verbeteren. Als laatste werd in dit proefschrift een eerste stap gezet in een nieuwe richting 
van rapporteren van uitkomsten. Meer dan bij oudere patiënten is het in het geval van 
jonge patiënten belangrijk om de uitkomst van de primaire prothese te koppelen aan de 
uitkomst van de daaropvolgende revisie-prothese aangezien deze patiënten hun prothese 
vaak zullen overleven. In toekomstig onderzoek zal daarom ook meer de nadruk moeten 
liggen op het combineren van deze resultaten met het identificeren van factoren die 
op een positieve dan wel negatieve manier de resultaten van revisiechirurgie kunnen 
beïnvloeden. We moeten blijven proberen hier zo goed mogelijk onderbouwd bewijs 
voor te krijgen. Op die manier kunnen we de jonge patiënten met coxartrose zo accuraat 
mogelijk voorzien van informatie alvorens hij of zij een THP ontvangt.
In de toekomst moeten we ons richten op:
• de langetermijnresultaten van de acetabulaire component in combinatie met 
impaction bone grafting in het geval van afwezigheid van een acetabulair 
botdefect ten tijde van primaire chirurgie;
• ‘patient reported outcome measurements’ (PROMs) inclusief de tevredenheid op 
lange termijn en het activiteitenniveau van patiënten die impaction bone grafting 
ontvangen zonder acetabulair defect;
• kosten-effectiviteitsanalyse van het toevoegen van impaction bone grafting aan 
de totale heupprothese procedure in jonge patiënten zonder een acetabulair 
defect;
• de reviseerbaarheid van primaire componenten en de invloed van de aanwezige 
botconfiguratie ten tijde van de revisiechirurgie. 
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